Western University

Scholarship@Western
Electronic Thesis and Dissertation Repository
12-3-2014 12:00 AM

Are Patients at the Centre of Care?: A Qualitative Exploration of
Myotonic Dystrophy Type 1 (DM1)
Kori A. LaDonna, The University of Western Ontario
Supervisor: Shannon L. Venance, MD, PhD, The University of Western Ontario
Joint Supervisor: Andrew M. Johnson, PhD, The University of Western Ontario
A thesis submitted in partial fulfillment of the requirements for the Doctor of Philosophy degree
in Health and Rehabilitation Sciences
© Kori A. LaDonna 2014

Follow this and additional works at: https://ir.lib.uwo.ca/etd
Part of the Nervous System Diseases Commons, and the Other Medicine and Health Sciences
Commons

Recommended Citation
LaDonna, Kori A., "Are Patients at the Centre of Care?: A Qualitative Exploration of Myotonic Dystrophy
Type 1 (DM1)" (2014). Electronic Thesis and Dissertation Repository. 2634.
https://ir.lib.uwo.ca/etd/2634

This Dissertation/Thesis is brought to you for free and open access by Scholarship@Western. It has been accepted
for inclusion in Electronic Thesis and Dissertation Repository by an authorized administrator of
Scholarship@Western. For more information, please contact wlswadmin@uwo.ca.

ARE PATIENTS AT THE CENTRE OF CARE?: A QUALITATIVE EXPLORATION
OF MYOTONIC DYSTROPHY TYPE 1 (DM1)

(Thesis format: Integrated Article)

by

Kori A. LaDonna

Graduate Program in Health & Rehabilitation Sciences

A thesis submitted in partial fulfillment
of the requirements for the degree of
Doctor of Philosophy

The School of Graduate and Postdoctoral Studies
The University of Western Ontario
London, Ontario, Canada

© Kori A. LaDonna 2014

Abstract
Health care for individuals living with myotonic dystrophy (DM1)—an uncommon, lifelimiting neurological condition for which there are few treatments—may be challenged by
patients’ symptoms including cognitive and behavioral impairments. Is patient-centered
care—which incorporates the values, experiences and expertise of patients and their
caregivers—feasible or achievable? Uncovering patients’ and their caregivers’ experiences
of living with DM1, their health care expectations, and their health care providers’ (HCP)
perspectives about care is essential for examining patient-centered care in this population.
Therefore, the purpose of this research is to: (1) add patients’ and caregivers’ voices to the
literature, (2) explore on-going care provision for individuals with DM1, and (3) probe
whether patients’ and caregivers’ needs are being met.
Forty-nine participants were purposively sampled from one academic centre in Ontario,
Canada to participate in three studies. Phenomenology, photovoice and grounded theory—
qualitative methodologies that prioritize participants’ experiences and recognize that
researchers and participants co-construct the data—were used to explore patients’,
caregivers’ and HCPs’ experiences about living— or caring for individuals—with DM1.
Semi-structured interviews were the primary data collection method; focus groups and
photographs were also used in the photovoice study. Data analysis varied by methodology.
Patient and caregiver participants’ described that DM1 symptoms—particularly fatigue and
weakness— impacted their daily activities and sense of self; however, participants were
resilient and problem-solved coping strategies. Patient and caregiver participants’
motivations for clinic attendance evolved along the disease trajectory, but most participants
perceived that clinic attendance had tangible benefits. HCPs described that their main role
was to provide hope for patients and their families. Most importantly, this research revealed
that patient, caregiver and HCP participants described clinic as a ‘safe place’ for patients and
caregivers to be understood, and to be empowered to take a proactive role in health care.
DM1 participants derived a therapeutic benefit from attending clinic despite providers’
concerns that patient-centered care was challenged by complex biopsychosocial issues. This
ii

research raises questions about whether a physician-led model is the most efficient mode of
care provision, or whether other models warrant investigation.

Keywords
Myotonic Dystrophy; caregiver; dysphagia; Huntington’s disease; patient-centered care;
qualitative research
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Chapter 1

1

Introduction

“Helping patients to be more active in consultations changes centuries of physiciandominated dialogues to those that engage patients as active participants” (Epstein &
Street, 2011, p. 100). ‘Patient-centered care’ is widely accepted as a key component of
quality health care (Institute of Medicine, 2014), and health care professionals (HCPs) are
taught and encouraged to put patients at the centre of clinical care. However, patientcentered care is poorly defined and variably enacted in practice (Berwick, 2009). What,
then, is ‘patient-centered care’, and is it achievable for all patients, particularly those
challenged by cognitive and behavioral impairments? To explore this, I used a variety of
qualitative research methodologies and methods to explore on-going clinical care
provision for individuals living with myotonic dystrophy (DM1). DM1—the most
common adult muscular dystrophy—is a chronic, progressive and life-limiting, multisystem neurological disorder in which affected individuals may experience apathy and
borderline IQ (Harper, 2001).
Research suggests that care for individuals with muscular dystrophy may be insufficient
(Hill & Phillips, 2006); in particular, care for individuals with DM1 may be complicated
by patients’ variable symptoms, their complex biopsychosocial needs, few treatment
options, or patients’ and health care providers’ divergent goals (Heatwole, 2012; Gagnon
et al, 2010; Meola & Sansone, 2007; Udd & Krahe, 2012). Despite these challenges,
only two studies have used qualitative research methods to explore perspectives about ongoing clinical care for patients with muscular dystrophy (Hartley, Goodwin & Goldbart,
2011; Nätterlund & Ahlström, 1999). Only 18 individuals with DM1 participated in this
research, suggesting that DM1 patients’ voices are relatively absent from the literature
when compared to patient populations with other uncommon neurological conditions
(LaDonna, 2011). There is also insufficient research regarding caregivers’ and HCPs’
perspectives about care for individuals with DM1.
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No exploration or evaluation of patient-centred care can be complete without including
and accounting for the voices and the experiences of the patients, caregivers and health
care providers who are at the centre of that care. The goal of this research is to add DM1
patients’, caregivers’ and HCPs’ perspectives to the literature, and to explore the current
clinical care model at one academic centre in Ontario, Canada. Three qualitative research
methodologies—phenomenology (van Manen, 1990), photovoice (Wang & Burris, 1994;
1997) and grounded theory (Charmaz, 2006)—that recognize, prioritize and emphasize
individual experience were used. In this introduction, I will locate myself within the
constructivist qualitative research paradigm, describe how I came to my interest in
patient-centered care, introduce DM1 and care provision for these individuals, describe
‘patient-centered care’, and state my research questions.

1.1 Background
Hereditary neurological conditions like DM1 may have a physical, emotional, and social
impact on individuals and their families, particularly when there are few effective
treatments and no cure. I speculate that the lack of curative treatments—coupled with
DM1 patients’ complex and variable symptom presentation—may complicate on-going,
patient-centered care provision. However, patients’, caregivers’, and HCPs’ perspectives
about patient-centered care provision (and on-going follow-up) in DM1 have not yet been
explored. I contend that any exploration is challenged by (1) the relative absence of DM1
patients’ voices from the literature, and (2) the lack of a uniform definition or
conceptualization of what ‘patient-centered care’ is, or how it is experienced in practice
(Berwick 2009).

1.1.1

Locating the Researcher

My interest in patient-centered care stems from experiences working with patients with
neurodegenerative conditions, their caregivers and health care providers in a variety of
professional contexts. I began working in the Department of Neurology at the University
of Rochester in Rochester, New York as a fifteen-year-old summer student hired to do
filing and data entry for research that explored experimental therapeutics for patients with
Huntington’s and Parkinson’s disease. This experience gave me a behind-the-scenes look
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at—and an appreciation for—the long, and sometimes arduous, process of clinical trials
research. I had the opportunity to work with international leaders in Parkinson’s and
Huntington’s disease research and witnessed first-hand their passion to try to find
answers—if not tangible treatments—that would improve the daily lives of their patients.
Their passion sparked my own interest in health research, and I pursued a dual Bachelors
of Arts degree in English and Communication with a specialization in Health
Communication. Throughout my studies, I continued with secretarial and administrative
tasks in a neurology outpatient clinic where I had the opportunity to interact with patients
and observe their relationships with their providers. My growing interest in patientcentered health care led to an internship with the Huntington’s Disease Society of
America (HDSA) where my duties included charitable fundraising, organizing patient
education and advocacy events, and serving on the Board of Directors for the HDSA
Upstate New York Chapter. In addition, I acted as a support group facilitator for patients
and families with Huntington’s disease and young onset Parkinson’s disease, an
experience that illuminated how these conditions impact patients’ and families’, and
underscored their resiliency while living with a chronic and progressive health condition.
My research career began as a clinical research coordinator for studies exploring
depression and Parkinson’s disease and the natural histories of rare neuromuscular
disorders. My work with Dr. Shannon Venance and Wilma J. Koopman, Nurse
Practitioner on a groundbreaking project exploring the transition of young men with
Duchenne Muscular Dystrophy from the pediatric to the adult neuromuscular clinic
introduced me to the impact that qualitative research methodologies and methods may
have on exploring illness experiences and health care. This research led me to pursue
graduate studies using qualitative methodologies. My doctoral research program has
provided insight into the day-to-day experiences of individuals living with chronic
neurological conditions, and emphasizes the importance of qualitative research for adding
individuals’ voices to the literature.
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1.1.2

Locating the Researcher Within the Qualitative Research
Paradigm

Guba and Lincoln (1994) define a research paradigm as a worldview that guides a
researcher’s epistemological and ontological approach to inquiry. In particular,
epistemology is a theory of knowledge that considers what can be known and the
relationship between the ‘knower’ and the ‘known’, while ontology refers to the ‘form
and nature of reality’ (Guba & Lincoln, 1994).

Common research paradigms include

positivism, postpositivism, post-modernism and constructivism. Given my personal and
professional experience working with individuals with chronic neurological illnesses, I
come to this research with assumptions, biases, and theoretical presuppositions. In
particular, I believe that individuals have the best insight into how their disease impacts
their lives, and are thus able to provide important information to health care professionals
that may improve health care. Further, researchers do not come into the research field
without leaving an imprint of their knowledge and interpretations. The interplay between
researchers and research participants is not only unavoidable, but is essential for
developing authentic and important data.
Therefore, I align myself within the constructivist paradigm. The constructivist paradigm
includes a relativist ontological position and transactional/subjectivist epistemological
position (Guba & Lincoln, 1994). Ontologically, a constructivist researcher believes that
there are multiple realities that change over time. Epistemologically, constructivists
believe that data is co-constructed between the researcher and the participant. Findings
therefore are subjective, and there is not one objective truth that can be discovered. As a
relativist, I acknowledge that meanings are fluid and constructed by the language
participants use to describe them (Finlay & Ballinger, 2006).

1.2 Myotonic Dystrophy (DM1)
Myotonic dystrophy (DM1) is a chronic, progressive, inherited and life-limiting
neurodegenerative disorder. DM1 is a multi-system condition presenting with central,
muscular, endocrine, cardiac, ocular and gastrointestinal system abnormalities; in turn,
patients may experience cognitive and behavioral manifestations, muscle weakness,
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diabetes, arrhythmias, early-onset cataracts and incontinence (Harper, 2001). Severe
disability generally occurs in the fifth and sixth decades of life (Schara & Schoser, 2006),
and respiratory failure, cardiac rhythm disturbances, and pneumonia are common causes
of death for individuals with DM1 (de Die-Smulders et al., 1998; Mathieu et al., 1999).
DM1 is caused by a CTG repeat expansion in the 3′ region of DMPK on chromosome
19q13, and is autosomal dominantly inherited; consequently, each child of an affected
parent has a 50% chance of inheriting the condition. Moreover, DM1 is characterized by
anticipation and symptoms are highly variable; that is, the condition tends to present
earlier and with greater symptom severity in subsequent generations. For example,
individuals with shorter CTG repeat expansions may experience mild or minimally
impactful symptoms while those with longer expansions may have significant physical
disabilities and cognitive impairments (Harper, 2001). Consequently, it is common for
entire families to be affected; that is, a mildly affected parent may provide care for a
severely affected child, or a non-affected caregiver may help manage the health of
multiple family members.
Researchers have developed a DM1 cognitive and personality profile suggesting that
patients may have difficulty with executive function (Sistiaga et al, 2010) and display
avoidant personality traits (Delaporte, 1998; Meola et al, 2003). However, research
examining cognitive and behavioral impairment in adult-onset DM1 is inconclusive.
Some studies have found minimal or no difference in intelligence and cognitive function
between individuals with DM1 and healthy controls (Gaul et al., 2006; Rubinsztein,
Rubinsztein, McKenna, Goodburn, & Holland, 1997; Van Spaendonck et al., 1995).
Others, however, have found significant differences (Perini et al., 1989; Perini et al.,
1999), and suggest that affected individuals have structural brain abnormalities including
white matter lesions (Minnerop et al., 2011; Tanaka, Arai, Harada, Hozumi, & Hirata,
2012) or frontal lobe impairments (Meola et al., 2003; Modoni et al., 2008; Sansone et
al., 2007; Tanaka et al., 2012). Cognition and personality may be related to patients’
CTG gene repeat length (Perini et al, Sistiaga et al, 2010) suggesting that patients with
more severe disease experience greater cognitive and behavioural challenges. However,
this was not found in a study conducted with a different cohort (Winblad, Lindberg &
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Hansen, 2005). Individuals with late onset disease and mild symptoms (i.e., smaller CTG
repeat expansions) may experience progressive cognitive decline (Modoni et al., 2004;
Modoni et al., 2008; Sansone et al., 2007) or develop focal dementia (Modoni et al.,
2004).
The DM1 cognitive and personality profile suggests that affected individuals have
paranoid or avoidant personality traits that render it difficult for them to participate in
activities or develop relationships (Delaporte, 1998; Sistiaga et al., 2010; Winblad,
Lindberg, & Hansen, 2005). Affected individuals may also experience impaired
executive dysfunction related to cognitive inflexibility (Sistiaga et al., 2010), reasoning,
planning, attention and verbal and visual memory (Antonini et al., 2006; Modoni et al.,
2008; Sistiaga et al., 2010; Zalonis et al., 2010). Depression and anxiety are variably
experienced, but may be related to central nervous system involvement (Antonini et al.,
2006), or to social withdrawal or maladjustment to living with a chronic and progressive
illness (Meola et al., 2003; Minnerop et al., 2011). Causality, however, is difficult to
determine. Cognitive dysfunction and personality traits may be an organic part of DM1
(Perini et al., 1999), or the result of limited social or educational opportunities (Bird,
Follett, & Griep, 1983; Modoni et al., 2008; Sistiaga et al., 2010).
Regardless, the impact of symptoms on DM1 patients’ health related quality of life
(HRQOL) have been described (Antonini et al, 2006; Peric et al, 2010, Laberge et al,
2013). Twenty patients with DM1 had significantly lower scores on the short-form 36
(SF-36)—a HRQOL questionnaire that assesses 8 health domains including physical and
emotional health (Ware & Sherbourne, 1992)—than the general population (Antonini et
al, 2006). In particular, findings suggest that age and disease severity are inversely
related to SF-36 scores (Antonini et al, 2006; Peric et al, 2010), and that cognition,
fatigue and mood may decrease HRQOL (Laberge et al 2013). Research suggests that
individuals with DM1 living in Quebec, Canada had low educational attainment, high
rates of unemployment, low income and were highly reliant on social assistance (Laberge
et al, 2007). Moreover, DM1-affected individuals may experience disrupted social
participation resulting from their difficulty or inability to engage in employment and
recreational activities (Gagnon, Mathieu & Noreau, 2007); the social participation of 200
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DM1-affected individuals was impacted by factors including problems navigating the
physical environment, poor access to government, health or community services, and
limited support from family or friends (Gagnon et al, 2008). Additionally, results from a
study exploring the lifestyle risk factors for 200 DM1 individuals found that being
overweight or obese, using addictive substances and being physically inactive impacted
their health. Finally, the clinical manifestations of DM1 including fatigue, weakness, and
low educational attainment and socioeconomic status may challenge patients’ ability to
engage in health promotion behaviors (Gagnon et al, 2013). Symptoms causing
decreased HRQOL—for example, constipation, cataracts, and depression— may be
amenable to treatment (Peric et al., 2013), but the complex and variable symptom
presentations may challenge care for individuals with DM1 (Heatwole et al 2012; Meola
& Sansone, 2007). It is therefore imperative to explore DM1-affected individuals’
understanding of their health, and the perspectives of caregivers and HCPs providing care
for this population.
DM1 families may experience significant psychosocial problems that may not be
adequately addressed by HCPs (Cup et al, 2011). Instead, clinicians may preferentially
monitor patients’ breathing, cardiac, and swallowing symptoms because they are the most
likely to cause serious complications or sudden and/or early death. However, these may
be challenging to identify and manage due to the multitude of physical, cognitive, and
behavioral impairments that patients may experience (Gagnon et al, 2010; LaDonna,
Koopman, & Venance, 2011).
There are no treatments to halt the progressive muscle weakness associated with DM1,
and health care providers provide surveillance for both symptomatic and asymptomatic
complications (Gagnon et al, 2010; Turner & Hilton-Jones, 2008). DM1 is relatively
uncommon, affecting approximately 1 in 8,000 individuals (Harper, 2001), therefore few
family or generalist physicians follow these patients. However, DM1 is more prevalent
in certain areas of Canada, and the prevalence of DM1 in the Saguenay-Lac-Saint-Jean
region of Quebec is 30-60 times higher than the worldwide prevalence (Mathieu, De
Braekeleer & Prevost, 1990). Consequently, extensive biopsychosocial and clinical
management research has been conducted in this region. For example, researchers in
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Quebec have proposed that DM1 patients’ complex needs—including the potential for
individuals to have limited educational, economic and social opportunities—often
requires specialist clinicians to follow a systematic surveillance and treatment plan
(Chouinard et al., 2009; Gagnon et al., 2007; Gagnon et al., 2010). Researchers have
proposed DM1 management and health supervision models that address routine
symptomatic surveillance in addition to potential life-threatening complications. At the
neuromuscular clinic where this research was conducted, cardiac conduction
abnormalities would typically be monitored with an annual electrocardiogram (ECG),
and a referral to a cardiologist would be initiated if there were any symptoms or changes
on the ECG. Similarly, pulmonary function tests and inquiry about symptoms related to
breathing help to anticipate the need for a referral to a respirologist to follow individuals
with chronic respiratory failure. Those with excessive daytime sleepiness may be
referred for a sleep study to consider the role of obstructive sleep apnea and are often
prescribed a central nervous system stimulant (e.g. modafinil or methylphenidate).
Individuals with chronic respiratory failure or sleep apnea may benefit from noninvasive
ventilation (Turner & Hilton-Jones, 2008). Often, individuals either complaining of, or
suspected of having dysphagia are sent for a swallowing evaluation and instructed on
strategies for safe swallowing. Cataracts are treated surgically. Health care providers
may assess patients’ mobility, social and recreational opportunities, employment and
financial status, and overall quality of life (Chouinard et al, 2009). Further, individuals
with DM1 may require referrals for genetic counseling, community services and
individual or family support resources (Gagnon et al, 2007; Gagnon et al, 2010).
However, the published literature suggests that clinical care for these individuals may be
complicated by their cognitive and behavioral challenges. There are reports in the
literature documenting that DM1 individuals may miss clinic appointments, poorly
adhere to rehabilitation treatment recommendations, and seem indifferent about their
health (Chouinard et al., 2009; Meola & Sansone, 2007); however, this has not been the
experience of others where DM1 individuals are found to be diligent about keeping their
appointments (personal communication, Dr. Shannon Venance). To date, there has been
no research that explores DM1-affected individuals’ motivations for maintaining ongoing clinical follow-up.
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1.3 Coming to the Question
‘Patient-centered care’ is loosely defined as “providing care that is respectful of and
responsive to individual patient preferences, needs, and values, and ensuring that patient
values guide all clinical decisions” (Institute of Medicine, IOM, 2014). Patient-centered
care approaches are taught in medical school as a marker of good patient-physician
communication that may lead to better patient self-management and improved health
outcomes (de Haes, 2006). However, de Haes (2006) contends that these improved
outcomes may be difficult to attain in practice and that “a more nuanced standpoint has to
be taken” (p. 291). It may also be difficult to evaluate patient-centered care outcomes
because ‘patient-centered care’ is poorly conceptualized and variably defined (Berwick,
2009); in turn, the lack of a cohesive definition and set of goals makes it difficult to
evaluate patient-centered care approaches, particularly when these approaches are
enacted for patients with complex needs. Regardless, researchers suggest that patientcentered care means:
Helping patients to be more active in consultations (which) changes centuries of
physician-dominated dialogues to those that engage patients as active participants.
Training physicians to be more mindful, informative, and empathic transforms
their role from one characterized by authority to one that has the goals of
partnership, solidarity, empathy, and collaboration. (Epstein & Street, 2011)
How do physicians, nurses and allied health professionals approach care for
individuals with DM1, and is it possible to take a ‘patient-centered’ care approach
with a chronic disease population that presents with cognitive and behavioral
impairments? Since the literature suggests that patients may lack awareness about
the significance of their symptoms, I speculate that the complex physical, cognitive
and behavioral clinical manifestations of DM1 may influence on-going patientcentered care provision. Others have hypothesized that cognitive impairment may
cause patients to be in denial about their diagnosis; consequently, patients may
refuse to seek information about their condition, ask for help (Nätterlund, Sjöden &
Ahlström, 2001) or miss clinic appointments because they are disinterested in their
health (Meola & Sansone, 2007). There is a paucity of research exploring DM1
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patients’, caregivers’ or health care providers’ (HCPs) experiences seeking or
providing on-going patient-centered care. This is a considerable gap because (1)
patients’ and caregivers’ voices are relatively absent in the literature and therefore
we do not know if their needs are being addressed, and (2) it is difficult—if not
impossible—to provide, examine or evaluate ‘patient-centered’ care if patients’
experiences are absent.

1.4 Qualitative Explorations of DM1
A review of the literature found few studies that used a qualitative or mixed methods
approach to explore adult DM1 (Boström, Alhström & Sunvisson, 2006; Cup et al, 2011;
Faulkner & Kingston, 1998; Geirdal, Lund-Peterson & Heiberg, 2014; Heatwole et al
2012; Nätterlund, Sjöden & Ahlström, 2001; Timman, Tibben & Wintzen, 2010); of
these, very few occur in a North American context. Moreover, most studies explore
individuals living with a range of muscular dystrophies, while only a few are DM1specific (Cup et al, 2011; Geirdal, Lund-Peterson & Heiberg, 2014; Heatwole et al, 2012;
Timman, Tibben & Wintzen, 2010). Regardless, all provide a rich description of
symptom impact on patients’ and/or caregivers’ daily lives; in particular, caregivers
describe feeling anxious—and burdened—by their family member’s complex needs
(Boström, Alhström & Sunvisson, 2006; Cup et al, 2011), and DM1 participants perceive
that their altered physical appearance and progressive functional decline impact their
sense of identity (Nätterlund, Sjöden & Ahlström, 2001). Furthermore, clinicians and
researchers interviewed 20 DM1 patients to elucidate the ‘patient reported impact of
symptoms in DM1’ (PRISM); this exploration was the first phase of a longitudinal
project intended to develop patient-centered outcome measures for clinical trials
(Heatwole et al, 2012). Findings suggest that patients and HCPs may prioritize different
symptoms; that is, participants reported that fatigue had the greatest impact on their lives,
yet citations in the literature typically consider myotonia or muscle weakness, not fatigue,
to be the primary or characteristic symptoms of DM1. Similarly, Nätterlund, Sjöden and
Ahlström (2001) used a descriptive, qualitative approach and interviewed 15 individuals
with muscular dystrophy (n =5 DM1) to explore how their lives were impacted by their
condition. Findings were condensed to create a ‘generic’ patient profile that represented
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patients’ experiences. The DM1 narrative profile suggests that patients’ worlds
essentially ‘shrink’ as their disease progresses; that is, patients are no longer able to be
employed or to participate in athletic or recreational activities that they once enjoyed.
Individuals may also have difficulty making new friends, partly because of a lack of
desire to have to continuously explain symptoms like speech impairment and frequent
falls (Nätterlund, Sjöden & Ahlström, 2001). Physical symptoms—particularly weakness
and fatigue—preclude individuals from engaging in education or employment and restrict
their recreational and leisure activities, which resonates with findings from the PRISM
study (Heatwole et al, 2012). It is possible that fatigue is widely reported and highly
impactful to patients because other symptoms—including muscle weakness, depression
or excessive daytime sleepiness—may be labeled and experienced as ‘fatigue’ (Heatwole
et al., 2012). Moreover, patients may lack awareness about their symptoms; an interview
study assessing 25 affected females understanding of DM1 found that participants’ had
variable understanding about their condition, and that their symptomatic knowledge was
sometimes informed by their personal experience and family history, not ‘book’ or
medical knowledge. The participants also had misunderstandings about prognosis and
genetic information that—in turn—were used to make important health and reproductive
decisions (Faulkner & Kingston, 1998). Regardless, weakness and fatigue seem to
significantly reduce patients’ quality of life. Consequently, findings suggest that these
are the symptoms that patients are most concerned about (Heatwole et al, 2012), not
those—like cardiac, swallowing or respiratory issues--that clinicians prioritize because of
their potential to be life-limiting.
Symptoms and functional decline may negatively impact relationships between patients
and caregivers (Cup et al, 2011), and some caregivers describe feeling burdened and
anxious about their loved one’s deteriorating health (Boström, Ahlström, Sunvisson,
2006). Geirdal, Lund-Peterson and Heiberg (2014) used a mixed methods approach—
including quality of life questionnaires and semi-structured interviews—to investigate the
quality of life of 13 individuals with DM1 and 8 caregivers. The analysis of the
qualitative findings suggests that individuals with DM1 experienced reduced quality of
life as a consequence of having to change their expectations; that is, participants
acknowledged making difficult reproductive choices, and having reduced levels of
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employment and social participation. Individuals with DM1 perceived that others judged
them as “lazy” (p. 5) because they were unemployed and limited in their ability to
participate in daily activities. In turn, caregivers reported that their quality of life was
impacted by isolation and increased responsibilities at home and at work. Life was
described as a “roller-coaster”: “Life goes up in the sense that they feel they have the
energy, and down when they feel they cannot meet expectations and desires, tasks and
challenges…” (p. 5). These findings resonate with results from a hermeneutic study in
which five couples living with DM1 were interviewed to explore the effect of DM1 on
their relationship (Cup et al., 2011). The couples described that the challenges of living
with—and managing—DM1 was akin to the “give and take” of marriage, but that
patients’ functional decline required couples’ to renegotiate their roles and reconsider
their social and leisure activities. The experience of caregiving may depend on whether it
is done out of love or out of a sense of obligation (Boström, Ahlström & Sunvisson,
2006).
However, despite the significant challenges that patients and their caregivers face—and
evidence that patients and clinicians prioritize different symptoms--there are no studies
that explore DM1 patients perspectives regarding on-going, clinical care. However, a
phenomenological approach was used to explore the experiences of patients with various
muscular dystrophies (n= 16 DM1) at a multi-disciplinary rehabilitation program in
Sweden (Nätterlund & Ahlström, 1999). Patients reported that they felt listened to and
understood by expert HCPs who provided them with information about their condition,
support and strategies to cope with their illness-related challenges. They also appreciated
having the opportunity to interact with others living with similar conditions. These
findings resonate with a qualitative study that explored the experiences of adults with
neuromuscular disease (n =1 DM1) who attended a neuromuscular rehabilitation centre in
the United Kingdom (Hartley, Goodwin & Goldbart, 2011).

1.4.1

Gaps

While the perspectives of patients living with other uncommon neuromuscular conditions
like amyotrophic lateral sclerosis and Duchenne muscular dystrophy are well-represented
in the literature, there are relatively few studies that use qualitative research to explore
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the experiences of individuals living with DM1 (LaDonna, 2011). It is possible that
researchers and clinicians do not use qualitative methodologies and methods with DM1
patients because of their perception that individuals with DM1 are likely to have
significant cognitive or behavioral impairments. For example, researchers who explored
the illness experience of patients living with muscular dystrophy excluded some
individuals with DM1 because of difficulty understanding their speech (due to
oropharyngeal muscle weakness) and cognitive impairment (Nätterlund, Sjöden &
Ahlström, 2001). Furthermore, the authors noted “these conditions prevented them from
reflecting deeper upon their situation” (Nätterlund, Sjöden & Ahlström, 2001, p. 790).
As a result of limited qualitative research exploring DM1-affected individuals
perspectives about their health care, we do not know if the voices of those with DM1 are
being heard by clinicians and researchers, or if their clinical and psychosocial needs are
being met. Moreover, no studies provide an exploration of health care providers’
experiences providing on-going care for individuals along the DM1 disease trajectory.
Therefore, we know little about clinicians’ approaches, or whether HCPs perceive that
they are meeting patients’ needs. The multi-system nature of DM1 makes it an important
condition to explore because findings may have implications for a host of complex,
chronic conditions that present with multiple co-morbidities.

1.4.2

Purpose

The purpose of this research was to explore patients’ and caregivers’ experiences of
living with DM1, including their health care expectations and motivations for
maintaining on-going clinical care in an outpatient neurology clinic. This research also
sought to explore HCPs perspectives about care provision for persons living with DM1. I
chose a qualitative research approach to: (1) add patients’ and caregivers’ voices to the
neuromuscular disease literature, (2) explore on-going care provision for individuals with
DM1, and (3) probe whether patients’ and caregivers’ clinical and psychosocial needs are
being met. Finally, I was interested in exploring what patient-centered care provision
‘looks like’— if it is feasible, and if it occurs—in DM1 clinical care. Therefore,
individuals with DM1 and their caregivers were recruited from a neuromuscular clinic at
one academic centre in Ontario, Canada. To facilitate a deeper exploration of patient-
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centered care provision in chronic neurological conditions, I invited patients with
Huntington’s disease (HD), their caregivers and health care providers to participate in a
study exploring motivations for clinic attendance. HD is an uncommon neurological
movement disorder characterized by involuntary movements, progressive physical and
cognitive decline, and significant psychiatric manifestations including depression,
anxiety, obsessions, and psychosis (Roos, 2010; Sturrock & Leavitt, 2010). DM1 and
HD have a number of similarities: (1) both conditions are autosomal dominantly inherited
and characterized by anticipation, (2) they have highly variably clinical manifestations
that include motor, cognitive and behavioral features, (3) present with complex
biopsychosocial issues, and (4) there are no treatments to cure, slow, or reverse
neurodegeneration. The purpose of adding an exploration of care provision in HD was
not to compare the two populations; instead, the goal was to add breadth and depth to
how care at one academic centre is provided for patients with chronic neurological
disease who present with cognitive and behavioral impairments.

1.5 Research Summary
This research includes three studies that produced five manuscripts (Figure 1; Table 1).
The perspectives of 49 participants are included in this research; details about the
research setting and study sample are described in the relevant chapters. Twenty-one
patients including 13 individuals with adult-onset DM1 and 9 individuals with HD, 16
caregivers (n= 8 DM1) and 11 HCPs participated. The HCPs included 5 neurologists,
two specialist physicians including a psychiatrist and a respirologist, a nurse, two social
workers and a physiotherapist. Of note, one individual with DM1 participated in two
studies.

Figure 1-1 : Dissertation Research
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1.6 Chapter III: Hard to Swallow: A Phenomenological
Exploration of Caring for Individuals with Myotonic
Dystrophy and Dysphagia.
The literature suggests that cardiac, respiratory and swallowing dysfunction are the most
life-threatening symptoms in DM1—and the symptoms that clinicians may preferentially
monitor—because they have the propensity to cause serious complications including
sudden death (Garrett, DuBose, Jackson, & Norman, 1969). Dysphagia should be one
symptom that clinicians, patients and caregivers can proactively address through
education, evaluation and dietary management. The literature suggests that caregivers for
patients with other chronic illnesses that present with dysphagia are responsible for
managing their loved one’s diet and responding to choking emergencies (Johansson &
Johansson, 2009), therefore, the purpose of this study was to explore the experience of
caring for an individual with DM1 and known dysphagia. Phenomenology—a qualitative
research methodology that explores lived experience (van Manen, 1990)—was used, and
individuals with DM1 and dysphagia (by physician report) were approached by their
health care provider and asked to identify a caregiver and provide him or her with a letter
of information about the study.

Six caregivers consented to participate in interviews

about their caregiving experiences. The interview transcripts were transcribed verbatim
and analyzed by considering participants’ experiences in the context of their “lived
body”, “lived time”, “lived space” and “lived relations”.

1.7 Chapter IV: Picturing the Experience of Living with
Myotonic Dystrophy: A Qualitative Exploration Using
Photovoice.
Following the exploration of the caregivers’ perspectives, I was interested in exploring
patients’ experiences of living with DM1. Since the literature suggests that patients may
have cognitive, behavioral and speech impairments, an innovative approach for
conducting research with this population was warranted. Therefore, photovoice—a novel
qualitative visual research methodology that was developed to engage participants with
low literacy as research collaborators (Wang & Burris, 1994; 1997)—was used to explore
participants’ illness experiences and the barriers and facilitators to living successfully
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with DM1. Nine participants were given digital cameras and asked to “take pictures of
what it is like to live with DM1”; in turn, participants’ photographs stimulated individual
interviews and focus group discussions. The purpose of this study was (1) to use an
innovative qualitative research methodology to explore the experiences of living with
DM1, (2) to identify barriers and facilitators to living successfully with DM1, and (3) to
assess if photovoice is a useful methodology to use to conduct research in this population.

1.8 Chapter V: Truths and Misinformation: A Qualitative
Exploration of Myotonic Dystrophy Type 1.
While analyzing the data from Picturing the Experience, it became evident that
participants had variable knowledge about their condition, and “Truths and
Misinformation” – a theme that was identified during data analysis for the Picturing the
Experience study—warranted a deeper exploration. Therefore, I worked with two
clinicians to conduct a content analysis of this theme to examine how participants talk
about—and make sense of—their condition. Transcripts were re-read and re-coded to
determine patients’ understanding of DM1—including their awareness or misinformation
about symptoms, treatment and prognosis; in turn frequently occurring codes were
collapsed into themes and categories, and supporting quotations were extracted from the
data set.

1.9 Chapter VI: “[The Neurologist] is Throwing you a Raft”:
Exploring Motivations for On-going Clinic Attendance
for Individuals Living with Chronic, Progressive and
Life-limiting Neurological Conditions.
The literature suggests that individuals with DM1 and HD may lack awareness about
their symptoms (Boström & Ahlström, 2005; Hoth et al, 2007) and our findings resonate
with previous literature suggesting that individuals with DM1 have variable knowledge
about their condition (Laberge et al, 2010; Faulkner & Kingston, 1998). Given the lack of
disease-halting or curative treatment options for DM1 or HD—coupled with the potential
that patients are disinterested in their health and unaware of problematic symptoms—it is
unknown why individuals with these conditions maintain regular, on-going follow-up at
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an outpatient neurology clinic. Therefore, this research sought to elucidate patients’ and
caregivers’ motivations for clinic attendance and their health care expectations, and HCPs
perspectives about care provision for these conditions.
Constructivist grounded theory (CGT)—a qualitative research methodology that studies
basic social processes to generate an explanatory theory—informed the iterative data
collection and analysis process (Charmaz, 2006; 2014). 14 patients (n=5 DM1), 10
caregivers (n=2 DM1), and 11 HCPs (n=5 neurologists; 2 specialist physicians; a nurse;
two social workers and a physiotherapist) participated in semi-structured interviews that
were transcribed verbatim and coded using words or phrases that represented the
participants’ experiences. DM1 and HD data were not analyzed separately, and the
themes and categories represent the perspectives of patients, caregivers, and HCPs from
both groups.

1.10 Chapter VII: “We Like to Think We’re Making a
Difference”: Health Care Providers’ Perspectives About
Caring for Individuals with Myotonic Dystrophy and
Huntington’s Disease.
The HCPs’ perspectives about motivations for clinic attendance for individuals with
DM1 and HD warranted a deeper exploration and were presented in a separate
manuscript; this analytical project used the same data collection and analysis procedures
as the previous study.

1.11 Acknowledging the Boundaries
In summary, my doctoral research has three main goals: (1) to use qualitative research
methodologies and methods to explore the experiences of patients, caregivers and health
care providers who live with—or provide care for—individuals living with myotonic
dystrophy, (2) to add patients’ and caregivers’ voices to the largely biomedical
neuromuscular literature, and (3) to explore what DM1 care ‘looks like’ at one academic
medical centre in Ontario, Canada. The purpose of this research, however, is not to
evaluate patient-centered care in DM1 because: (1) there is not a uniform definition or
conceptualization of patient-centered care, therefore rendering it impossible to evaluate,
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(2) the literature does not yet report whether ‘patient-centered care’ is implemented,
feasible or achievable in DM1 care, and (3) DM1 patients’ and caregivers’ perspectives
are under-represented in the literature suggesting that the ‘patient’ is not currently present
in conversations about DM1 ‘patient-centered care’. Rather, the intention of this research
program is to contribute to a scholarly conversation about patient-centered care provision
in DM1.
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Chapter 2

2

Methodologies and Methods

This chapter describes the background and theoretical underpinnings of phenomenology,
photovoice and grounded theory, and describes the methods associated with these
methodologies. Methodologies and methods are distinct; methodologies are guiding
frameworks that are based on conceptual, theoretical, or philosophical foundations, while
methods are the tools used to conduct research within the framework of the chosen
methodology (Finlay, 2006). For instance, an in-depth or semi-structured interview is a
frequently used research method for many qualitative methodologies like
phenomenology, photovoice or grounded theory (van Manen, 1990; Wang & Burris,
1994; 1997; Charmaz, 2006; 2014). The researcher’s choice of methodology and method
generally reflects his or her research question and location along the spectrum of
qualitative research paradigms. Therefore, a researcher located within the positivist
research paradigm might choose to combine statistical analysis with a traditional
grounded theory approach (Glaser & Strauss, 1967), while critical theorists—who are
located on the opposite end of the spectrum—would be more likely to use methodologies
and methods based on participatory action research or feminist theory (Finlay, 2006). I
align myself within the constructivist paradigm because I do not believe that there is an
‘objective truth’ that can be discovered; rather, I believe that truth is subjective and that
meaning is influenced—and therefore co-constructed by—researchers’ and participants’
experiences. Consequently, I chose three qualitative research methodologies—
phenomenology (van Manen, 1990), photovoice (Wang & Burris, 1994; 1997) and
constructivist grounded theory (Charmaz, 2006; 2014)— that recognize how individual
experience and the research setting may influence data collection, analysis and findings.
Following a description of the methodologies, considerations for ensuring the
trustworthiness of qualitative research data will be discussed.
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2.1 Participants and Research Setting
The specific data collection and analysis procedures for each study will be described in
Chapters III-VII. However, all research participants were recruited from one academic
medical centre in Ontario, Canada. At this centre, one neuromuscular physician—with
clinical support from a nurse practitioner and/or medical students, residents or fellows—
provides care for most DM1 patients within the specialist’s general adult muscle disease
clinic. Patients are typically followed every six months to two years (depending on
need), and the clinic staff has access to other specialist physicians and allied health
professionals including a social worker, dietician, occupational therapist and a
physiotherapist on a referral basis. However, the allied health professionals typically
only see DM1 patients on a one-time referral basis for a specific issue. Huntington’s
disease patients (who were explored in Chapters VI and VII) may be seen by any of the
four movement disorder specialists at the centre, but most are followed in a dedicated
Huntington’s disease clinic that is held once a month. At the HD clinic, a neurologist,
psychiatrist and social worker typically conduct clinic visits concurrently. At both
clinics, caregivers and other family members may also access clinic staff.

2.2 Chapter III: Hard to Swallow: A Phenomenological
Exploration of the Experience of Caring for Individuals
with Myotonic Dystrophy (DM1) and Dysphagia
The purpose of this study was to explore the lived experience of caregivers for
individuals with DM1 and swallowing dysfunction. Participants were posed with an
open-ended question about the experience of caring for someone with DM1 and
dysphagia. To follow-up, participants were asked to describe their caregiving duties,
ideas about strategies for safe swallowing, their opinions about their loved one’s
perceptions of DM1 and swallowing dysfunction, and the impact of DM1 on their lives.
A phenomenological research approach was chosen to explore the lived experiences of
caregivers for individuals with DM1.
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2.2.1

Methodology: Phenomenology

Phenomenology is both a philosophy and a research methodology that encompasses a
variety of European and North American traditions (Dowling, 2007; Earle, 2010). The
philosophy of phenomenology was developed in early 20th century Germany to discuss
the idea of truth (Dowling, 2007), and the ‘father of phenomenology’, Edmund Husserl,
devoted much of his work to understanding “what is real and valid, what constitutes
evidence, and what is the relationship between the knower and the known” (Todres,
2005, p. 104). In particular, Husserl (1970) was interested in the lifeworld (Lebenswelt)
and essences, and he sought to understand human experience by examining things as they
appear. Husserl was interested in intentionality, reduction and the constitution of meaning
- concepts that continue to influence the various and evolving phenomenological
traditions (Earle, 2010). Intentionality invokes the ability of humans to be aware of, and
to be able to reason and communicate about objects in their lifeworld (Earle, 2010). For
Husserl, this understanding should be pre-reflexive. To do this, Husserl proposed that
individuals engage in phenomenological reduction to ‘bracket’ or set aside their
knowledge and their preconceptions about an experience; that is, individuals should
attempt to understand a phenomenon without a cultural context (Dowling, 2007),
preconceived theoretical ideas (van Manen, 1997), or interpretations (Dowling, 2007).
Through intentionality and reduction, individuals are able to identify the essences and
meaning of an experience (Earle, 2010).
Husserl was primarily interested in the description of experiences (Earle, 2010).
However, the writings of Martin Heidegger, a student—and later critic—of Husserl
shifted phenomenological inquiry from descriptive to interpretive (Dowling, 2007).
Heidegger’s main interest surrounded the meaning of Being, or the individual’s presence
in the world, and he differed from Husserl in his belief that to understand an experience is
more important than describing it (Dowling, 2007). Heidegger’s Being and Time (1927)
focuses on the meaning of being in the world (Dasein) (Earle, 2010). For Heidegger,
exploring existential concepts like temporality (i.e., the past, present and future) is
essential for understanding being, and he criticized Husserl’s ideas of intentionality and
reduction (Dowling, 2007; Earle, 2010). In particular, Heidegger believed that it is
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impossible to set aside one’s assumptions and pre-conceptions about an experience.
Instead, Heidegger proposed the idea of the hermeneutic circle in which individuals
examine the ‘parts and whole’ of a phenomenon by continuously examining and
comparing their pre-suppositions and understandings of an experience with the unfolding
essence of being (Earle, 2010).
French philosopher Maurice Merleau-Ponty’s work evolved from the writings of Husserl
and Heidegger, but he emphasized the “primacy of perception” (Dowling, 2007, p. 134).
Merleau-Ponty was interested in viewing experiences pre-reflexively, not using predefined categories, and he was particularly interested in exploring the existentials of lived
space, lived time, lived human relation, and lived body (Dowling, 2007). The next
generation—or New Phenomenologists—follow the tenets of either interpretive (e.g.
Heidegger or Merleau-Ponty) or descriptive phenomenology (Husserl). However, Max
van Manen (1990) incorporates both interpretive and descriptive phenomenology in his
version of the methodology. Further, van Manen views phenomenological inquiry and
analysis through the lens of the four existentials of being in the world, and also considers
the role of the researcher in data collection and analysis (van Manen, 1990).
In her monograph titled Illness: The Cry of the Flesh (2008), philosopher Havi Carel
argues that the naturalistic approach to illness is insufficient for understanding the life
changing impact that chronic illness has on an individual. Thus, Carel makes a strong
argument for using phenomenology to study the experiences of individuals living with
chronic illness. In particular, Carel believes that “phenomenology does not deny the
importance of the physiological description or of the clinical interventions offered by
current mainstream medicine. It does, though, propose to augment this approach to
illness by emphasizing the importance of the first person experience” (2008, p. 8).

2.2.2

Method: Van Manen

One of the difficulties facing novice researchers undertaking a phenomenological
exploration is that there is no uniform method to collect or analyze data (Caelli, 2000).
Van Manen (1997), however, articulates an approach to human science research that
engages researchers in six research components: (1) to explore a phenomenon of interest;
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(2) explore this experience as lived rather than as it is conceptualized; (3) reflection on
essential themes; (4) describing a phenomenon through the art of writing; (5) remaining
orientated to the phenomenon, and (6) being mindful of the ‘parts and wholes’ of the
research context.
Van Manen describes several possibilities for data collection and analysis; however he
cautions against using these suggestions as a ‘prescription’ for phenomenological work.
Instead, he encourages researchers to approach the question creatively.
Phenomenological research views the lifeworld as the “source and object” of inquiry;
therefore, the “nature of data” (van Manen, 1997, p. 53) can take many forms including
the researcher’s personal experience, research participants’ descriptions, observation,
biography, literature and art. In particular, interviews with research participants may
serve two purposes: (1) to explore a participant’s experiences to gain a deeper
understanding of a phenomenon, or (2) to embark on a conversation with a participant to
explore the meaning of an experience (van Manen, 1997). Van Manen (1997) suggests
asking participants a concrete question about a phenomenon, then encouraging them to
describe anecdotes, incidents, and stories regarding this experience. It is not necessary to
ask a litany of questions; rather, participants should be given the freedom to articulate
their experience. The researcher may then use probes to gain a deeper understanding of
the participant’s narrative.
Once data has been collected, the researcher reflects on the findings to try to understand
their meaning. Van Manen (1997) distinguishes between the researcher’s pre-reflective
and reflective understanding of an experience; that is, one may be able to describe that
life is regulated by time, but have difficulty discussing what time actually means or ‘is’.
Therefore, “the insight into the essence of a phenomenon involves a process of
reflectively appropriating, of clarifying and of making explicit the structure of meaning
of the lived experience” (Van Manen, 1997, p. 77). This may be done in a variety of
ways including thematic analysis. Thematic analysis may be explored using a holistic,
selective, then detailed approach (van Manen, 1997). During the holistic or sententious
approach, the researcher reads the text as a whole, then writes a sentence or phrase that
captures the essence of the narrative. Next, the researcher may highlight statements or
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phrases that exemplify the experience as lived. Finally, the researcher reads each
sentence or sentence cluster in detail to determine what they ‘reveal’ about the
phenomenon being explored. Once a list of themes has been drafted, the researcher may
return to the participants to ask them to reflect on the findings to ensure that the themes
resonate with their experience. Therefore, participants become active collaborators in
interpretation and analysis.
Van Manen suggests using the lifeworld existentials of corporeality, spatiality,
temporality and relationality as guides for hermeneutic phenomenological reflection.
These four existentials may guide the way humans experience the world (van Manen,
1997). Corporeality refers to the idea that humans are always “bodily in the world” (p.
103). Van Manen describes how human bodies may unconsciously ‘reveal’ or ‘conceal’
aspects of the human experience; that is, he suggests that one may behave awkwardly
when looked at by another critically, or conversely, develop grace when gazed at
admiringly. Spatiality refers to “felt space” or “the world or landscape in which human
beings move and find themselves at home” (p. 102). How one experiences a physical
space gives meaning to a phenomenon, and influences how an individual feels in certain
situations. For example, one may feel small in a large, open space, or feel lost or
vulnerable in an unfamiliar space (van Manen, 1997). Van Manen argues that, in a sense,
humans become the space they inhabit. Temporality, or lived time, is subjective time
rather than ‘clock’ time. The idea that ‘time flies when you’re having fun’ speaks to
temporality, and the past, present and future make up an individual’s “temporal
landscape” (van Manen, 1997, p. 104). Finally, relationality refers to the lived relation
individuals have with each other in a shared space. Relationality may confirm—or not—
notions one has of others.
Writing is an intrinsic part of the phenomenological research process that should occur
simultaneously with data collection and analysis, not simply as a means to report findings
(van Manen, 1997). In order to balance the ‘parts and wholes’ of the research context,
researchers should have an understanding of how the study will be conducted and how
the text may be structured, but that researchers are free to flesh out these details and make
decisions as the study unfolds (Earle, 2010; Van Manen, 1997).
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2.3 Chapter IV: Picturing the Experience of Living with
Myotonic Dystrophy (DM1): A Qualitative Exploration
Using Photovoice / Chapter V: Truths and
Misinformation: A Qualitative Exploration of Myotonic
Dystrophy
The purpose of the study described in Chapter IV was to use photovoice—an innovative
qualitative research approach— to explore the experience of living with DM1. Nine
participants were given a digital camera and asked to take pictures of ‘what it is like to
live with DM1’. The goals of this study were to elucidate individual experience about
DM1, to identify barriers and facilitators to living successfully with DM1, and to assess
whether photovoice is a useful methodology for conducting research with this population.
One theme identified during data analysis was titled DM1: Truths & Misinformation, and
pertained to affected individuals understanding or misperceptions about DM1. The
purpose of the paper described in Chapter V was to provide a deeper exploration of this
theme and to examine patients’ variable understanding of their condition, and the
potential implications of ‘truths & misinformation’ for patient-centered care provision.
Content analysis (Miles & Huberman, 1994) was used in conjunction with participantdirected analysis to analyze the data for both studies.

2.3.1

Methodology: Photovoice

There seems to be a debate amongst researchers as to whether photovoice is a
methodology, a method, or both. A scan of titles produced during a literature search
illustrates this confusion. That is, titles—even by the author who conceptualized
photovoice—variably refer to photovoice as a method or a methodology (Wang & Burris,
1997; Baker & Wang, 2006). I argue that Wang and Burris (1994; 1997) originally
intended photovoice to be a method for Participatory Action Research (PAR), but that
photovoice has since evolved into its own distinct methodology, yet continues to be used
as a data collection method for other methodological approaches (Plunkett, Liepert &
Ray, 2013). A scoping review of the photovoice literature found that 55% of the 191
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studies use photovoice as the sole methodology and method for data collection and
analysis, while 45% use photovoice as method for other qualitative or quantitative
methodological approaches (Lal, Jarus & Suto, 2012).
Regardless, photovoice is rooted in—and shares many of the philosophical and
theoretical conceptualizations as—PAR. Both methodologies are located within the
critical research paradigm and are a “systematic investigation, with the collaboration of
those affected by the issue being studied, for the purposes of education and taking action
or effecting social change” (cited in Minkler, 2000). Social psychologist Kurt Lewin
(1946; 1952) coined the phrase “action research” to describe a cyclical research process
that includes planning, action, observation and evaluation. Both PAR and photovoice
were influenced by Paulo Friere’s work on critical consciousness (Freire,1970; FalsBorda, 1987; Wang & Burris, 1994; 1997); in particular, Freire was an educator and
proponent of problem-focused education and believed that a student can be an educator
while the teacher can become a student. In turn, a problem or opportunity for change is
identified by a group of community members who then work together with a researcher
to determine where and how to make improvements (McTaggart, 1991; Minkler, 2000).
“Put simply, action research is the way groups of people can organize the conditions
under which they can learn from their experiences and make this experience accessible to
others” (McTaggart, 1991, p. 170). PAR and photovoice distinctly differ from research
done to or on research participants (McTaggart, 1991). Instead, PAR and photovoice
strive to include participants in all stages of the research process, from the
conceptualization of the question, to data collection and analysis, and finally to
dissemination of the findings and decision-making about actions to change or improve
community outcomes (McTaggart, 1991). In PAR and photovoice studies, participants
are viewed as experts about their experiences and community concerns, and are engaged
as active collaborators on important research decisions (Wang & Burris, 1994; 1997).
Attention to power differentials is an important component of both methodologies,
particularly because there may be a real or perceived power imbalance between academic
researchers and participants (Wang & Burris, 1994; 1997).
However, photovoice –which was developed by Wang and Burris (1994; 1997) as a
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needs assessment tool to explore the reproductive health issues of rural Chinese
women—has combined aspects of a number of methodologies and theories to form its
own distinct methodology with innovative data collection and analysis procedures.
Originally titled photo novella, Wang and Burris (1994) created their method based on
concepts from educator Paulo Freire (1970), feminist theory, and documentary
photography. In particular, they emphasize the use of female intellect and experience to
inspire problem-posing education and individual development for personal and social
change. Ultimately, Wang and Burris (1994) believe that the visual image is a powerful
conduit for discussion and change because photographs provide evidence and validation
of community concerns.
There are three major goals of photovoice: (1) to have community members record their
perceptions of the strengths and weaknesses of their surroundings, (2) to use photography
to encourage dialogue among community members, and (3) to disseminate this
information to policy makers (Wang & Burris, 1997). Arguably, the most important
aspect of photovoice as a needs assessment tool is that participants become advocates for
change (Wang & Burris, 1997), and to empower participants by putting “cameras directly
in the hands of people who otherwise would not have access, and allows them to be
recorders, and potential catalysts, in their own communities” (Wang & Burris, 1994).
Photovoice adds humanity to data (Wang, Burris, & Ping, 1996) thus, participants, not
researchers, determine what is important to document and discuss with peers, academic
researchers, and policy makers.
Photovoice has been used with adult and children in a variety of contexts including
explorations of homelessness (Aitken & Wingate, 1993; Fortin, 2014), motherhood
(Booth, 2003) and child and adolescent programs (Berinstein & Magalhaes, 2009).
Additionally, it has been widely used in health research to explore a variety of chronic
illnesses including HIV/AIDS (Kubicek et al, 2012; Moletsane et al, 2007), cancer
(Lopez et al, 2005), chronic pain (Baker & Wang, 2006) and mental illness (Andonian,
2010); moreover, it is becoming an important research methodology to explore patients
with complex needs including speech, cognitive and behavioral impairments. In
particular, it has been successfully used to explore chronic neurological disease
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populations including spinal cord injury (Newman, 2009; 2010), traumatic brain injury
(Lorenz & Kolb, 2009), dementia (Genoe & Dupuis, 2013), stroke (Levin et al, 2007),
Alzheimer’s disease (Wiersma, 2008; 2011), and with Huntington’s disease caregivers
(Aubeeluck & Buchanan, 2006).

2.3.2

The Photovoice Method: Data Collection and Analysis

While there are no set guidelines for a photovoice study, descriptions from Wang and
Burris (1994) suggest that a photovoice study might include an orientation session, focus
groups and/or individual interviews, and a forum to disseminate findings. Camera
orientation sessions should be tailored to the culture of the community, and ethics, power
regarding data ownership and dissemination, camera operation, and guiding principles
about the project are typically discussed (Wang & Burris, 1997). In particular, the
authors suggest that facilitators guide participants about the appropriate and ethical way
to approach others to be in pictures, the ethics of taking pictures without the knowledge
of others, the criteria to be used when analyzing photographs, and the personal and
societal implications of taking pictures and sharing them publicly.
While Wang and Burris (1997) suggest that the discussion of camera use should be
minimal to prevent “stifling creativity” (p. 378), it is important to ensure that participants
are comfortable operating the camera. A significant portion of the camera orientation
session should be devoted to discussing ethics, power, and data ownership. Participants
should be reminded that confidentiality is of utmost importance, and that anything shared
during interviews or focus groups will be de-identified prior to dissemination. Further,
participant names or faces (unless specific permission is granted) will never be published.
Importantly, the camera orientation session might include a discussion about academia
and the desire for researchers to publish findings or present at conferences. However, the
participants should be free to determine if and how they wish to disseminate findings.
An individual interview is an opportunity for participants to discuss as many of their
photographs as they wish, and to offer insight that they may be unwilling to share in a
group setting. It is important that participants guide the discussion by choosing and
discussing the implications of their photographs. Participants are also encouraged to
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keep a journal or log book of what they photographed and why. It is also important to
note what a participant was either unable to, or chose not to, photograph. Log books may
serve as guideposts for the interview discussion and become an important part of data
analysis. It may be advantageous at this stage to ask participants about the benefits and
challenges associated with participating in the project. Another strategy to facilitate the
participants’ participation in data collection and analysis might be to ask participants to
title each of their photographs.
There is no singular method for analyzing photovoice data, and authors (Oliffe &
Bottorff, 2007; Oliffe, Bottorff, Kelly, & Halpin, 2008) have chosen a variety of
analytical approaches. However, Wang and Burris (1997), and Wang and RedwoodJones (2001) describe their data analysis methods. Wang and Burris (1997) offer
guidelines for data analysis, and they reinforce that participants are an integral part of this
process. In particular, the authors discuss a three-stage approach to analysis in which
participants select, contextualize, and codify the data. By selecting which photographs to
discuss, the participants guide the first step of data analysis. Participants then
contextualize their photographs by describing why they chose to capture certain objects,
people or settings, and therefore give meaning to their images. This part of the analysis
typically occurs during the individual interview or focus group session when participants
have the opportunity to discuss how their photographs relate to community issues and
personal experiences. Finally, participants codify the photographs through discussion of
emerging themes, theories, and issues embedded in their photographs and collective
experience. Participants therefore engage with researchers to analyze the data; in turn,
researchers use their own experiences and expertise to co-construct findings.
In addition, several studies have used content analysis (Hergenrather, Rhodes, & Clark,
2006; Thompson, et al., 2008) or tenets from grounded theory (Lopez, Eng, RandallDavid, & Robinson, 2005) to analyze data. Lopez et al. (2005) chose to blend grounded
theory and photovoice to “provide the means for participants to move beyond merely
reporting results to policy and decision makers to suggesting strategies and participating
in developing interventions tailored to specific conditions of their social context” (p.
101).
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2.3.3

Ethical Considerations

Wang and Redwood-Jones (2001) write extensively about the ethical considerations of
the photovoice method. In particular, the authors discuss privacy laws and note that
intrusion into public spaces, disclosure of embarrassing issues, being placed in a false
light, and using a person’s likeness without compensation are serious concerns that must
be addressed throughout the process. In terms of a photovoice project, participants must
understand that photographers create meaning by capturing and interpreting a subject or
location (Wang & Redwood-Jones, 2001). Also, the authors discuss the importance of
ensuring participants that they own their photographs by giving them the negatives of all
of their pictures. Also, when possible, subjects of photographs should be provided
compensation if their images are disseminated publicly. In particular, camera orientation
facilitators should ask participants to reflect on the responsibilities of using a camera,
how to respectfully approach someone about having his or her picture taken, and how to
minimize risks to self and others (Wang, 2004 #38).
Informed consent is an integral part of the photovoice project. Participants should be
given a consent approved by a university ethics board describing the purpose of the
study, their rights and responsibilities, and their willingness to allow their images to enter
the public domain. While participants may not be required to obtain consent when taking
a group photograph in a public setting where individuals are non-identifiable (Wang &
Redwood-Jones, 2001), participants should provide their photography subjects with a
separate consent outlining the study and the rights of those having their pictures taken. In
particular, all identifiable subjects should understand how and why their image will be
used, and that no image shall be published or disseminated publicly without their written
consent. As with all research studies, consent is a process that should be revisited
throughout the project.

2.3.4

Considerations and Benefits

Since photovoice is an innovative and relatively new methodology, the conceptual and
theoretical underpinnings need to be critically examined (Guillemin & Drew, 2010),
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particularly since there is considerable debate whether photovoice is a PAR method or its
own distinct methodology. Also, using cameras to document experiences may be a
novel concept that may be challenging for some participants, and in-depth discussions
about the purpose of the research and instructions about how to use the camera are crucial
and should be re-visited throughout the research process (Guillemin & Drew, 2010).
Further, Foster-Fishman, Nowell, and Deacon (2005) discuss the importance of
understanding the impact that a photovoice project may have on both the participants and
their community. Thus, these authors argue that it is essential to ask participants to not
only discuss their photographs, but to ask them about their experience using the method,
and how the project impacted them. Potential impacts of participation may include
enhanced self-competence, greater awareness of their environment, and the potential for
photovoice projects to result in increased resources for social and political action (FosterFishman, Nowell, Deacon, Nievar, & McCann, 2005). However, one must be cognizant
of the negatives that may be encountered by being both the participant in, and the subject
of, publicly disseminated photovoice data. In particular, participation may have negative
political consequences (Wang & Burris, 1994), or participants may fear public disclosure
of personal health issues. Therefore, questions of who owns the photos and data are
important to consider and communicate with participants: “This is particularly pertinent
during analysis, when considering questions of who had control over the camera and the
image-making moment, and whose understanding or experience is being represented in
the image; the commentary of participants is crucial in understanding this element of
construction of the visual story” (Guillemin & Drew, 2010). It is difficult—if not
impossible—to know the extent to which the researcher may influence what and how
participants choose to capture their experiences. Guillemin and Drew (2010) are
interested in the concept of the ‘audience’ for a photovoice project—and the role of the
researcher in particular-- and suggest that ‘audience’ is a concept that needs to be
explored.

2.4 Chapter VI: Understanding Motivations for Clinic
Attendance and Expectations for Care for Individuals
with Myotonic Dystrophy (DM1) and Huntington’s
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Disease (HD) / Chapter VII: “We Like to Think We’re
Making a Difference”
The studies that will be presented in Chapters VI and VII sought to elucidate patients’,
caregivers’ and health care providers’ perceptions about the motivations for patients with
DM1 and HD to maintain regular follow-up at an outpatient neurology clinic despite the
lack of curative treatments. Participants were asked to describe a ‘typical’ clinic visit,
and to reflect on their expectations of—or approaches to—health care. Constructivist
grounded theory (Charmaz 2006) guided the iterative data collection and analysis
process. A deeper exploration of HCPs perspectives about providing care for individuals
with DM1 and HD is explored in Chapter VII.

2.4.1

Methodology: Constructivist Grounded Theory

Grounded theory is an appropriate methodology to use to study the process of motivation
and decision making for individuals with a chronic neurological illness who choose to
receive regular care in an outpatient clinic despite the lack of a cure or treatment to slow
the progression of their disease. Not only is grounded theory a relevant methodology to
use when little is known about a topic (Stanley, 2006), but Charmaz (1990) argues that
research using grounded theory may offer physicians an exploration of patients’ views
that cannot be gained during a clinic visit. In particular, study findings may encourage
better communication between doctors and patients, and focus attention on concerns that
patients identify (Charmaz, 1990). Constructivist grounded theory (Charmaz, 2006), the
proposed methodology for this project, is a version of grounded theory that considers the
interplay of the researcher and the research participant in co-constructing the data.
However, prior to proposing a constructivist grounded theory approach, it is important to
understand the evolution of the grounded theory methodology.

2.4.1.1

Methodology

Grounded theory was first introduced in the 1960s by sociologists Barney Glaser and
Anselm Strauss as a methodology to generate theory that is grounded in data. The
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ultimate purpose of grounded theory is to use induction, deduction, and verification to
develop a theory about a social phenomenon (Schwandt, 2007). In particular,
practitioners of grounded theory use their preliminary data analysis to guide data
collection, and iterative data collection and analysis inform emerging theory (Charmaz,
2003).
Glaser and Strauss’ book The Discovery of Grounded Theory (1967) was written at a time
when qualitative research was losing prestige and quantitative methods were gaining
momentum. Following World War II, quantitative research that gathered evidence to test
theories gained momentum, thus consigning qualitative methods to data gathering or
exploratory tools for survey development. In other words, qualitative research was useful
for generating hypotheses, but then quantitative research would “take over” to test
theories (Glaser & Strauss, 1967, 16). Glaser and Strauss (1967) responded by arguing
that both quantitative and qualitative data are useful and important for verifying or
generating theory, and they proposed a methodology in which “qualitative analysis had
its own logic and could generate theory” (Charmaz, 2006, p. 5). Charmaz (2008) argues
that Glaser and Strauss’ work legitimized qualitative research. According to Glaser and
Strauss (1967), a grounded theory study should include the following: an iterative process
of data collection and analysis, codes and categories that are grounded in the data, a
constant comparative method, theory development at each stage of research, memo
writing, theoretical sampling, and a literature review that is conducted after the analysis.
However, the guidelines and methods for study conduct may be flexible and emerge
throughout the process (Charmaz, 2008).
According to Charmaz (2006), Glaser and Strauss each brought experiences from their
respective training at Columbia University and the Chicago school culture while
developing grounded theory. In particular, Glaser wanted researchers to develop middlerange theories, and he “imbued grounded theory with dispassionate empiricism, rigorous
codified methods, emphasis on emergent discoveries, and its somewhat ambiguous
specialized language that echoes quantitative methods” (p. 7). Strauss emphasized the
importance of process, problem-solving, the study of action, and subjective meanings.
Further, the grounded theory of Glaser and Strauss is influenced by symbolic
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interactionism. Symbolic interactionism, both a theory about human behavior and an
approach for studying it (Annells, 1996), defines an individual as being socially
constructed, and argues that individuals use social interaction processes to navigate their
world (Stanley, 2006). This definition is based on the work of social psychologist
George Herbert Mead (1962) who proposed that individuals define themselves through
social interactions and perspectives. In other words, “humans come to understand social
definitions through a socializing process” (Annells, 1996, p. 381). Blumer (1969)
extended Mead’s work by coining the term ‘symbolic interactionism’ and proposing three
basic tenets about the concept: (1) the meanings that individuals ascribe to others,
objects, or situations will determine their actions towards them, (2) meanings stem from
social interactions, and (3) individuals undertake an interpretive process to determine or
modify meaning in a situation. Annells (1996) notes that these concepts are open to
criticism and interpretation by scholars, calling social interactionism a “microsociological
theory” (p. 381) because it focuses on the individual, not the larger social environment.
However, despite criticisms, practitioners of grounded theory assume that reality is a
social construct and that theory can be derived from the social processes individuals
experience to make sense of a phenomenon.
Glaser and Strauss eventually disagreed about the direction grounded theory should take,
and Strauss collaborated with Juliet Corbin to evolve the methodology (Strauss & Corbin,
1990). Traditionally, grounded theory reflects a positivist and objectivist worldview that
assumes an external reality, although Strauss and Corbin moved grounded theory into a
more postpositivist light by advocating for unbiased data collection, and a fair
representation of the participants’ voices (Charmaz, 2003; Strauss & Corbin, 1990).
Strauss and Corbin offered specific procedures for conducting a grounded theory study in
Basics of Qualitative Research (1990), but Charmaz (2008) argues that this caused
researchers to design their studies too concretely. Despite the evolving nature of
grounded theory, Charmaz (2003) argues that all forms espouse strategies including
simultaneous data collection and analysis, emergence of themes, discovery of basic social
processes, category construction that explain these processes, theoretical sampling, and
the integration of categories into a theoretical framework. Traditional grounded theory is
paradigmatically aligned with postpositivism and based in critical realist and objectivist

46

philosophies. However, a version of grounded theory that emphasizes subjectivity and a
relative perspective is moving the methodology into the constructivist paradigm (Annells,
1996; Charmaz, 2006).

2.4.1.2

Constructivist Grounded Theory

In response to her position as a social constructionist researcher, Charmaz adapted the
methodology she named constructivist grounded theory (2006; 2008). In contrast to
Glaser and Strauss who did not consider that the researcher might influence the analysis
(Charmaz, 2008), researchers using constructivist grounded theory assume that there are
multiple realities, and that the researcher and the research participants co-construct and
analyze the data (Charmaz, 2003; 2006). Constructivist grounded theory argues that data
does not reflect an objective reality; that is, the data offers a view of the participants’
world that is influenced by time, by cultural and structural contexts, and by the
researcher, the participants, and the research process (Charmaz, 2003; 2006; 2008).
Therefore, constructivist grounded theory methods are tools for discovery, not conveyors
of truth. Further, researchers also have preconceptions, experiences, and biases that may
color the research experiences and must be handled reflexively. Charmaz (2006)
suggests that the research question should shape the research methods, and she offers
suggestions for conducting a grounded theory study including strategies for sampling,
semi-structured interviews, data analysis, memoing, and for assessing the quality of a
study.

2.4.2

Data Collection: Sampling

Initially, purposeful sampling is done to identify participants who may provide rich data
about the research question (Charmaz, 2006). However, theoretical sampling is a core
component of grounded theory that is useful once data is analyzed through constant
comparative methods and themes and categories begin to emerge. Theoretical sampling
is a strategy used to flesh out emerging categories and theory (Charmaz, 2006). In
particular, a researcher may ask participants new questions, or follow-up with, or recruit
new participants. Memo writing is a useful tool for determining the direction of
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theoretical sampling. Theoretical sampling is particularly useful for identifying the
characteristics of a category, identifying relationships between categories, to make the
analysis more abstract, to ground the theory in the data, and to make analytic connections
between categories (Charmaz, 2006).
Finally, theoretical sampling may lead to saturation of theoretical categories. Categories
are considered saturated when no new insights are forthcoming, although Charmaz
(2006) cautions that saturation is not the same as seeing similar phrases or events.
Moreover, early saturation may result if the researcher does not critically analyze
categories. To evaluate whether saturation has been reached it is important to have a
good understanding of the comparisons of category properties and of the relationships
between categories. It is then important to assess if and how these comparisons provide
theoretical insight, specifically if new relationships or themes need further development.
Saturation is achieved when no new patterns or abstract analyses between categories
emerge (Charmaz, 2006).

2.4.3

Data Collection: Semi-Structured Interviews

Charmaz (2003) offers a guideline for conducting constructivist grounded theory
interviews that focuses on locating a participant’s story within a basic social process.
According to Charmaz, interviews begin by defining a central problem (e.g., “Tell me
about what happened when you were first diagnosed with condition of interest?”) and
evolve as the researcher and participant co-construct the data. Constructivists emphasize
the importance of context, whether of the interview, the participant’s experience, or the
context of the research question within larger society (Charmaz, 2003). Since
constructivist grounded theorists are attempting to uncover the social processes that shape
events, interview questions should reflect symbolic interactionism, and “be sufficiently
general to cover a wide range of experiences as well as narrow enough to elicit and
explore the participant’s specific experience” (Charmaz, 2003, p. 315). Charmaz
suggests using a conversational interview style using open-ended questions. The
interview script will likely evolve as participants are interviewed and new questions arise
(Charmaz, 2003), thus multiple interviews with each participant may be necessary to

48

fully explore emerging themes and to ensure that data saturation is reached. This is
especially important considering that multiple realities exist, and that perceptions and
experiences may change over time. Charmaz (2003) also argues that multiple interviews
serve as “independent checks” (p. 318) and allow the researcher to probe for more details
that may enhance emerging theory.

2.4.4

Data Analysis

The process of data collection and data analysis is iterative and emergent, and grounded
theory coding occurs in three phases including an initial phase in which the researcher
codes a word, line, or segment of data, a focused phase that uses the most frequently
occurring initial codes to sort and organize the data, and theoretical coding to analyze
increasingly abstract ideas about the data (Charmaz, 2006). Charmaz (2006) argues that
the researcher is not “neutral” (p. 46) when coding because he or she codes using
language that is based on a particular worldview. Charmaz (2006) suggests using action
codes during initial coding (namely gerunds), arguing that this prevents the researcher
from developing theories too early. In addition, in vivo codes, codes using the symbolic
language used by participants, may be useful for merging common phrases into the
theory (Charmaz, 2006). Initial codes should be open-ended and “grounded” in the data.
Importantly, the initial codes provide the researcher with the tools to understand where
more information needs to be collected, to flesh out data, and to determine the “fit and
relevance” of the data (Charmaz, 2006, p. 54). Initial coding may be conducted word-byword, line-by-line, or incident-by-incident.
After a list of codes has been developed, and a number of transcripts have been reviewed,
Charmaz (2006) suggests that the next step is focused coding. Focused coding is done to
organize the data using the initial codes that occur most often, and it checks the relevance
and analytic value of the initial codes (Charmaz, 2006). At this stage, some codes will be
collapsed into themes. Constant comparative methods are an integral part of focused
coding (Charmaz, 2006).
Constant comparative methods (Glaser & Strauss, 1967) are an important part of
grounded theory analysis, and are used to collapse codes into more abstract categories.
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Stanley (2006) describes that constant comparative analysis involves comparing all coded
data within each category to move from simple description of categories to theory.
Constant comparative analysis in grounded theory includes comparisons of participants’
responses, the data from the same participant at different time points, incidents, data with
categories, and a comparison of categories with categories (Charmaz, 2003; Ghezeljeh &
Emami, 2009). By using constant comparative methods, statements made in the same
interview are compared, and then they are compared with statements in other interviews
(Charmaz, 2006). Constant comparison is an on-going process that occurs throughout
data collection and analysis.
The final step in grounded theory coding is theoretical coding. Theoretical coding
involves assessing the relationships between data coded during focused coding (Charmaz,
2006). At this point, it is helpful to draw diagrams to help sort the data, and to make
comparisons between categories to begin to develop theory. Glaser (1978) argued for the
six C’s to examine categories based on causes, consequences, contexts, contingencies,
covariance, and conditions. Charmaz (2006) argues that using these categories can
strengthen the analysis and the emerging theory. Theoretical coding both guides
theoretical sampling and identifies relationships between categories (Stanley, 2006).
Theoretical sorting, diagramming, and integrating are important components of theory
development in grounded theory (Charmaz, 2006). Theoretical sorting of memos
encourages theory evolution by abstractly combining and comparing categories
(Charmaz, 2006). Sorting and diagramming may be useful tools for organizing data and
integrating categories (Charmaz, 2006).

2.4.5

Memoing

Memoing is a critical analytical and reflexive tool for grounded theorists, and Charmaz
(2003) considers memoing the step that bridges coding with drafting the research report.
The purpose of memoing is to record hypotheses and thoughts about emerging themes,
and to reflect on the interaction between the researcher and the participants as themes
evolve from the data (Mills, Bonner, & Francis, 2006). Memoing may also increase
abstract thinking (Charmaz, 2006), and a memo provides a schematic for how thoughts,
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data collection, codes, and categories evolve (Ghezeljeh & Emami, 2009). However,
constructivist researchers should keep abstract thinking firmly grounded in the data that
was co-created by the participant and the researcher (Mills, Bonner, & Francis, 2006).
Importantly, memo writing is essential for capturing the researcher’s biases and
preconceptions, the interplay of researcher and participant, and other elements that
influence the data (Mills, Bonner, & Francis, 2006).

2.4.6

Developing Theory

“Interpretive theory calls for the imaginative understanding of the studied phenomenon.
This type of theory assumes emergent, multiple realities; indeterminacy; facts and values
as inextricably linked; truth as provisional; and social life as processual” (Charmaz, 2006,
p. 127). Theory is established by making connections between, and asking questions
about, the data, which leads to abstract thinking (Charmaz, 2006). Using gerunds to code
data, and studying processes are helpful tools for theory development. Charmaz (2006)
cautions against coding for themes rather than actions which may lead to descriptions
rather than theory. Again, memo writing is an integral part of theory development
because it enables the reader to think carefully about the data and connect categories
(Charmaz, 2006).

2.4.7

Assessing Qualitative Research: Trustworthiness

This section describes procedures that can enhance the rigor of qualitative research;
specific strategies used to ensure the trustworthiness for each study will be described in
Chapters III-VII and discussed in Chapter VIII.

The constructivist paradigm

acknowledges the importance of the researcher, including her/his opinions, beliefs, and
perceptions, in co-constructing data (Morrow, 2005). Researcher bias is both
acknowledged and embraced. Thus, reflexivity—the practice of engaging in an “explicit
and self-aware meta-analysis of the research process” to evaluate if and how findings are
influenced by “subjective and intersubjective elements” (Finlay, 2002, p. 531)—is an
essential component of qualitative research that allows the researcher to examine her/his
own biases, perceptions, theories, and worldview in order to understand how they help
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shape the data. There is no consensus amongst qualitative researchers about how to best
assess the rigor and quality of qualitative inquiry (Rolfe, 2006; Sandelowski & Barroso,
2002; Morse et al, 2002). One widely accepted approach is to use criteria including
credibility, transferability, dependability and confirmability to evaluate the
trustworthiness of qualitative research (Guba, 1981; Lincoln & Guba, 1985). This
approach corresponds to criteria—including internal validity, external validity and
generalizability, reliability and objectivity –that is commonly used to evaluate positivist
or quantitative research (Guba, 1981; Shenton, 2004).
Lincoln & Guba (1985) consider credibility to be the primary and perhaps most
significant criteria for evaluating the trustworthiness of qualitative inquiry. Credibility—
the degree to which a “true picture” (Shenton, 2004, p. 63) of the research question and
participants’ responses is portrayed—can be enhanced by a number of strategies
including—but not limited to—triangulation, member checking, iterative data collection
and analysis, frequent debriefing sessions with advisors, and peer review of the study
findings (Shenton, 2004). Transferability reflects whether findings resonate with—or can
be applied—to other settings. Researches need to provide sufficient detail about the
research setting and the participants in order for a reader to be able to decide whether
findings are applicable elsewhere. Dependability—often difficult to achieve in
qualitative work (Shenton, 2004) because findings are based on the interpretation and coconstruction of data between researchers and participants —can be established by
providing adequate details about study design and methods for another researcher to
follow the data collection and analysis procedures and recreate the study. Finally,
methods described previously—including triangulation and sufficient detail about
research methods and setting—can help readers assess the confirmability of qualitative
research. The researchers’ reflexivity and an audit trail of research procedures is
important for establishing confirmability; that is, researchers must demonstrate that
findings ‘emerged’ or were identified through rigorous data collection and analysis, and
are therefore not the result of the researchers own biases and preconceived ideas
(Shenton, 2004).
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2.5 Summary
This chapter includes a description of the research setting and study participants, a
summary of phenomenology, photovoice and grounded theory, and strategies for
ensuring the trustworthiness of qualitative research. Proponents of all three
methodologies state that the proposed methods are flexible, and that researchers do not
have to adhere to them prescriptively. Instead, methods may be modified to fit the context
and goals of the study, to encourage creativity, and to meet the needs of the participants
(Charmaz, 2006; van Manen, 1990; Wang & Burris, 1994; 1997). A detailed description
of the data collection and analysis procedures for each study will be described in the
relevant chapters.
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Chapter 3

3

Hard to Swallow: A Phenomenological Exploration of
the Experience of Caring for Individuals with Myotonic
Dystrophy (DM1) and Dysphagia

3.1 Abstract
Background: Myotonic Dystrophy (DM1), a genetic, multi-system disorder, is the most
prevalent adult form of muscular dystrophy. Dysphagia is a common symptom that may
be difficult to diagnose and treat and can be associated with increased morbidity and
mortality. Pre-existing cognitive impairment or apathy, both well described in the DM1
literature, may contribute to management challenges. Caregivers may become important
for managing a family member’s swallowing dysfunction. While clinicians place great
importance on swallowing difficulties, it is unknown how dysphagia impacts patients and
their caregivers. Therefore, the purpose of this study was to explore the experiences of
caregivers living with those with DM1and dysphagia.
Methods: An interpretive phenomenological approach was used to study the lived
experience of six caregivers for individuals with DM1 and dysphagia. Audio-taped semistructured interviews were used for data collection, and data was analyzed using van
Manen’s steps for phenomenological analysis.
Results: Despite the potential for dysphagia to cause morbidity and mortality in DM1
individuals, caregivers did not describe this as a problematic symptom. Instead, they
described more debilitating symptoms like fatigue or weakness and discussed the
caregiving experience. Themes pertaining to participants’ lived body, lived relationality,
lived time and lived space were identified.
Conclusion: Health care providers need to balance issues of clinical concern with those
that are important for individuals and their family members. Assessments of caregiver
knowledge and burden at each clinic visit may be warranted.
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3.2 Introduction
Myotonic dystrophy (DM1) is an inherited, chronic, and progressive neuromuscular
disorder that may occur rarely at birth (congenital form) or more commonly manifest
during adulthood. Given the autosomal dominant inheritance, DM1 generally affects
roughly 50% of every generation of a family. Complications of DM1 include muscle
weakness, fatigue, hypersomnolence, cardiac conduction deficits, cognitive dysfunction,
apathy, and gastrointestinal manifestations including dysphagia (Harper, 2001; Turner &
Hilton-Jones, 2010).
Dysphagia is defined as difficulty swallowing foods or liquids safely that may result in
malnourishment or an aspiration pneumonia that occurs when foreign substances enter
the lungs (National Institute on Deafness and Other Communication Disorders [NIDCD],
2014). Swallowing difficulties are common in DM1, and may affect between 25% to
80% of patients (Bellini et al., 2006; Ronnblom & Danielsson, 2004). Individuals
experiencing dysphagia may report coughing while eating, heartburn, chest pain, or
reflux (Bellini et al., 2006). Dysphagia may cause embarrassment and lead to decreased
social participation, low self-esteem, and poor quality of life. Relationships with
caregivers may also be negatively affected by an individual’s inability to share meals
(Ekberg, Hamdy, Woisard, Wuttge-Hanning & Ortega, 2002; Plowman-Prine et al.,
2009). Health care professionals consider dysphagia particularly serious in DM1 due to
the risk of sudden death from choking (Garrett, DuBose, Jackson, & Norman, 1969).
Moreover, in addition to respiratory failure and cardiac problems, aspiration pneumonia
is a common cause of death for individuals with DM1 (de Die-Smulders et al., 1998;
Mathieu et al., 1999; Turner & Hilton-Jones, 2010).
However, diagnosis of dysphagia in DM1 is complicated because patients rarely
complain about or describe difficulties with their swallowing. Remarkably, patients with
DM1 did not report symptoms of dysphagia despite evidence on videofluroscopy
suggesting abnormal swallowing function (Leonard, Kendall, Johnson, & McKenzie,
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2001). It is possible that muscle weakness and swallowing dysfunction progress so
slowly that individuals develop compensatory strategies that leave them unaware of their
dysphagia (Leonard et al., 2001). Moreover, findings from a survey study of 360 frail
elderly patients suggest that participants believed that dysphagia was untreatable, and
therefore there was little to gain by mentioning symptoms to health care providers
(Okberg et al., 2002). It is unknown if this phenomenon occurs in DM1
Apathy and cognitive impairment may further complicate the diagnosis and treatment of
DM1-related dysphagia (LaDonna, Koopman & Venance, 2011). In particular, there is a
well-described cognitive and personality profile for DM1 individuals that may be
characterized by low IQ, an avoidant personality, lack of motivation and difficulty with
executive function (Delaporte, 1998; Meola et al., 2003; Sistiaga, et al., 2010). Clinical
experience suggests that some individuals with DM1 manifest apathy and therefore may
minimize their symptoms, miss clinic appointments, and may not express interest in their
health (Meola & Sansone, 2007). While speculative, it is possible that these
characteristics impact an individual’s ability and/or willingness to recognize and manage
swallowing dysfunction.
As a result, informal caregivers may play an important role in assessing and managing
swallowing dysfunction for their loved ones. To our knowledge, there are relatively few
studies researching the experiences of caregivers for adults with muscular dystrophy
(Boström & Ahlström, 2005a, 2005b; Boström, Ahlström, & Sunvisson, 2006; Boyer,
Drame, Morrone, & Novella, 2006; Cup et al., 2011; Timman, Tibben, & Wintzen,
2010). These studies explored a variety of muscular dystrophies using quantitative
and/or qualitative methods, and did not specifically address the implications of caring for
individuals with DM1 and swallowing dysfunction. However, a qualitative study
explored nine individuals who cared for loved ones experiencing dysphagia after stroke
or other traumatic injuries and found that caregivers prompted their family members
about safe eating practices, spent extra time preparing meals, and experienced a sense of
fear or worry (Johansson & Johansson, 2009).
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While clinicians provide surveillance for swallowing problems and are concerned about
the potential for dysphagia to increase the risk of morbidity or mortality, it is unknown if
and how swallowing problems impact the daily lives of DM1 patients and their identified
caregivers. Therefore, it may be important to consider the potential disconnect between
health care provider’s clinical concerns and patients’ and family members’ perceptions.
However, much of the DM1 literature considers dysphagia largely from the clinicians’
perspectives, therefore little is known about the experience from the perspectives of the
patients and caregivers. Therefore, the purpose of this research is to explore the
experiences of providing care for a person with DM1 and known dysphagia. Findings
may influence clinicians’ approach to dysphagia diagnosis and treatment; that is, findings
may help identify appropriate questions to ask patients and caregivers during clinical
encounters, and/or to refine management strategies.

3.3

Methodology

The methodological framework used to guide this study involved a philosophical inquiry
of an interpretive phenomenological nature as articulated by Merleau-Ponty (1962) and
van Manen (1998). Using the viewpoints of van Manen (1990) and Merleau-Ponty
(1962), we explored each participant’s experience of embodiment, as being situated and
relational, or as “being-to-the-world”. This refers to the idea that human knowledge is
relational, temporal, and present in the world, instead of just being a static object in the
world, independent of the researcher. According to van Manen (1990), Merleau-Ponty
offers four existentials: “1. Lived body (Corporeality) 2. Lived space (Spatiality), 3.
Lived time (Temporality), and 4. Lived human relation (Relationality)” (p.101). These
four existentials were utilized and reflected upon throughout the research process to
understand the realities of the participants and their lived experiences and to allow the
findings to be grounded on the fundamental life world structures which all human beings
experience, although not all in the same ways. The four existentials of lived body, lived
space, lived time, and lived human relation are categories for phenomenological
questioning, reflecting, and writing (van Manen, 1990).
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3.3.1

Methods

For the purposes of this study, a caregiver was defined as a spouse, family member or
friend who provided some degree of supportive care to a person living with DM1. We
designed the study and collected and analyzed the data using an interpretive
phenomenological approach (van Manen, 1990). Interpretive phenomenology seeks to
explore and understand the nuances of lived experience by uncovering taken-for-granted
assumptions (van Manen, 1990). Individuals with mild to moderate DM1 and swallowing
problems (by physician report) who attended an outpatient neuromuscular clinic were
invited to identify and approach a caregiver about the study; six caregivers (two females;
four males) agreed to participate. Data was collected during semi-structured interviews
lasting up to an hour; the interviews began by asking participants to reflect on the
meaning of the term ‘caregiver’. Next, the interviewer (KAL) used a series of prompts to
probe about awareness and understanding of swallowing dysfunction and other DM1related symptoms, strategies for management, and symptom impact on daily life. All
interviews were recorded and transcribed verbatim.
Data was analyzed using van Manen’s (1990) suggested steps for phenomenological
analysis. Two researchers (KAL and WJK) began by reading each transcript twice to
gain a holistic sense of the data, and then independently chose a sentence or phrase that
captured the essence of each transcript. ‘Caregiving is a full-time job’ and ‘caregiving is
a partnership’ are examples of sentences that described the essence of two transcripts.
Next, a selective reading approach was independently used to code the data and extract
statements that described the caregiving experience. KAL and WJK independently
underlined key passages from the text related to dysphagia or caregiving and developed a
list of codes using words or phrases that reflected the participants’ experiences. KAL and
WJK then met to discuss their codes and combined them into overarching preliminary
themes. Key quotes supporting the themes were extracted from the data. The themes and
quotations were then discussed with all authors, and a final list of findings was developed
by consensus. Recruitment ceased when no further themes emerged. This does not
mean, however, that new information would not have been gained by further data
collection; rather, the data collected was sufficient to allow a rich understanding of the
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phenomenon under study. As suggested by van Manen (1998) the use of temporal,
spatial, relational, and bodily existentials to guide the analysis yields a richly-textured
understanding of the embodied nature of caregiving for those with DM1 and dysphagia.
To further ensure the rigor of our study (Morse, Barrett, Mayan, Olson, & Spiers, 2002),
we sent a letter to participants that described the preliminary findings, and invited each
caregiver to participate in a second interview to comment on the emerging themes. Only
two participants agreed to participate in follow-up interviews.
The Western University Research Ethics Board approved this study. To protect the
confidentiality of our research participants, we have assigned each person a pseudonym.
At the time of his follow-up interview, Sam was a 79-year-old living with his moderately
affected wife. Sam has three children with DM1 and a grandchild with congenital DM1;
Sam also provides some degree of care for his moderately affected son. Laura is in her
60s and lives with her mildly affected husband. Laura also has a son with moderate DM1
for whom she does not consider herself a caregiver, although she often run errands for
him. Daisy is a caregiver for her moderately affected husband, and she also works
outside of the home. Michael is a retired gentleman in his 60s who lives with his mildly
affected wife, and John is in his 50s and he cares for his mildly affected wife. Finally,
Greg is in his late 40s and provides care for his mildly affected partner and for her son
with congenital DM1. Greg’s affected father-in-law died unexpectedly following a
choking episode.

3.4 Results
While dysphagia is one of the most life-threatening symptoms of DM1 (Harper, 2001;de
Die-Smulders, 1998), five of the caregivers in the present study did not consider it to be
their family members’ most problematic symptom. Instead, most identified fatigue and
weakness as symptoms that impacted their affected family members’ function and quality
of life. However, despite the interviewer’s attempts to circle the conversation back to the
experience of caring for someone with dysphagia, participants chose to focus on their role
as caregivers rather than on their loved ones’ symptoms. While caregivers offered insight
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into their beliefs about DM1 and swallowing dysfunction, and were able to describe
strategies for managing symptoms, the participants continually returned to discuss their
caregiving roles and responsibilities. This divergence from the original research question
is not wholly unexpected given that the purpose of interpretive phenomenology is to have
participants reflect on their lived experience and to uncover taken-for-granted
assumptions (van Manen, 1990). We identified five themes that reflected the bodily,
spatial, temporal and relational existentials described by van Manen (1990):
Relationships Drive Perceptions; The Meaning of Caregiving; The Physical Experience
of Caregiving; Carving Out a Space for Respite, and Looking Into a Crystal Ball.

3.4.1

Relationality—Relationships Drive Perceptions

Relationality refers to the lived relations and spaces that are shared with others (van
Manen, 1990). In particular, sharing human relationships with others develops
impressions of others that are confirmed—or not—through interactions. For instance,
participants’ relationships with their affected family members influenced their beliefs
about the meaning of caregiving and the impact of DM1 symptoms on their lives. For
example, it was evident that health care providers were concerned about the swallowing
function of several DM1 patients since Sam, Daisy and Michael all stated that their
family member had been referred for a videofluroscopic swallowing assessment, yet
participants were largely unconcerned about their swallowing dysfunction. This was
despite being shown video evidence of their loved ones’ swallowing abnormalities. Sam
described that it was “the most fascinating thing to see this food go back, stop, and then
go down”, yet he did not consider swallowing to be a particularly troubling symptom
because his day-to-day experience of living with his wife reinforced his belief that she
had developed appropriate compensatory strategies. However, a health care provider
would likely be concerned about the potentially serious strategies he described:
So, as far as that's concerned, she has a way...we have morning vitamin pills.
There was about 6 or 7 when washed down and they go down then the Omega 3,
6, 9, they're a lot bigger so but she has an excellent way of popping them back up.
So in that sense she doesn't have a problem swallowing. But like yesterday, we
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had stew so she just put it through the blender. Because I think more than just
swallowing problem it is her muscles are weak—too weak—and so she says that's
enough...and that's obviously related to the myotonic. But, so in a way,
swallowing she handles quite well.
Moreover, Greg’s father-in-law died following a choking episode, an occurrence that
made his partner more vigilant about her swallowing function. However, Greg was less
concerned about swallowing abnormalities; instead, he focused on his partner’s difficulty
breathing.
My concern is the breathing more so than her choking. Everybody can get out of
a choking situation, but the breathing problem is the big issue. She keeps losing
percentages of her lungs’ capacity because of her diaphragm. That’s my big
concern.
This was surprising given his father-in-law’s unexpected and sudden death from choking
and his partner’s concern about her swallowing dysfunction. Further, respiratory failure
is a slowly progressive symptom as opposed to choking which can cause an acute
complication like aspiration pneumonia or sudden death. However, Greg seemed
confident that he could help his partner should she choke, yet seemed to feel helpless
about the progressive decline of her lung capacity. The fear of losing his partner to a
symptom or event that he could not control may have influenced how he evaluated the
impact of his partner’s symptoms, and in turn, where he chose to focus his energy.
In general, dysphagia appeared to be a symptom that participants felt the individual with
myotonic dystrophy had compensated for and managed; therefore swallowing
dysfunction did not seem to cause great concern or to affect shared experiences like
mealtimes or social activities. In particular, caregivers described that their loved ones
were aware of their limitations, and had identified strategies like avoiding certain foods,
cutting things into smaller pieces, or having liquids with meals to facilitate safer
swallowing.
As she told the fellow we were talking to, she’s very careful how she eats. And
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by careful, I mean she cuts small pieces. She eats very slow. I could probably eat
two meals to her one (Michael).
Instead, caregivers considered weakness and fatigue far more troubling symptoms.
Fatigue impacted the social participation of caregivers and their affected family members,
and seemed to negatively affect the marital relationship. Daisy described that it was not
uncommon for her husband to fall asleep at inappropriate times, and Greg’s partner stated
that Greg must feel like he “lives alone” because she falls asleep so frequently.
Moreover, Sam noted that his wife’s fatigue, coupled with her multitude of
complications, made it difficult for her to be motivated to be active or social. He
regularly had to prompt her to leave the house to “get some fresh air”. Laura and
Michael described changing their expectations about, and opportunities for, social outlets.
Michael described staying in to play cards instead of engaging in activities outside of the
home, and Laura prepared special meals to ensure that her husband could participate in
meals with friends:
We know they (husband and son) have muscular dystrophy and we accommodate
time or meals so that...basically, if we have company and I'll make sure it it's
something that maybe not 100% of the meal (husband) can eat but a good
portion—75% maybe even 80%-- and he wants that too because then it's – he's
not depriving me of doing things.

3.4.2

Relationality— The Meaning of Caregiving

While participants did not speak at length about assisting their affected family member
with managing swallowing dysfunction, they did speak in-depth about the overall
caregiving experience. The data suggested that there were three main reasons for being a
caregiver: (1) It is the nature or personality of the individual to be a carer; (2) There is no
one else to do the caregiving, and (3) Caregiving is done out of love. Five of six
participants endorsed that ‘caregiver’ was a term that they would use to describe
themselves. Sam put caregiving for his wife in context with his volunteer work as a
palliative caregiver in a hospice:
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Well, it's interesting. Because in a way, it's different than with the palliative care. I
always felt that we gained an awful lot by giving time to chat and so on. It was
very enriching in many cases. With my own wife, it's not so much enriching as to
feel that I have made it a little more comfortable and I have been able to assist her
in something that she found difficult or because we've been married for 48
years...so we've exchanged a lot... And, it isn't quite the same.
On the other hand, Laura felt that she was not a caregiver because her spouse and child
“manage on their own”. For Laura, a ‘caregiver’ is a defined role and title that must be
earned by performing specific tasks. She viewed her work checking on her son and
preparing meals for her husband not as caregiving duties, but as intrinsic parts of her
lived relations as a wife and mother
Um...well, the word caregiver is used and it's used for people who actually need
that kind of care and I think – I guess mostly personal care, feeding and all of that.
So, I'm not a caregiver for either one of them. But I help when I can.
Similarly, for Sam and Michael, caregiving was seen as part of the marital relationship
that would be present even without factoring in a chronic disease.
Well, I guess I could look at it that way too. … definitely [she] does what she’s
capable of doing. And I guess I do that for her too. In my opinion, she would be
a caregiver of me too. To me it’s a 50/50 deal. You don’t know what life’s going
to deal you. You’ve got to make the best of what you have and go from there.
(Michael)
Also, some participants seemed to have a nurturing nature in all facets of life that
influenced their experience of caregiving. For Sam, his experience of caregiving
transcended caring for his family members with a chronic, progressive disease. Sam’s
caregiving took many forms throughout his life, both as an educator and as a volunteer in
a hospice. He perhaps chose these vocations because of an inherent need to serve and
support; in turn, he used these experiences to shape how he cared for his wife.
I was a teacher for 31 years and there definitely is caring for the kids that they
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succeed. Now with [spouse] it definitely is love, I mean she is my wife. And it
has become, or it has become a little bit more. Just last night she said, how did
she put it, you are doing things that I used to do…
In contrast, John’s experience of caregiving was one of burden and burnout. John
described being responsible for all of the household chores in addition to working full
time, and he resented what he perceived as his wife’s learned helplessness: “She needs to
get back on her CPAP and it’s just finding the phone number for her. And she expects
me to do that but that’s not my job. ‘I’m not doing that for you dear. That’s drawing the
line there, you can call.’” When asked if there were any rewards of caregiving, he noted
that the one positive aspect of caregiving was the knowledge that his wife was receiving
appropriate care:
No. Other than I know she’s getting good care. So, you know, that’s the biggest
thing. She’s being taken care of. ‘Cause I know what else is out there…But, no,
other than I know she’s getting good care and being taken care of. Not being
abused by anybody or nothing, so...Yeah, that’s about it. (John)

3.4.3

Corporeality—The Physical Experience of Caregiving

“Lived body” (corporeality) refers to the phenomenological fact that we are always
bodily in the world” (van Manen, 1990). For most participants, their physical body
affected either how they interpreted their loved one’s symptoms or how they were able to
provide care. Despite not being cognizant of the extent of their loved one’s swallowing
dysfunction, some caregivers had good awareness of their loved one’s bodies. Caregivers
knowledgably discussed the main DM1 symptoms and the variability of disease
progression. Caregivers were readily able to describe the “lived body” of fatigue, cardiac
and respiratory problems, dysphagia, and weakness as primary symptoms affecting their
family members. For example, Michael was mindful about taking objects from his wife
because her myotonia made it difficult for her to release her grip:
Well, probably lots of times I help her get dressed, maybe do up her shoes for her.
The big thing is getting stuff out of the cupboards because of with her grip. I’m
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going to have to do that type of thing. Or you’ve got to be careful when … if she
hands me something I’ve got to realize that it takes her a while to let go of it, so if
I don’t, like sometimes pull her over or pull her arm type of thing.
Participants described that the experience of caregiving involved both physical and
emotional work. Most caregivers cared not only for their family member with DM1, but
for other affected family members and/or aging parents. Participants described that the
work of caregiving involved the bodily work of cooking, cleaning, heavy-lifting, running
errands, and assisting with bathing and dressing. Participants also discussed that
attending and asking questions at medical appointments were important aspects of their
roles that facilitated the work of caregiving. The task of ‘prompting’, whether to take
medication, chew slowly, or for their family member to be social, was described.
Moreover, Sam used his body to provide comfort and healing for his wife: “And I do
Reiki, I give her Reiki treatment. We do massage, light massage with maybe a bit of
aromatic oil.” However, caregivers’ physical limitations sometimes impacted their
ability to perform the physical tasks of caregiving. John described having a pinched
nerve, and Sam stated that a shoulder injury affected his ability to assist his wife in lifting
or carrying heavy objects.
Caregiving also enacted an emotional toll on Greg and John who described that the
constant duties of caregiving were “annoying” and frustrating. In particular, John stated
that he felt “down”, and his emotions affected him both physically and emotionally to the
point that he was on a number of prescription medications to treat his anxiety and
depression. Overall, caregivers described that much of the perceived effort of caregiving
was found to be emotional, with “worry” as a prominent theme. Participants disclosed a
variety of concerns, including whether their family member was eating enough, the
impact of DM1 on their own physical and emotional health, increased caregiving tasks as
DM1 progresses, and the constant fear of the likelihood of an early or unexpected death.
You know, that's the most important right there cause you never know one day he
could be lying dead somewhere and I'd never know it…. Like I say, you never
know if he could end up one day in bed dead, you know, and I wouldn't know it….
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That's something I don't want to think about. You know, nobody wants to think
about that but if it happens it happens. (Daisy)

3.4.4

Spatiality—Carving Out a Space for Respite

Spatiality, or lived space, is “felt space” that describes how individuals experience spatial
dimensions in their everyday lives (van Manen, 1990). In general, participants described
that it was difficult to find physical spaces that accommodated individuals with a
disability, and navigating in public spaces was impacted by their loved ones’ bulky
mobility aids like wheelchairs or oxygen tanks. As a result, social circles and outlets
diminished.
Other than going places – that’s the biggest drawback, going and figuring out
whether we need to take her machine and all the stuff, and when it’s really hot out
she doesn’t bother going outside, it’s so humid. (John)
Moreover, the emotional toll that Greg and John described also affected their ability to
feel comfortable and relaxed in their homes because they always felt that they should be
performing tasks or supporting their partners. Therefore, for John and Greg, caregiving
constrained their ability to achieve a physical distance from their duties and
responsibilities.
They’re (caregiving duties) intense right now as far as I’m concerned because I
can’t go out on my own without worrying about her. As I said, we travel with cell
phones, so if I’m out and about, I’m always close. I can’t go anywhere without
always worrying about her. So I don’t go too far away. I stay close to the house.
So it’s really restricted my life in that respect. I don’t want to go out and get a
part-time job, because if I do that, I’m on the job, she phones you up and she has
trouble, what am I going to do? (Greg)
Therefore, there was a sense that burden was part of the experience of caregiving for John
and Greg. To cope with the stress of caregiving, they attempted to carve out both an
emotional and a physical lived space for respite.
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She just takes it (caregiving) for granted. Which can be real annoying. I try to sit
down and relax and she’s going jibber, jibber at me. Shhh, I’m trying to relax.
So I just end up going sitting on the porch or going out in the back yard with the
dogs. Here we go, here’s some relaxing (John).

3.4.5

Temporality—Looking Into a Crystal Ball

Temporality refers to subjective time rather than ‘clock time’, and an individual’s
‘temporal landscape’ is colored by the past, present and future (van Manen, 1990). Prior
to their loved one’s diagnosis, few participants had knowledge about DM: “Like I've
watched the Jerry Lewis Telethon and there's a bunch of families there with different
muscular dystrophy diseases but coming up with myotonic dystrophy—no. No, I [had]
never heard of the word before (Daisy).” Daisy also reflected on the changes in their
lives since her husband’s diagnosis; they had previously enjoyed parties and being social,
but now spent more time at home alone. Further, Sam discussed the past with a sense of
regret and wondered whether he and his wife would have had children had they known
about the genetic nature of DM1: “We haven't dwelt on that. Once in a while it came up
and you know what ‘That's it...that's the way it is.’”
However, most participants focused on the present and living in the moment with their
loved one. In particular, participants described living with their loved one’s symptoms
and adjusting to them as they progressed. Therefore, swallowing was not considered
problematic because the affected individual was coping and managing in the here and
now. Overall, there was a sense that while the complications of DM1 (namely fatigue
and weakness) affected daily life, DM1 was manageable. Therefore, while some
caregivers described a sense of regret or fear of the unknown about DM1, others like
Laura, described DM1 as “no big deal”
We work with him rather than it dictates what we do. It's just--you just do it...
there’s no hardship at all. (Laura)
There was, however, greater concern for other symptoms including breathing difficulties
and progressive weakness. Many participants had a ‘crystal ball’ mentality in which they

77

envisioned that their partners’ decline in time was inevitable and that they would have to
take on an increased caregiving role. Caregiving was already viewed as time lived as a
consuming “24/7 job” (Greg) that was done in addition to full-time employment:
Like it's hard for me because I work and coming home, you know making meals
and stuff, keeping our place clean and whatever, you know it's really hard, really
really hard. (Daisy)
However, Michael, Greg and John discussed that their retirement afforded them more
time as lived to devote to caregiving; this was positive for Michael and Greg, but not for
John who was overwhelmed at the thought of being a full-time caregiver.
The experience of caregiving also involved future temporality as making plans and being
prepared for eventual complications, and participants discussed their varying degrees of
preparedness for the future. Only two participants (Sam and Greg) had previous
experience with CPR or the Heimlich maneuver; however, they took first aid courses for
employment or other purposes, not in preparedness for their loved one’s impaired
swallowing function. When prompted, however, all caregivers expressed an interest in
learning more about what might be done in an emergency or unforeseen situation, but no
one had plans to be formally trained. Despite this, most caregivers believed that they
would be able to appropriately respond should a choking episode occur in future time.
Well if she were to choke, I could do the Heimlich on her. I plan on
getting my CPR certificate. I’m working on that in (location). I’m
waiting for a clinic to open up in case I ever need it. Then I’m certified. I
used to be a trainer for a boy’s hockey team. I had to get certified for that.
So general first aid and stuff like that, I’m familiar with. I’m not totally
lost when it comes to something like that. But CPR is what I’ve got to
follow through on.
While there was a sense that caregivers understood that their loved one’s condition would
decline, the participants continually circled back to focus on the present time during the
interviews. Overall, the experience of caregiving seemed to be one of love and duty,
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tempered by the expectation that caregiving responsibilities would intensify in future
lived time. The experience of caregiving for an individual with DM1, therefore, was
influenced by their corporeality or lived body in lived time, lived space and lived
relations when being with their affected family members.

3.5 Discussion
Given the attention, concern and surveillance that health care providers impart on DM1
affected individuals with dysphagia, we set out to explore caregivers’ perceptions about,
and their experiences with, their family members’ swallowing dysfunction. However, the
goal of interpretive phenomenology is to uncover taken-for-granted assumptions (van
Manen, 1990), and study findings suggest that the overall caregiving experience, coupled
with troubling symptoms like weakness and fatigue, have a far greater impact on the
participants’ lived experiences than dysphagia. Therefore, the study evolved into an indepth examination of participants’ knowledge and attitudes about DM1 and the meaning
of their caregiving experiences. This speaks to the uncertain, fluid and emergent nature
of qualitative inquiry (Lincoln, 1995; Whittemore, Chase & Mandle, 2001).
The participants in our study described their beliefs about DM1 and dysphagia, the
impact of DM1 symptoms on their lived body, lived time, lived space and lived relations;
in turn, the four existentials described by van Manen (1990) also influenced caregivers’
descriptions of the meaning and work of caregiving. The relative lack of concern about
dysphagia echoed other studies suggesting that individuals with DM1 are often not aware
or concerned about swallowing or other consequences of their condition (Boström &
Ahlström, 2005a; Meola & Sansone, 2007) despite significant concern from health care
providers. This disconnect has been explored in other neurological disease populations,
but to our knowledge it has not been studied in DM1. In a study of the multiple sclerosis
population, for example, physicians tended to focus on mobility issues, while patients
were more concerned about cognitive decline (Heesen, Kopke, Richter, & Kasper, 2007).
In Parkinson’s disease, while clinicians may attend preferentially to the motor features of
the disease, it is often the non-motor features including mood problems, nocturia and
drooling that most impact patients’ health related quality of life (Martinez-Martin et al,
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2011). Similarly, there is evidence that the cognitive and psychiatric features of
Huntington’s disease (HD) are far more disabling than chorea, yet research is often
geared toward the motor symptoms (Bonelli & Hofmann, 2004). Finally, clinicians and
patients may differ in their perception of the severity of HD symptoms, with clinicians
objectively assessing symptom impact on disability, while patients subjectively assess
symptom impact on daily life. This suggests that quality of life measures may be more
indicative of symptom impact than disability scores (Banaszkiewicz et al, 2012).
Arguably, patients’ description of symptoms may impact their caregivers’ beliefs about
how they are living with and managing their condition. In turn, clinical management may
be influenced by patients’ and caregivers’ subjective reports of symptom impact on
functional ability (Shulman, et al., 2006). However, caregivers were aware of health care
professionals’ concerns that dysphagia increases individual risk of morbidity and
mortality related to choking, aspiration and sudden death. Others have hypothesized that
this dichotomy may occur because there may be a distinction between knowing the
symptoms of DM1 and fully understanding their implications (Boström & Ahlström,
2005a). We speculate that caregivers’ lack of concern mirrors that of patients because
the swallowing dysfunction evolves gradually over time allowing for strategies to
compensate. A survey of 286 older adults with osteoporosis or osteoarthritis found that
participants used a variety of strategies to compensate for their declining function
including asking for help, giving up certain activities, performing behaviors that optimize
their current function, and using assistive devices (Gignac, Cott & Badley, 2000). While
this study did not speak to dysphagia, it does illustrate how individuals with chronic
disease compensate for progressive functional loss. Our findings suggest that individuals
with DM1 compensate for their abnormal swallowing by avoiding certain foods, having
liquids with meals, or regurgitating objects that were not safely swallowed. For
caregivers, therefore, there is no additional perception that swallowing is difficult to
manage or is a hardship because their lived relations with their partners reinforce the
belief that their loved ones have compensated appropriately.
However, similar to the experiences of thirty muscular dystrophy (n=10 individuals with
DM1) caregivers described in a questionnaire study by Boyer, Drame, Morrone and
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Novella (2006), the participants in our study expressed a sense of emotional and physical
burden, primarily related to the anxiety of disease progression and sudden death. Further
in line with our findings regarding the “work” of caregiving, five partners of DM1
individuals described that they increasingly became responsible for prompting their
family members, for doing household chores, and for planning social activities (Cup et
al., 2011).
Many of our findings resonate with the experiences of thirty-six caregivers for
individuals with muscular dystrophy (19 DM1 caregivers were included) ascertained
through inductive content analysis (Boström, Ahlström and Sunvisson, 2006). In
particular, the sense that caregiving is shared with the individual living with muscular
dystrophy and is done out of love or obligation were similar to our findings. Also, worry
about disease progression and an increased care load, and the idea that individuals and
families living with other conditions or life situations are worse off, resonated with our
participants’ experiences. Using a hermeneutic qualitative approach, Cup et al (2011)
found that the marital relationship can be affected by DM1 but that the five couples
studied found ways to cope including giving each other space, respecting each other’s
abilities, and allowing each partner to pursue his or her own interests. Moreover, we
found that individuals with DM1 and their caregivers who see caregiving as part of the
marital relationship and/or those who provide care out of love tend to view caregiving
more positively. This is similar to studies that suggest that being in a healthy relationship
was associated with the psychological well-being and better quality of life for individuals
with muscular dystrophy and their partners (Boström & Ahlström, 2005b; Timman et al.,
2010).
This is a small study reporting the experiences of six caregivers of individuals with DM1
and dysphagia and provides preliminary data that may inform future research questions.
A longitudinal study with a larger sample that explores the experiences and processes of
caregiving for individuals with DM1 and dysphagia may be warranted. Moreover, an
exploration of patients’ experience of dysphagia, or an observational study exploring
DM1 individuals’ daily activities, food choices and eating patterns may be helpful to
guide the development of educational initiatives or interventions. In particular, future
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research might consider appropriate questions to ask during clinical encounters or an
examination of patients’ condition-specific knowledge and their uptake of clinical
information. Further, areas of education for health care providers might attempt to bridge
the chasm between health care providers areas of concern with the complications that are
most impactful to patients and their family members. Finally, a condition-specific
assessment tool measuring swallowing function for individuals with DM1 may be useful
(LaDonna, Koopman & Venance, 2011) to quickly assess for dysphagia during follow-up
visits. While often outside a routine clinic visit, an assessment of caregiver burden for
those caring for family members with DM1 may be necessary (Boyer et al., 2006).
Health care providers may need to pay particular attention to the effect of DM1 on daily
life for individuals and their families (Cup et al., 2011). While our results may not be
immediately generalizable to the broader DM1 population, the findings may resonate
with caregivers and other friends and family of those living with DM1.

3.6 Conclusion
In conclusion, while we set out to explore the experiences of caregivers for individuals
with DM1 and dysphagia, we found that caregivers did not consider dysphagia a major
concern. Instead they focused on other troubling symptoms like weakness or fatigue, and
the impact of caregiving on their lived body in lived time, space and relations. This
raises questions about the dichotomy between the concerns of health care providers and
patients and their families, and how clinicians can assess the needs important to families
while addressing clinical concerns. We suggest that clinicians emphasize the importance
of monitoring and managing potentially life-limiting symptoms like dysphagia while also
assessing how DM1 symptoms impact the quality of life for patients and their caregivers.
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Chapter 4

4

Picturing the Experience of Living with Myotonic
Dystrophy (DM1): A Qualitative Exploration Using
Photovoice

4.1 Abstract
Background: Myotonic dystrophy (DM1) presents with multi-systemic complications;
moreover, there is a well-recognized DM1 personality profile that is characterized by
executive dysfunction, an avoidant personality and impaired cognition. Understanding
symptom impact on patients’ lives is crucial for providing appropriate patient-centered
care; however, much of the DM1 literature reflects the biomedical model and there is a
paucity of articles exploring patient experience.
Objective: To use a novel research approach to explore DM1 patients’ experiences.
Methods: Nine individuals participated in a qualitative study using the photovoice
methodology. Photovoice uses the visual image to document participants’ lives, and
participants took pictures pertaining to living with DM1 that stimulated individual and
focus group interviews. We used content analysis to analyze the data; in turn, codes were
collapsed into themes and categories. Findings were presented to participants to ensure
resonance.
Results: Participants took 0-40 photographs that depicted barriers and facilitators to
living successfully with DM1. We identified two categories that include participants’
challenges with everyday activities, their worries about the future, grief for lost function
and social opportunities, and their resilience and coping strategies. Participants also
described their experiences using the photovoice method.
Conclusion: Photovoice is a useful approach for conducting research in DM1.
Participants were active research collaborators despite perceptions that DM1-affected
individuals are apathetic. Our findings suggest that participants’ are concerned about
symptom impact on reduced quality of life, not symptoms that clinicians preferentially
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monitor. Nurses, therefore, are essential for providing patient-centered, holistic care for
DM1 patients’ complex biopsychosocial needs. Research exploring current physician-led
clinical care models is warranted.

4.2 Introduction
Myotonic dystrophy (DM1)—the most common adult form of muscular dystrophy—is a
chronic, progressive and inherited neuromuscular condition presenting with multi-system
complications including distal muscle weakness, myotonia, hypersomnolence, early-onset
cataracts, cardiac conduction abnormalities, and slurred speech and swallowing problems
(Harper, 2001). DM1 patients’ complex needs—including their cognitive and behavioral
impairments— may complicate patient-centered care provision. In particular, patients’
lower educational attainment, problems with executive function, and avoidant personality
traits may make it difficult for them to take risks, make friends, or participate in new
activities (Delaporte, 1998; Gagnon, Mathieu, & Noreau, 2007; Meola et al., 2003;
Sistiaga et al., 2010); consequently, individuals with DM1 may be apathetic and
disinterested in their health (Meola & Sansone, 2007).
Despite these challenges, it is essential that DM1 patients’ values and experiences drive
clinical care. Clinicians are concerned about the potential for cardiac, respiratory or
swallowing abnormalities to cause morbidity or sudden death, yet research exploring
patients’ perspectives suggests that weakness, fatigue and myotonia have a greater impact
on patients’ quality of life (Boström & Ahlström, 2004; Cup et al, 2011; Gagnon,
Mathieu & Noreau, 2007; Heatwole et al, 2012; Nätterlund et al., 2001). In particular,
these symptoms often challenge DM1-affected individuals’ ability to socialize, complete
household chores, or engage in employment or educational opportunities. Moreover,
progressive physical symptoms—coupled with patients’ difficulties with motivation and
planning— may impact patients’ personal relationships (Cup et al, 2011). Consequently,
patients may experience significant disruption and decreased satisfaction with
employment and social recreation (Gagnon, Mathieu, & Noreau, 2007); in turn, impaired
mental and physical function and reduced quality of life may result (Laberge et al., 2013).
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However, despite evidence that clinicians and patients have different concerns and goals,
much of the current DM1 literature is written from a biomedical perspective, and
relatively few qualitative studies explore the perspectives of patients with muscular
dystrophy (Authors, 2014; Boström & Ahlström, 2005; Boström & Ahlström, 2004;
Boström, Ahlström, & Sunvisson, 2006; Cup et al., 2011; Faulkner & Kingston, 1998;
Heatwole et al, 2012; Nätterlund, Sjöden, & Ahlström, 2001). These studies use a range
of methods including content analysis and phenomenology to explore questions
pertaining to living with muscular dystrophy; few of these studies represent the
perspectives of North American patients, and individuals with DM1 are a small
proportion of the overall sample. We believe that individuals living with DM1 have
valuable insights into their condition and life experiences that can inform their health
management, and that their voices should be more widely distributed in the literature. To
address this, we used an innovative qualitative research method called photovoice (Wang
& Burris, 1994; 1997) to explore the experience of living with DM1.
Photovoice is rooted in participatory action research (PAR) and was developed to study
populations with low literacy residing outside of the traditional power structure (Wang &
Burris, 1994). “Participatory Action Research (PAR) differs from most other approaches
to public health research because it is based on reflection, data collection, and action that
aims to improve health and reduce health inequities through involving the people who, in
turn, take actions to improve their own health” (Baum, MacDougall, & Smith, 2006).
While we do not believe that individuals with DM1 are ‘powerless’, we argue that their
unique physical and emotional challenges, coupled with the power imbalance inherent in
some medical encounters (Goodyear-Smith & Buetow, 2001) warrants a strategy that
utilizes their strengths and experiences. In particular, photovoice uses photography to
augment traditional interviews by offering participants a creative way to communicate
their expertise, experiences, knowledge, and needs. In an effort to educate or enact
change, participants may choose to disseminate their photographs and experiences to
‘stakeholders’ like clinicians or patient advocacy groups (Wang & Burris, 1994, 1997).
Photovoice has been used with individuals with intellectual impairment (Jurkowski &
Paul-Ward, 2007), acquired brain injury (Lorenz & Kolb, 2009), stroke (Levin et al.,
2007), dementia (Genoe & Dupuis, 2013) and Alzheimer’s disease (Wiersma, 2011).
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The purpose of this study was to add DM1 patients’ voices to the literature; therefore, we
used an innovative qualitative research approach to explore patients’ experiences of
living with a chronic and progressive neurological disease. In particular, we asked
participants to reflect on the impact of DM1 symptoms on their daily lives, and to
consider the barriers and facilitators to living successfully with DM1. We also sought to
engage individuals with DM1 as research collaborators; the literature describes that DM1
patients may be apathetic or cognitively impaired, so we also asked the question: is
photovoice an effective method for exploring the perspectives of individuals living with
DM1?

4.3 Methods
Participants with mild to moderate DM1 (by physician report) attending an academic
neuromuscular clinic were invited to participate. We purposively selected individuals
who were able to provide informed consent and comply with study procedures; nine
participants (four females) consented, and each was given a pseudonym to ensure
confidentiality (Table 1).
We used a typical photovoice study consisting of a camera orientation session, an
individual interview, and a focus group (Wang & Burris, 1997). Participants attended a
camera orientation session in which they (1) discussed the ethics of picture taking, (2)
were given a digital camera and instructed about its use, and (3) were asked to “take
pictures of what it is like to live with DM1.” Additionally, participants were asked to
take pictures of people or things that either hindered or facilitated living successfully with
DM1. Instructions were purposely kept vague to avoid the potential for researchers to
influence picture taking. Participants were instructed that they had to seek written
consent from each person they wished to photograph. Researchers asked questions to
check the participants’ comprehension and understanding of the task and instructions, and
participants were given the opportunity to practice taking pictures.
Following the camera orientation session, participants had 2-3 weeks to take pictures and
then returned for an individual interview. Participants were asked to describe each of
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their photographs; in turn, their narratives directed the content and flow of the interviews.
To further probe participants’ responses, the researchers prepared general questions about
their DM1-related medical history, their symptoms, and the impact of DM1 on their daily
activities. We also asked participants to share their opinions about study participation
and the photovoice method. Participants were then invited to choose 2-3 photographs to
share during a focus group.
All 9 participants completed the camera orientation session and an individual interview.
The first 7 participants were scheduled to participate in a focus group, and two focus
groups were held with two and three participants each. Two individuals declined
participation; one participant felt her fatigue precluded focus group participation, and one
participant was lost to follow-up. All data was retained and analyzed. Following the
focus groups, two additional participants were recruited, and their photographs and
individual interview data were used to verify preliminary themes (Table 1). All
interviews were recorded and transcribed verbatim.
In keeping with the tenets of PAR and photovoice (Wang & Burris, 1994, 1997),
participants collaborated with the iterative data collection and analysis process. The first
step in data collection and analysis began when participants chose what to photograph.
Photographs were then selected, contextualized and coded. Participants selected
photographs to discuss, and gave them meaning by describing what was captured and
how and why they chose the subject matter (contextualization). KAL and SLV then used
content analysis to analyze the interview transcripts; in particular, a double coding
qualitative method was used to enhance the reliability of the data coding system
(Miles, Huberman, & Saldana, 2014) . The researchers independently coded
segments of the individual interview and focus group data using words or phrases that
described participants’ actions or experiences. The researchers held regular meetings to
discuss the coding, and a preliminary list of themes was developed by consensus. Data
collection and analysis were iterative, and preliminary themes were discussed during
subsequent interviews to ensure that the findings resonated with participants’ experiences
(Bradbury-Jones, Irvine, & Sambrook, 2010). No new themes emerged during the final
two interviews, and recruitment ceased when we determined that the collected data was
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sufficient for exploring our research questions. While additional participants might have
generated new insights, we determined that our themes and categories provided a robust
exploration of participants’ experiences of living with DM1. Transcripts were reexamined then re-coded using the finalized list of themes. Themes were then
consolidated into categories. The authors kept a reflexive journal throughout the study to
record general impressions of emerging findings and to track theme and category
development. Nvivo, a qualitative software program, was used to organize and manage
the data.
This study complies with the Helsinki Declaration of 1975 and was approved by the
Western University Research Ethics Board.

4.4 Results
All participants were actively engaged research collaborators who took 0-40 photographs
that captured symptom impact on their activities and quality of life, their management
strategies, and their sense of self. We identified seven themes that were consolidated into
two categories titled A Shifting Identity and Managing Limitations. Participants described
that their shifting identities caused them to lose their sense of self and to grieve for their
lost abilities; however, they were able to find solutions to cope with their evolving needs.
Participants also discussed their variable degrees of study participation; while some
participants had difficulty following study procedures, others were able to problem-solve
strategies to mitigate challenges. Regardless, all participants provided rich descriptions
about their experiences living and coping with DM1.

4.4.1

Participating in Research

In general, participants were actively engaged in the project and stated that they enjoyed
participating because it gave them the opportunity to share their experiences and
socialize. Some participants were either the first in their family to be diagnosed, or had
never met anyone with DM1 outside of their immediate families. Consequently, the
focus group was an opportunity for them to meet other DM1-affected individuals and
discuss common experiences:
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I meet a lot of people with MD (muscular dystrophy), but it’s a big umbrella. So there’s
all different kinds. But I only know one person that has myotonic dystrophy and I’d like
to meet other people that have myotonic dystrophy. Like males, females, different ages,
and stuff like that. Maybe there’ll be a friendship, you know? ‘Cause we can talk and we
understand what each other is going through, or something like that (Tim).

There were, however, challenges associated with using an innovative qualitative research
approach with this population. Transportation was problematic; two wheelchair bound
participants (Jenny and Frank) lived approximately two hours from the study site. While
Jenny’s caregiver was able to drive her, we had to arrange special transportation for
Frank. As a result, Frank’s individual and focus group session were conducted the same
day, and he stated that the long study visit made him feel fatigued. Also, Frank’s speech
impairment rendered it difficult to understand and transcribe his comments. Moreover,
two participants (Laura and Marjorie) did not complete the study; Marjorie withdrew
citing DM1-related fatigue, and Laura did not attend her scheduled focus group meeting.
Finally, two participants (Max and Peter) had difficulty using the digital camera:
I was trying to … on Wednesday I was trying to take pictures of my bath seat and my
walker. I put the camera on, I pushed it and it didn’t go off, the flash stopped
working. So…Well, I wasn’t sure what to do, so I thought I’d just come down and
tell you. Maybe I pushed the button that I shouldn’t have, you know? (Peter).
However, four individuals (Tim, Laura, Marjorie, and Jenny) facilitated their
participation by asking a friend or care partner to help them take pictures. Together,
Marjorie and her husband created a list of her challenges and most problematic symptoms
and then brainstormed scenarios to photograph these limitations. Other care partners
assisted with picture taking and/or participated in the individual interviews. All
participants described their interest in participating in research in general—and this
project in particular—because it gave them the opportunity to educate researchers and
clinicians about their lives.
It gives them an idea of what it’s like and learn that it’s not all negative and that
… like I say, you don’t know what it’s like unless you live it, but to take pictures
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you can see what my life is like. Not all negative, but not all positive either.
Yeah, it’s a good idea (Frank).

4.4.2

A Shifting Identity

Participants described that their DM1 diagnosis caused an identity shift; that is,
participants’ symptoms altered their physical appearance and challenged their abilities to
be employed, complete household chores or participate in recreational activities.
Consequently, progressive disability impacted their self-esteem and caused participants to
lose their sense of self and grieve their pre-symptomatic identities.

4.4.2.1

A Changing Body

Participants’ evolving physical appearance triggered their perception of a shifting
identity; in particular, participants stated that their altered appearance and progressive
functional decline challenged their self-confidence and their social participation.
Participants commented that their changing bodies,—including low muscle tone,
drooping eyelids, premature balding and facial atrophy—coupled with their need for
assistive devices, significantly impacted their self-esteem. Consequently, participants
worried that they were unattractive, and that their functional decline made them feel older
than their chronological age:
I can’t wear high heels ‘cause I fall off them! I gotta buy shoes with a low heel
and that makes me feel so stupid because I feel like an old lady. You know, with a
walker I feel like an old lady. I’m not—I’m 51—but that’s not old to me you
know? (Laura)
Even participants in stable and loving relationships experienced poor self-esteem; some
participants were not only embarrassed by their physical appearance, but also by
impaired mobility and their propensity for falls: “It’s not so much the scrapes on your
hands and knees, it’s the scrapes on your dignity...” (Meg). Further, participants felt
judged and believed that members of the general public lacked empathy and treated
disabled people unfairly. When asked to comment about her shifting identity, Jenny
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stated: “Thank God I knew people when I was still okay—walking around and stuff—
because otherwise I think I'd probably be treated differently, being in a wheelchair,
people not knowing. Personality doesn't change because you're in a wheelchair.”
Similarly, other participants believed that members of the general public perceived them
as slovenly or cognitively impaired, particularly if they had a speech impairment or fell in
public: “I fall, they judge me as clumsy, and when I appear with mud on me because I've
fallen, they assume I don't bother bathing regularly. So …that bothers me, the people
that assume” (Meg).

4.4.2.2

The Challenges of Everyday Activities

Figure 4-1: : Improvising to Manage the Challenges of Everyday Activities: Using a
Rubber Grip to Open a Door
I find sometimes, especially if it’s cold, if I’m cold, they (hands) don’t always work, like
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when they seize up. And some door handles, the outside doors are easy, it’s just a push
latch, it’s fine, which I like better… But sometimes it’s just too damn hard. (Joe)
Symptoms including weakness, gastrointestinal problems and chronic respiratory failure
impeded participants’ from fully participating in activities they once enjoyed. In
particular, participants with diarrhea were concerned about incontinence, and individuals
with breathing difficulties found it cumbersome to travel with their bipap machines.
Participants described that DM1 symptoms also impacted their ability to do activities
usually taken for granted like bathing, walking a short distance or climbing stairs: “I
don’t like stairs…Walking down stairs is fine, but going up stairs... It’s hard on my legs,
eh? I go up two flights and I breathe hard…Yeah, and I have to sit there and wait for a
while. I sit there for a while, and then we’ll go up two stories. I’ve got five flights of
stairs to go up” (Peter). Additionally, participants described having difficulty exercising
or opening doors (Figure 4-2) and bottles or jars. Moreover, the local environment was
described as inaccessible to those with disabilities; narrow aisles, sidewalks in poor
condition, and a lack of handicapped accessible entrances made it difficult to navigate
these spaces:
I was going to take a picture of the mall because it’s the only one that on the
centre doors it has no buttons. It doesn’t make sense because the bus, the
Paratransit van, goes to a different door. That doesn’t make sense to me because
it should be on these two doors (Frank).
While myotonia, swallowing dysfunction (Figure 4-1), cardiac abnormalities and
cataracts minimally impacted participants lives, fatigue was described as “a vicious
enemy” (Marjorie) that exacerbated other symptoms. For example, Frank stated that his
speech impairment worsened when he was tired, and excessive daytime somnolence
caused participants to fall asleep at inappropriate times, making it difficult to work,
complete chores or socialize:
Falling asleep in the middle of conversations, it's embarrassing because I'll fall
asleep in the middle of sentences, and it's not for lack of attention or lack of
interest, it's just the myotonic dystrophy makes me tired (Meg).
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Figure 4-2: Making Swallowing Safer
Well, that’s (swallowing) not good now… But my jaw is not working well. I can’t
chew. …I can’t eat beef, steak or, yeah, the chewing is a problem and I just get tired of
chewing at the table and I stop…You know, I manage to have ground meats, but even
so, I don’t chew them. I just mush them around and swallow and I know that’s not
good but that’s all I can do. (Marjorie)

4.4.2.3

Loss and Grief

Participants’ functional decline and physical appearance left them “constantly grieving”
(Marjorie) their pre-symptomatic identity. Others described grieving for lost dreams,
opportunities, and their previous physical abilities. DM1 was isolating; some participants
had few social connections because their symptoms precluded full-time employment or
participation in recreational or leisure activities. Consequently, participants’
relationships were impacted by limited finances, fatigue or a lack of motivation to be
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social. Tim and Frank perceived that their disabilities were off-putting to potential
romantic partners, and some participants mourned their childless state due to infertility or
because they feared transmitting the gene. Ultimately, participants grieved who they had
been prior to their diagnosis, and who they might have become had they not inherited
DM1:
All through high school, I wanted to be a dancer. I used to take dance class and
vocal class because I thought I was going to make it big and be discovered one
day. There were times when I couldn’t do stuff and they didn’t understand why I
couldn’t do it. My flexibility was going and that was probably early signs of MD.
Now, there’s no way I could do that now, no way at all. I couldn’t stand on a
stage for long periods of time, dance or anything like that. There’s no way (Tim).

4.4.3

Managing Limitations

Despite mourning their lost opportunities and progressive functional decline, participants
were resilient and proactive about finding solutions to manage their limitations.
Participants tempered their concerns about the future by adjusting their self-perceptions;
that is, participants strategized solutions for mitigating their physical challenges and for
finding purpose within their current abilities.

4.4.3.1

Desiring a Sense of Purpose

Participants expressed the need to feel valued and to be seen as contributing members of
society: “Sometimes I’ll sort it (laundry) upstairs and that way at least they know I’m
doing something … (Laura).” Many described desiring a sense of purpose and sought to
maintain their independence and sense of control. Individuals took pride in their abilities
and sought validation in volunteering or engaging in part-time work, being proactive
about their health, driving, and completing household chores. There was a clear sense
that they tried to reframe their lost identity by focusing on their achievements and current
abilities. Like Joe and Frank, Max described that he had once been an award-winning
athlete; however, when asked about his current accomplishments, he quietly stated that he
took pride in:
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Staying alive, basically. Being able to live on my own and function as a human
being to do what I do. I’m able to watch TV, listen to the radio, talk on the phone
and try to keep my place presentable to anybody who’s going to come over.

4.4.3.2

Finding solutions

Participants described changing their expectations, creating new goals, and finding
solutions for everyday challenges. In particular, individuals discovered tools or strategies
to help them maintain their independence and functional ability while bolstering their
self-esteem. These strategies included engaging in volunteer or paid employment, using
mobility aids (Figure 4-3), taking medication for excessive fatigue, and facilitating

Figure 4-3: Mobility Aids Mitigate Functional Decline
That’s my cane, my best friend. You know, it’s like my third leg. I go everywhere with
that cane. And I think it’s great. (Tim)
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household chores by using devices like rubber grips for opening jars or doors (Figure 42). Participants also adjusted their expectations about social and recreational outlets:
It’s there, it’s going to just get worse, but it hasn’t really changed my lifestyle.
Other than, yeah, less exercise, less sports … But I mean participating, even
kicking a ball around with the kids. I can’t do it. Which is pissing me off, but
you get over it, you know, and do something else. I can still play cards. (Joe)
Participants also coped by moving to accessible or community oriented housing,
appreciating humor, and having pets. To preserve a “non-disabled” sense of self, some
participants were selective about disclosing their diagnosis. For example, Tim’s friends
and family were aware of his condition, but he stated that he did not take his cane to work
because he worried that his co-workers would treat him differently.

4.4.3.3

Family Dynamics

However, participants relied on family members or friends to assist them with completing
tasks and maneuvering the local environment. Strong family, friend (Figure 4-4), and
marital relationships seemed key to living successfully with DM1. Individuals with a
strong support system described having more coping strategies (particularly if there was
financial stability or someone to help with chores) and feeling less isolated (particularly if
they lived with their spouse or children). Overall, there was a sense that supportive
family and community members eased the burden of disease and made individuals feel
safe. When asked what information would be important for researchers and health care
providers to know, Marjorie replied:
To fight depression. Because she’s (neurologist) asked me about that. My doctor
too. But I am not depressed because I have that man (husband) in my life. I
couldn’t be depressed.
Conversely, patients who lived alone, were unemployed or lacked family support
described feeling bored and isolated. Limited finances made it difficult to participate in
recreational activities; therefore, watching television was the primary leisure activity for
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Figure 4-4: Supportive Relationships are Key to Living Well with DM1
That’s in front of our building. We have a little pavilion. We sit on the benches and
chat, and socialize, there. That’s just off to the side, it’s just another table where we
socialize a lot. It was cold that day, so no one was there. But usually there’s seven or
eight people outside, chatting. (Frank)
several participants. Moreover, family or friends could exacerbate participants’ feelings
of isolation, disability and dependence. Tim’s gene negative sister would not
acknowledge his DM1, and some non-affected family and friends did not understand the
limitations imposed by fatigue and weakness. For example, Peter felt pressured to
participate at a level that was discordant with his symptoms:
That’s part of the myotonic dystrophy, it makes you tired, eh? Mom tells me I
should be out longer. I say, Mom, you haven’t got it. I’m tired. She says, ‘well,
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you shouldn’t be tired.’ ‘Well, I am, Mom.’ You know, I’m almost 50 years old,
I get tired.

4.4.3.4

What will the future hold?

Participants were resilient despite worries about what the future might hold as their
condition progressed. Many of these fears stemmed from having watched a family
member decline; some participants had a ‘crystal ball’ mentality and envisioned that total
disability was imminent and inevitable: “Probably as my disease starts deteriorating. My
hands – you know, pretty soon I won’t be able to do anything and I’ll go to a nursing
home (Peter).” Meg worried about what would happen to her son with congenital DM1
should she become incapacitated, and others were concerned about burdening family
members with their care. In general, participants seemed more concerned about the
effects of their decline on others, than for themselves.
Participants described problem-solving strategies to assuage their fears. In particular,
participants described using bath seats and grab bars in the shower, and putting spikes on
their shoes during the winter to prevent falls. Moreover, some made plans for the
future—albeit reluctantly—including financial plans and medical directives. For
example, Marjorie stated that she did not want a feeding tube should her dysphagia
worsen. However, there was a variable amount of financial and supportive resources
available to participants, and those with supportive care partners or paid employment
seemed more secure about their future.
Others, however, coped by not dwelling on DM1, and described that there were others
living with far worse conditions or limitations: “So you do what you can, you do what
you have to deal with, there's a lot of people who have a lot of bigger deals than this”
(Meg). The primary coping strategy for most participants was to “just deal with it” and
to take each day as it comes:
When it changes, you’ve got to make the change. That’s all there is to it. You
can’t get it back. When it’s gone, it’s gone. That’s the way this disease works.
You have to learn to function with it. You’ve got do what you can do with what
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you’ve got left. You do need assistance. You do need people around you who
can help you when you need help. Don’t be afraid to ask for help, that’s what
they’re there for, utilize that. It may not be what you’re used to but you have to
make the change if you’re going to get along with the disease. (Max)

4.5 Discussion
Shared decision making is the ‘pinnacle’ of patient-centered care (Barry & EdgmanLevitan, 2012) and patients are increasingly collaborating with researchers to set clinical
goals and research agendas (Schipper, Dauwerse, Hendrikx, Leedekerken, & Abma,
2014; Teunissen, Visse, de Boer & Abma, 2013). Recently, a mixed methods study
assessing the research goals of patients with neuromuscular disease found that patients
prioritize research that explores symptomatic management and medical care, their quality
of life, and educational initiatives to raise awareness about neuromuscular disease
(Nierse, Abma, Horemans, van Engelen, 2013). There remains, however, a relative lack
of patient-centered, qualitative research that explores the experiences of individuals
living with myotonic dystrophy; consequently, there is little evidence that patients’ voices
are being heard, or that their clinical and psychosocial needs are being met.
To address this, we successfully used a novel and innovative qualitative research
approach that explores all of the patient-identified psychosocial research goals reported
by Nierse, Abma, Horemans & van Engelen (2013). While photovoice has been used
with patients with a variety of chronic neurological conditions (Genoe & Dupuis, 2013;
Levin et al., 2007; Lorenz & Kolb, 2009 & Wiersma, 2011) it has not been used in DM1.
We found that photovoice is a useful research method for exploring the experiences of
individuals living with DM1; our research participants captured a range of experiences
including symptom impact on their quality of life, their concerns about the future, and
their coping strategies. While the qualitative approaches used in previous muscular
dystrophy research provide rich data, we believe that photovoice is particularly beneficial
for providing a unique perspective of patients’ lives while giving them the opportunity to
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collaborate in research. Participants’ photographs literally provide clinicians and
researchers with a ‘picture’ of patients’ lives that would not be elucidated during a
clinical encounter.
There were, however, limitations and challenges to using this innovative method with this
population. Some participants had difficulty using the digital camera, and two
participants did not complete the study. We speculate that Max and Peter’s hand
weakness or myotonia made it difficult for them to hold the camera and depress the
shutter; in turn, they were unable to problem solve a solution for taking pictures.
Moreover, DM1 symptoms including fatigue, speech impairments, mobility problems and
apathy may have further impacted participants’ ability to comply with study procedures.
However, while DM1-related symptoms complicated participation, the benefits of
photovoice far outweighed the challenges. We suggest that modifications or adaptations
may be necessary to facilitate participation for some individuals. For example, while we
gave participants the opportunity to practice taking pictures, we suggest that more time
should be spent during the camera orientation session to clarify instructions and verify
that participants are comfortable using the camera. It may also be advantageous to
present participants with scenarios and then discuss potential problem-solving strategies
should the camera fail to work, or fatigue or mobility impairments hinder their ability to
take pictures. Finally, we did not set out to include caregivers as research collaborators,
but our research participants identified them as a valuable strategy that facilitated their
study participation. Therefore, it may be helpful to include caregivers at the outset of
photovoice projects exploring patients with complex needs. Despite challenges,
participants were enthusiastic research collaborators who were candid about the impact of
their progressive symptoms on their self-esteem, their social participation and their
relationships.
Therefore, this study provides a rich exploration of the impact of symptoms on DM1
patients’ lives, and illustrates patients’ shifting identities, a concept that has not yet been
fully articulated in the DM1 literature. In particular, our study participants emphasized
the impact of their changing bodies and their functional decline on their self-esteem and
their sense of self. Our findings suggest that symptoms like dysphagia or cardiac
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abnormalities are not overly troubling for participants despite their propensity to cause
sudden death (de Die-Smulders et al., 1998; Garrett, DuBose, Jackson, & Norman, 1969).
Instead, participants were troubled by symptoms that directly impacted their quality of
life like weakness, fatigue and their altered physical appearance. These findings resonate
with other muscular dystrophy patients (Boström & Ahlström, 2004; Cup et al, 2011;
Gagnon, Mathieu & Noreau, 2007; Heatwole et al, 2012; Nätterlund et al., 2001), and
clinicians’ and patients’ divergent goals are well-described in the neurological disease
literature (Bonelli & Hofmann, 2004; Heesen, Kopke, Richter, & Kaspar, 2007;
Martinez-Martin, Rodriguez-Blazquez, Kurtis, Chaudhuri, & Group, 2011). In
particular, a study of caregivers for individuals with DM1 and dysphagia found that
weakness and fatigue are more concerning to caregivers than swallowing dysfunction
despite the potential for choking to lead to aspiration pneumonia or sudden death. It is
likely that the caregivers’ concerns mirror those of their affected family members
(Authors, in press).
Study participants also described the impact of DM1 on their relationships and discussed
their feelings of isolation and boredom. Participants articulated that the genetic and
progressive nature of DM1 caused them to mourn for lost abilities and opportunities.
This sense of grief and loss permeated the photographs and interview transcripts, whether
it was the death of a child with DM1 or the progressive loss of function and social outlets.
Grief resulting from being childless—due to infertility or fear of transmitting the gene—
was echoed by participants in a qualitative study examining the experiences of 46
individuals living with a hereditary muscle disease (Boström & Ahlström, 2005). In
addition, some of our study participants also expressed a sense of failure or self-blame for
their infertility or for giving birth to a child affected by congenital DM1. Finally, while
mourning the loss of the pre-diagnosis self is a common theme for individuals with
muscular dystrophy--particularly in regard to embarrassment or self-consciousness about
one’s appearance (Boström & Ahlström, 2005)— the extent and complex nature of DM1
patients’ grief over their progressive functional decline has not yet been described. We
posit that our participants experienced a cyclical pattern of loss: disability caused the loss
of independence through reduced recreational opportunities and employment. In turn,
these losses caused financial and social restrictions that resulted in greater social isolation
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and loss of independence. Ultimately, these losses contributed to a decreased sense of
self that was attributed to disability, thus perpetuating the cycle.
However, participants were resilient; their strategies for coping and maintaining
independence were similar to those reported by other research participants, and included
doing chores or other activities at their own pace, or re-framing their expectations for
personal, social or recreational goals (Boström & Ahlström, 2004). In the present study,
while participants reflected on their past accomplishments and their present limitations
with some degree of sadness and frustration, they demonstrated resilience by focusing on
their current achievements. Moreover, contrary to the established literature regarding the
DM1 personality profile (Delaporte, 1998; Meola et al., 2003), several of our participants
demonstrated initiative and showed resilience by putting their condition into perspective
and taking it “day-by-day”, having a good knowledge base about their condition and an
appreciation about prognosis, finding solutions to challenges, and being attentive and
engaged study participants. Three participants were employed (paid or volunteer) and
two were advocates for DM1; one is a leader in the DM1 community, and another chose
to attend a first-year Masters of Occupational Therapy course to discuss five of his
pictures and answer questions about living with DM1. The latter was in keeping with the
tenets of photovoice to disseminate information to ‘stakeholders’. Our results
demonstrating participants’ advocacy, perseverance and insight into their condition are
significant in light of the current literature that focuses on the apathy and limited
cognitive capacity affecting those with DM1.

4.6 Recommendations/Future Directions
Results from this study suggest that our study participants with mild to moderate DM1
are proactive about finding solutions for challenges. Moreover, their photographs offer a
window into participants’ lives that might not be accessible during a clinic
visit. Therefore, the participants’ photographs of barriers and facilitators to living
successfully with DM1 might inform clinical recommendations, particularly suggestions
for mobility aids or devices for assisting with daily tasks. It may also be helpful to use
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the photographs to create handouts or a poster of assistive devices or mobility aids for
patients to use as a reference guide.
This study identified a need for an in-depth, examination of facets of living with DM1
including isolation, grief, and opportunities for social and recreational pursuits;
qualitative research is well-suited to these inquiries. Finally, since participants in the
present study considered symptoms that clinicians provide rigorous surveillance for (e.g.,
dysphagia or cardiac abnormalities) to be minimally impactful, it would be valuable to
interview health care providers and patients to ascertain which symptoms are of personal
and clinical significance.
This finding also underscores the importance of, and need for, a multi-disciplinary team
that is situated in either a neuromuscular, rehabilitation or a family practice clinic. In
order to holistically address patients’ complex needs, it is imperative that the team
includes physicians, nurses, occupational and physical therapists, speech pathologists,
and social workers. Nurses are educated specifically to collaborate with patients and
their family members to address physical and emotional issues; in turn, nurses can help
patients and caregivers navigate the healthcare system and obtain appropriate care in the
hospital or in the community (personal communication, Wilma J. Koopman). Nurses,
therefore, are well-suited to providing holistic, patient-centered care for DM1 patients’
complex needs. In particular, nurses have the skill set to address patients’ and caregivers’
educational and psychosocial concerns while monitoring their symptoms and treating
complications. Research suggests that patients who attend nurse-led chronic disease
clinics have better self-care behaviors, improved outcomes, and greater satisfaction with
their care (Hill, 1997; Strömberg et al, 2003). There may be a unique opportunity for
nurse practitioners to care for patients with a chronic and progressive disease that may
not be of interest to some medical practitioners, particularly when their clinic time is
limited and compensation is fee-for-service (personal communication, Wilma J.
Koopman). While researchers have proposed a DM1 management model and a nurse-led
integrated clinical care pathway (Chouinard et al, 2009; Gagnon et al, 2007), these have
not yet been systematically studied or implemented across clinical sites. More research is
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therefore needed to explore HCPs and patients’ perspectives of—and expectations for—a
patient-centered approach to clinical care.

4.7 Limitations
This research study explored the experiences of nine individuals living with DM1 and is
therefore not generalizable to a wider population of patients. However, the results may
resonate with DM1 patients in other clinical settings, and findings from this article may
be useful for generating new research questions.

4.8 Conclusion
Photovoice offers an in-depth exploration of patients’ experiences that may impact
clinical care. While it is important to consider the unique challenges presented by those
living with DMI, photovoice is an informative and appropriate research method for
exploring their lived experience. In particular, the participants’ photographs and stories
offer insight into patients’ lives that would not typically be ascertained during a clinical
encounter. Further, incorporating patients’ knowledge about DM1 and their strategies for
disease management may be useful for guiding educational initiatives and clinical
recommendations. Finally, we argue that an awareness of—and appreciation for—
patients’ lived experience contributes to better patient-centered care, and that photovoice
is useful for uncovering patients’ illness experiences and generating research questions.
Nurses may be particularly well-suited to addressing DM1 patients’ complex
biopsychosoical needs, and we propose that current physician-led DM1 clinical care
models warrant further investigation.
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Chapter 5

5

Truths and Misinformation: A Qualitative Exploration of
Myotonic Dystrophy Type 1

5.1 Abstract
Background: Myotonic dystrophy (DM1) is an autosomal dominant, progressive, and
multi- system condition that impacts affected individuals physically, socially, and
emotionally. Understanding individuals’ perceptions of their disease is critical to
ensuring appropriate information, education and counseling.
Methods: We conducted a content analysis of findings from a larger study that used a
novel, qualitative research approach called photovoice to explore nine patients’
experiences of living with DM1. Participants took pictures that illustrated barriers or
facilitators to living with DM1; their photographs then formed the basis of semistructured interviews. Transcripts were analyzed and among themes, we identified one
titled DM1 Truths and Misinformation that described participants’ disease knowledge.
Analysis revealed four categories within this broader theme: The Physical and Emotional
Cost of DM1, Managing My DM1, Genetics and Me and Patients as Advocates and
Educators.
Results: Findings showed that DM1 participants had good core knowledge with respect
to their disease and its implications. However, each participant held as fact, fragments of
misinformation that shaped decision-making and pointed to a clear need for strategies to
mitigate variable interpretation of health information.
Conclusion: We conclude that there is a need for increased education and awareness
about symptoms, genetic information and treatment strategies for patients, their family
members, and health care providers.
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5.2

Introduction

Myotonic dystrophy type 1 (DM1)—the most common adult muscular dystrophy—is a
chronic, progressive and life-limiting condition for which there are few treatments and no
cure. DM1 is autosomal dominantly inherited and caused by a CTG repeat expansion in
the 3′ region of DMPK on chromosome 19q13 (Udd & Krahe, 2012). DM1 is
characterized by anticipation; consequently, subsequent generations experience earlier
disease onset and greater symptom severity (Arsenault et al., 2006). In addition to distal
extremity weakness, there is a variable occurrence of cardiac arrhythmias, respiratory
impairment, dysphagia, apathy, cognitive deficits, endocrine abnormalities, cataracts,
pain, and sleep disturbances (Udd & Krahe, 2012). The multi-system clinical
manifestations may impact the physical, emotional and social function of affected
individuals; in particular, DM1 affects family planning as well as other aspects of social
and psychological health (Boström, Nätterlund, & Ahlström, 2005). A DM1 personality
profile is emerging from the literature suggesting that those affected may have avoidant
personality traits and cognitive impairment. Therefore, it may be difficult for those living
with DM1 to participate in new activities or form relationships (Delaporte, 1998; Meola
et al., 2003; Sistiaga et al., 2010). Moreover, a study of 200 DM1 patients living in
Quebec found that affected individuals had lower educational attainment, lower
employment rates and were more reliant on social assistance than the general population
(Laberge, Veillette, Mathieu, Auclair, & Perron, 2007). As a result, individuals with
DM1 may experience disrupted social participation and dissatisfaction with their
employment status, recreational pursuits and mobility (Gagnon, Mathieu, & Noreau,
2007). Disease severity, fatigue, cognition and mood may impact DM1-affected
individuals health related quality of life (Antonini et al., 2006; Laberge et al., 2013; Peric'
et al., 2010).
The literature suggests that DM1 patients’ variable symptom presentations may challenge
care provision (Gagnon, Noreau, et al., 2007; Heatwole et al., 2012). Furthermore, we
speculate that health literacy—or “the degree to which individuals have the ability to
obtain, process, and understand basic health information and services needed to make
appropriate decisions” (Medicine, 2004) –may be impacted for affected individuals’
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presenting with cognitive impairment, apathy and low educational attainment (Censori,
Danni, Del Pesce, & Provinciali, 1990). Previous research suggests that affected
individuals have misunderstanding or misperceptions about DM1 (Faulkner & Kingston,
1998; Laberge et al., 2010); in particular, an interview study with 25 DM1-affected
women found that while most participants had a good understanding of their DM1
symptoms, half of the sample misunderstood genetic information regarding anticipation
and the potential risks associated with maternal transmission (Faulkner & Kingston,
1998). A questionnaire study of 200 DM1-affected individuals’ assessing their
knowledge and attitudes about DM1 found that participants were less likely than nonaffected participants to understand information about—and the consequences of—
inheritance patterns and clinical manifestations (Laberge et al., 2010).
Individuals with low health literacy may be unable to understand information provided by
their health care providers, including treatment advice and information about
appointments (Schloman, 2004). Therefore, the doctor-patient relationship may be
impacted because individuals may not understand information and may therefore be
unwilling or unable to ask for clarification (Peterson et al., 2011). In turn, a survey study
of approximately 1,500 patients with heart failure suggests that health literacy may
impact an individual’s ability and willingness to comply with treatment recommendations
(Peterson et al., 2011); low health literacy may be associated with poorer health status,
outcomes, increased hospitalization rates (Williams, Davis, Parker, & Weiss, 2002), and
an increased risk for mortality(Peterson et al., 2011). Given that DM1-affected
individuals may miss clinic appointments or seem uninterested in their health (Meola &
Sansone, 2007), it is essential that researchers and clinicians assess patients’
understanding of health information. To our knowledge, health literacy has not been
evaluated in DM1.
We speculate that patients’ misperceptions and misinformation about their health may
impede their ability to participate in shared decision-making (SDM) (Charles, Gafni, &
Whelan, 1997). This is problematic because SDM is widely considered to be the
‘pinnacle’ of a patient-centered care approach (Barry & Edgman-Levitan, 2012) that
strives to use patients’ needs, values and goals to guide health management (Medicine,
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2014). We contend that an understanding of DM1-affected individuals’ knowledge and
beliefs about their condition may directly impact patient-centered care approaches; that
is, this information may be crucial for informing clinical care guidelines and for
developing strategies for patient self-management. Therefore, exploring the health care
perceptions of individuals living with DM1 is important for uncovering their
understanding of DM1 to ensure that patients have the tools to proactively seek health
information and manage their care.
Few studies have used qualitative research methods to explore symptom impact on
affected individuals and their family members (Bostrom & Ahlstrom, 2005; Bostrom,
Ahlstrom, & Sunvisson, 2006; Boström & Ahlström, 2004; Cup et al., 2011; Geirdal,
Lund-Petersen, & Heiberg, 2014; Heatwole et al., 2012). We expect that an
understanding of patients’ experiences with—and knowledge about—DM1 will lead to
better patient-centered care. We explored the experiences of individuals living with DM1
using photovoice—an innovative research methodology that uses participants’
photographs to augment qualitative interviews (LaDonna & Venance, 2014; C. Wang &
Burris, 1994, 1997). One theme identified from this study related to participants’
knowledge about DM1. There was a mixture of fact and misperception that had the
potential to impact their health and ability to make informed decisions that has the
potential to influence shared-decision making. Furthermore, this information may begin
to inform health care providers about the level of health literacy in DM1. The purpose of
this analysis was to conduct an in-depth exploration of participants’ understanding about
DM1, and to identify knowledge gaps that may challenge patient-centered care.

5.3 Methods
Twenty-two individuals with mild to moderate adult onset DM1 attending an academic
neuromuscular clinic were invited to participate in a study using photovoice to explore
their experiences living with DM1; nine individuals (n = 4 females) consented (Table 1)
(LaDonna & Venance, 2014). Reasons for declining participation included lack of time
or interest and distance to travel. In addition, 7 individuals expressing interest in
participation were lost to follow-up contact.
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5.3.1

Data collection: Photovoice
Photovoice uses the visual image to document individual experience, and it is

useful for conducting research with participants with low literacy or poor cognition (C.
Wang & Burris, 1994, 1997). Photovoice has also been used to explore a variety of
chronic neurologic conditions (Aubeeluck & Buchanan, 2006; Guerra, Rodrigues, &
Demain, 2013; Levin et al., 2007; Lorenz & Kolb, 2009; Wiersma, 2011). Our
photovoice study design incorporated three data collection components: a camera
orientation session, an individual interview, and a focus group session (C. Wang &
Burris, 1994, 1997). KAL—a graduate student who does not participate in the clinical
care of DM1 individuals—conducted all information sessions and interviews with the
participants.
After consenting, all nine participants attended an individual camera orientation session
in which the purpose of the study was described, the ethics of picture taking was
discussed (C. C. Wang & Redwood-Jones, 2001) and participants were provided with a
digital camera and instructed about its use. Participants were asked to “take pictures of
what it is like to live with DM1”, and to photograph barriers and facilitators to their
health. Participants had 2-3 weeks to take pictures and then returned for an individual
interview. Each individual interview was open-ended and participant directed; that is, all
9 participants began the interview by discussing his or her photographs. KAL would then
use probes such as: “Can you tell me about DM1?” that were followed by questions
pertaining to participants’ disease history, symptoms and daily activities. At the end of
the individual interview, participants were asked to select 2-3 pictures to discuss during a
focus group session. Five participants participated in one of two focus group sessions of 2
and 3 participants. Participant 2 withdrew from the study citing fatigue, and Participant 3
did not attend her scheduled focus group session; their data was retained and analyzed.
Participants 8 and 9 only participated in individual interviews; their data was intended as
a ‘member check’ (Lincoln & Guba, 1985) to ensure that the themes identified resonated
with their experiences. We ceased recruitment when we determined that no new codes or
themes were emerging, and that our data was therefore sufficient for providing a robust
exploration of participants’ experiences living with DM1.
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5.3.2

Data Analysis

Participants were active collaborators in the data collection and analysis process; in
particular, participants chose—and gave meaning to—the subject matter captured in their
photographs (C. Wang & Burris, 1994, 1997). In turn, an inductive content analysis
(Miles, Huberman, & Saldana, 2014) was used in which the authors coded the interview
transcripts using words or phrases that described participants’ actions or experiences.
The most frequently occurring codes were collapsed into themes and categories. Of the
nine themes identified, one related to participant knowledge of their disease coded as
DM1: Truths and Misinformation, captured passages describing patients’ knowledge or
misconceptions about the etiology, inheritance patterns or symptoms of DM1. To provide
a deeper exploration of this theme, two neuromuscular clinicians (SLV and AG)
reviewed and coded these passages using words or phrases that described the topic being
discussed (e.g., “genetics” or “symptom impact”), then labeled them as a “truth” (i.e.,
‘good’ understanding) or as “misinformation”. KAL then reviewed and consolidated the
codes into categories. All researchers met regularly to discuss the codes and categories
and to resolve areas of discrepancy; in particular, discrepant issues were resolved with
discussion and/or by reviewing the patients’ transcript in tandem with his/her chart. The
final list of categories was developed by consensus. NVivo©, a qualitative research
software program, was used to organize and manage the data. To enhance the study’s
relevance and resonance for clinicians, we conducted a retrospective chart review to
collect demographic and clinical information (Table 2).
The study was approved by the Western University Research Ethics Board, London,
Ontario, Canada.

5.4 Results
All patients had been symptomatic for many years (range 8 to 34 years, mean ± SEM
19.2 ± 3 years) prior to participating (Table 2). Seven of the nine participants had a
family history of DM1, and all but one were ambulatory. In general, all participants
discussed DM1 symptoms and their impact on daily life with varying degrees of
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certainty. Yet, all participants stated as fact, opinions that reflected misperceptions on the
part of self, friends, family, family physicians, specialists and others. Four categories
were identified: The Physical and Emotional Cost of DM1, Managing My DM1, Genetics
and Me and Patients as Advocates and Educators.
Table 5-1: Participant snapshots
Participant 1

Mid 50s and has mild DM1. Participant 1 asked her husband to assist
with data collection; together, they took 4 pictures. She completed her
individual interview, but did not attend her scheduled focus group
session.

Participant 2

Early 70s and has mild-moderate DM1. Participant 2’s husband
helped her take pictures and he attended her individual interview.
They discussed 13 photographs. Although Participant 2 was an
enthusiastic research participant, she withdrew from the study because
of fatigue.

Participant 3

Early 40s and has moderate DM1. He took 15 pictures and
participated in Focus Group 1.

Participant 4

Mid 40s and is moderately affected. He took 40 pictures and
participated in Focus Group 1.

Participant 5

Early 40s and is mild-moderately affected. Participant 5 took 11
pictures and participated in Focus Group 2.
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Participant 6

Mid 40s and has moderate DM1. He was unable to take pictures
because he had difficulty using the camera. Instead, his interview was
structured around the images he would taken. Participant 6
participated in Focus Group 2.

Participant 7

Early 40s and has mild DM1. Participant 7 chose the subject matter of
her 28 images, but her partner took the pictures on her behalf. Both
participated in the individual interview session, and Participant 7 was
a member of Focus Group 2.

Participant 8

Late 50s and has moderate DM1. Participant 8 stated that he had
difficulty using the camera; consequently he was only able to capture
one image. Participant 8’s individual interview was used as a member
check of the preliminary findings.

Participant 9

Early 40s and is mildly affected. Participant 9 took 5 photographs,
and her individual interview was used as a member check of the
preliminary findings.
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Table 5-2: Clinical and demographic background of the participants continued
Duration of Disease at Time of Study

19.2 ± 3 Years

Age of Symptom Onset

27.6 ± 4.5 Years

Time to Diagnosis

5.4 ± 2.9 Years

Post-Secondary Education

2/9 (22%)

Employed

2/9 (22%)

Family Member with DM1

7/9 (78%)

Number of Trinucleotide Repeats

793 ± 38

Ptosis

7/9 (78%)

Dysphagia/Dysarthria

7/9 (78%)

Respiratory Involvement

5/9 (55%)

Weakness

9/9 (100%)

Ambulatory

8/9 (89%)

Diabetes

2/9 (22%)

Cataracts

6/9 (67%)

Cardiac Involvement

4/9 (44%)

Depression

3/9 (33%)

Excessive Daytime Sleepiness

6/9 (67%)
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5.4.1

Physical and Emotional Costs of DM1

All participants were aware of the variable presentation and progressive nature of DM1
and were able to accurately describe neuromuscular and systemic manifestations.
Participants were often knowledgeable about symptoms and disease complications
regardless of whether they had experienced them personally. In particular, patients
correctly identified weakness, droopy eyelids, fatigue, myotonia, sleep abnormalities,
pneumonia, diabetes, cataracts, and cardiac abnormalities as complications of the
disorder.
“You got muscles. Like my heart’s a muscle and since I have heart disease, I
said where’d that come from? Myotonic dystrophy they told me. And that
affected my muscle and my heart so they had to put in a pacemaker to pace it.
But like I said, what’s going to happen eventually? They just keep putting in a
new thing every ten years or whatever and after that they just said, it just stays in
until you die I guess” (Participant 1).
Occasionally, participants did not relate symptoms or consequences (e.g. excessive
daytime sleepiness or ptosis) to their DM1, or they stated that potentially unrelated
symptoms were caused by DM1. For example, Participant 2 identified a “cough” that was
chronic—and clearly unrelated to her DM1—as the symptom that led her to believe she
had inherited the disease from her father: “On my mother’s side there is no one. No one.
It was dad and I know that because I nursed dad and I was the oldest girl and I was a
nurse. So anyway, we spent a lot of time at their house. Dad got this cough and he would
almost whoop. Well I have that...” (Participant 2).
The emotional burden of DM1 on participants was significant (Figure 1), and participants
articulated their grief for lost function, limited social and employment opportunities, and
the ability – largely attributed to inheritance and the understanding of genetics - to have
children. Moreover, participants had insight that DM1 affected their physical appearance,
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resulting in body image concerns. These concerns were magnified by perceptions that the
general public’s lack of awareness about DM1 contributed to judgmental behavior.
“The main problem I have with this is not something you can see because a lot of
people don't understand. Like, if you don't have an arm, okay, they figure that out.
You know, if you don't have a foot or you have to wear shades, fine, but you can't
see the myotonic dystrophy, and people judge. But it bothers me the most with (son
with DM1) because they judge a person's intelligence by their speech. Son’s speech
is not the clearest so they assume he's not the brightest, and he knows they assume
he's not the brightest because of his speech, so that bothers me” (Participant 9).
Participants correctly perceived the likelihood of progressive disability over time, but
there was a ‘crystal ball’ mentality in which participants envisioned that worst case
scenarios were inevitable. Participant 8 described his concerns about needing assistance
in the near future: “Probably as my disease starts deteriorating. My hands – you know,
pretty soon I won’t be able to do anything and I’ll go to a nursing home.” Finally, some
participants were aware of the early mortality that is associated with DM1 when
symptoms present in adolescence or early adulthood: “Because, like people with
myotonic dystrophy do have a shorter lifespan. Usually late 50’s, 56 and up usually is
when... Not necessarily that you hit 56 and you die. But you’re still going to get worse
and probably be in bed more and stuff like that” (Participant 3).
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Figure 5-1: Physical and Emotional Costs of DM1: The Challenges of Everyday
Activities: When asked what household chores she had difficulty with, Participant 7
responded: Everything. Actually, vacuuming…Getting places to do the dusting and
whatnot, depending on how much room there is. I can't stand for long periods. I had
to get a new fridge where the freezer was on the bottom so I could reach down into it,
it's a drawer type. It makes it much easier to get things.

5.4.2

Managing My DM1

Participants understood that while DM1 is currently without treatments that slow disease
or provide a cure, there are a variety of strategies available for symptomatic management.
The need for multi-disciplinary care was acknowledged, and participants were able to
identify dietary management, feeding tubes, BiPAP, mobility devices, and regular
monitoring for cataracts and cardiac care as important strategies for managing DM1.
However, some participants engaged in a variety of self-care strategies of variable
efficacy:
“I am on a BiPAP machine but only during the night...I feel I need it because it is
easier to breathe with it on...Because I have an air purifier, it takes all the toxins
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out of the air and you get pure air and that takes away, that I don’t have to wear
that because the pure air is there. I still wear the thing at night but the pure air is in
the rooms all where I live so it’s just pure air and it’s clean, it’s fresh and it’s
good, good for the body” (Participant 6).
Furthermore, Participant 7 stated that her cough assist device improved her swallowing
difficulties, and others believed that strenuous exercise was detrimental and should be
avoided. Several participants, however, described that staying active could be beneficial;
for instance, Participant 9 encouraged her affected children to be physically active
because she erroneously believed that exercise would make them stronger, reverse their
muscle weakness and atrophy, and improve function:
“You know... there's no reason why my kids can't be great at karate even though
they have muscle weakness. That's part of why they're in karate is to strengthen
their muscles so when their muscles do let them down, they have more muscle
memory than the average so they'll buck up to normal.”
Finally, some participants articulated the rationale for being unable to drive due to
excessive daytime sleepiness or muscle weakness, and compensated by arranging
transportation through friends and family or by using mobility devices such as scooters
(Figure 2) wheelchairs, or canes.
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Figure 5-2: Managing My DM1: Using A Mobility Device to Navigate Public
Spaces: That’s my scooter, that’s very helpful. My hot rod…. So, yeah, I just use it to
go the library or just to go to downtown or whatever, the mall, around the building…it
helps me a lot. (Participant 4)

5.4.3

Genetics and Me

All participants described that DM1 was an inherited disease, but participants’ knowledge
about genetics was unpredictable. Therefore, while some participants were wellinformed about genetics, most described some incorrect information. In particular,
participants did not accurately describe genes, inheritance patterns and the relationship of
gender to the disease. While these beliefs were accepted as fact, it was also clearly
apparent that participants had grappled with, and tried to make sense of, this very
complex topic. In an effort to describe genetics to her child, one participant likened DM1
to a ‘broken stair’ in the DNA structure.
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“On one of the floors on (science museum) they have the double helix, so I was
demonstrating to (daughter), this is what the helix looks like, and this, and I broke
apart the stairs, is what ours looks like because that's where the myotonic dystrophy
is, so she understands that. So that's what the myotonic dystrophy is, a broken stair
in our spiral staircase.” (Participant 9)
Participants were able to describe anticipation and the severity of a childhood
presentation of DM1, yet misconstructions about inheritance were common. One
participant stated that the likelihood of an affected sibling having an unaffected child was
“slim”, another described that there was only a 25% chance of passing the gene on, and
several incorrectly described the effect of gender on inheritance: “… they say mother to
son, and son to daughter. It seems to go that way. My sister thought it goes from mother
to daughter. I said not. Most of the kids seem it comes from the father to the daughter
and vice versa for the father.” (Participant 1)
Moreover, Participant 2 expressed surprise (perhaps understandably) that all of her
children were affected because she believed that autosomal dominant inheritance meant
that only half of her children would inherit the gene: “I am sorry all of my children have
it. This was supposed to be 50%”. DM1 “skipping generations” was also reported;
Participant 3 stated that his sister had undergone genetic testing and tested negative, yet
he was concerned that his sister’s children might still inherit DM1: “Um, like they tested
my sister and she’s fine... So, my sister’s fine. Don’t know if her children are going to
have it but they’re too young to test right now. They gotta be at least in their teens and
they’re not there yet. But they can have it”.
Participants also stated that gender influenced disease severity and progression; they
believed that men were more likely to inherit and that DM1 progressed faster in males.
However, one participant believed that the disease was more severe in females, yet did
not attribute this to the risk of having a severely affect child with congenital onset.
Knowledge of genetics and inheritance influenced decisions around family planning. In
some cases, reproductive decisions were made prior to diagnosis. However, two
participants decided not to have children after confirmation of their diagnosis to prevent
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passing the gene to their children. Participant 6 had considered anticipation, and
understood that he could have a severely affected child: “Because I was told that if had a
child with my wife, it could be delivered with it (DM1) and so I said, ‘I can’t do that, I
can’t do it, I wouldn’t do it.’ It’s unfortunate I can’t have a child but it’s just not a good
idea.”
However, while others understood the concept of inheritance, they did not fully
comprehend the risk:
“Like I mean apparently they’ve found the gene that does it. That’s the normal
gene or whatever, ours is this. That’s as far as I know about it, that it’s mutated.
If you have two of the little ones, you’re good. But I’ve got one of each, so it’s
only 25% my kids will get it. It’s not like my partner has it. She has two normal
ones, so it’s 75% chance he’s going to be normal” (Participant 5).

5.4.4

Patients as Advocates and Educators

Participants identified that the relative rarity of DM1 meant that neither the general
public, nor most health care providers, were particularly knowledgeable about the
condition. Participants took it upon themselves to take leadership roles in the DM1
community (Participant 4) or to educate themselves, their health care providers or other
stakeholders about DM1. For example, Participant 3 visited a Masters of Occupational
Therapy class to educate students about his experiences, and Participant 5 was aware that
patient education resources were available. However, he stated that the medical language
was daunting: “I mean I can read Harper’s book, but there’s stuff there that is beyond me.
My doctor understood it, but then that’s his language. I don’t speak that language.”
However, participants also recognized that these resources were beneficial for their nonneuromuscular health care providers, and participants depended on specialists to distil
complex information:
“As I said, I gave him [family physician] that Harper book and he went to town
with that, and then he found as much as he could on his Blackberry. But he had
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never come across it, at least not myotonic. I’m sure he’s seen or heard about MD,
but not the myotonic. But, yeah, he found as much as he could” (Participant 5).
Participants also discussed that there was limited clinical or pharmacological research
available for DM1, particularly in comparison to other neurological illnesses. Participants
were however engaged in, and advocates for, more basic science or patient-centered
research:
“Well I like to see things get better in the healthcare field for people with what I
have and other people have what they have. Because like you said, there is no
medication for us with this disease, they’re working on that, I hope they find
something. ... So I’m here to try to help them the best I can, that’s why I’m here
(participating in research)...it’s my health. I want to do what I can” (Participant 6).

5.5

Discussion

We examined the DM1-specific knowledge of individuals who were part of a larger
qualitative research study that explored the experience of living with DM1. Findings
revealed that DM1 participants had an overall solid foundation of core knowledge with
respect to their disease and its implications. However, each participant held as fact,
fragments of misinformation that often shaped decision-making. We suggest that care
cannot be ‘patient-centered’ if patients do not have the correct information to make
informed health care decisions. Therefore, we identified a clear need for strategies to
mitigate variable interpretation of health information. Our findings have implications for
the health literacy of—and patient-centered care provision for— DM1; in particular, we
identified a clear need to address DM1-affected individuals’; knowledge gaps to optimize
their ability to participate in shared decision-making.
Study participants were able to knowledgably describe many of the multisystem
complications of DM1. It is possible that patients learn the clinical manifestations of the
disease through their lived experience. Twenty-five participants with affected children
had more knowledge of the disease than subjects without affected children suggesting
that experience rather than counseling may drive patient knowledge (Faulkner &
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Kingston, 1998). However, participants sometimes misattributed the causality of
symptoms such as excessive daytime sleepiness, and used their own strategies such as
increasing caffeine intake to try and ameliorate fatigue. These findings resonate with
studies that have examined the knowledge and perceptions of individuals with DM1
(Faulkner & Kingston, 1998; Laberge et al., 2010). Of the 200 individuals who
completed a DM1-knowledge assessment questionnaire, 30.5% believed that they had a
poor grasp of disease-specific information (Laberge et al., 2010). In particular, affected
individuals were less likely than non-carriers to recognize that physical limitations,
apathy, learning difficulties and decreased social and employment opportunities were
potential implications of DM1 (Laberge et al., 2010). Importantly, patients with a number
of neuromuscular diseases considered a lack of information about their condition more
concerning than their degree of disability (Abresch, Seyden, & Wineinger, 1998).
Genetics was the theme most frequently identified with inaccuracies in interpretation for
participants in the present study; although we recognize that this study was distant from
any genetic counselling participants might have received. Nevertheless, this finding is
consistent with the literature. Faulkner et al. interviewed 25 reproductive-age women
with DM1 and found that participants had sound knowledge of DM1 symptoms, yet only
56% of the subjects were able to describe the risk of transmission correctly (Faulkner &
Kingston, 1998). Similarly, Laberge et al. (Laberge et al., 2010) found that half of the
200 DM1 patients surveyed did not have a thorough understanding of the mode of
inheritance. In the present study, in addition to difficulties describing the inheritance
pattern, there were expressed beliefs that gender influenced both inheritance and disease
progression. While participants accurately described anticipation, the increased risk of a
severely affected infant was not ascribed to maternal inheritance. This finding has
implications for clinical care as all participants had received information from patient
education resources, either in the neuromuscular clinic or from genetic counsellors after a
genetics referral. However, this is perhaps not surprising given that findings from other
qualitative research studies suggest that variable knowledge about genetics is common in
other chronic disease populations (McKibbin et al., 2014; Saukko, Ellard, Richards,
Shepherd, & Campbell, 2007).
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We speculate that the intra- and inter-individual variability of disease expression within
families over time with mildly symptomatic or asymptomatic relatives in previous
generations contributes to the confusion regarding inheritance. Another potential
explanation is an interaction between mild cognitive impairments in DM1 affected
individuals and the complexity of genetic concepts, which are often not revisited in a
systematic way in the clinic after initial discussions around diagnosis and inheritance.
Cognitive deficits associated with DM1 have been described (Meola & Sansone, 2007;
Sistiaga et al., 2010) and we speculate this may explain some of the knowledge gaps in a
general population of DM1 patients. In patients with DM1, each additional 100 CTG
repeats reduced the odds of answering questions on the mode of inheritance correctly by
18% (Laberge et al., 2010). Subtle cognitive impairment, however, may remain
undetected on routine clinical assessment in the absence of the application of specific
assessment tools such as the Montreal Cognitive Assessment.
Regardless, the participants in the present study were active and engaged research
participants who perceived themselves as educators and advocates. Participants were
able to articulate a number of common disease features with good insight into how
symptoms impacted their daily lives. However, it may be inappropriate to attribute
misperceptions solely to cognition; instead, other factors including (1) the variable
presentation of symptoms in other family members (2) a large amount of complex
information being given to patients during time-limited clinic appointments, and (3) a
lack of ‘checking’ on the part of health care providers to ensure that participants are
retaining appropriate information may contribute to patients’ variable understanding of
complex health information.
To address these factors, we suggest that patients would benefit from follow-up
appointments at regular intervals with review and assessment of relevant knowledge and
given the opportunity to ask and answer questions that facilitate engagement with shared
decision-making. We recognize, however, that traditional, physician-led clinical care
models may be impeded by system capabilities— including time-limited appointments—
from fulfilling this need. Others have suggested that a more holistic or multi-disciplinary
clinical approach may be useful for addressing DM1-affected individuals’ complex needs
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(Gagnon, Chouinard, Laberge, et al., 2010; Gagnon, Chouinard, Lavoie, & Champagne,
2010; Gagnon, Noreau, et al., 2007). We therefore, suggest that patients would benefit
from referral to nurses and other allied health professionals familiar with myotonic
dystrophy, including social workers and occupational therapists, for further clarification
about symptoms or general disease-specific information, to assist patients in decisionmaking, and to provide reassurance, particularly in regard to disease progression and
genetic information. Counseling and educational interventions may improve patient
knowledge in this category (Furr & Kelly, 1999). It is likely that this information sharing
will be an ongoing process to ensure adequate comprehension, retention of information
and application to relevant decision making over the disease course. Anecdotally, we
hosted a DM1 patient education day in which patients not only had the opportunity to
learn about the latest DM1-related information and research from various health care
providers, but they were also able to share common experiences with others with DM1.
Given that one participant in the present study found the language of patient education
resources to be difficult to understand, patient education days provides good opportunity
for health care providers to simplify and clarify a wide range of health information.

5.2

Limitations and Future Directions

This is a small study that reported on the experiences of nine patients living with DM1;
Findings, therefore, are not generalizable, however may resonate with DM1-affected
individuals and clinicians in other settings. Similarly, we did not set out to evaluate the
health literacy of DM1-affected individuals; instead, findings pertaining to disease
knowledge were identified during data analysis of participants’ photographs and
narratives regarding their experiences living with DM1. Therefore, future research
questions could be directed at the health literacy assessment of individuals with DM1 that
can then be used to develop interventions and patient education materials. In turn,
qualitative interviews with patients would be useful for assessing the content, readability
and applicability of any education or research materials. It may also be advantageous to
examine current DM1 clinical care models to determine if they are meeting patients’
complex physical, psychosocial, and educational needs.
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Importantly, we identified that some participants felt responsible for educating nonneurology specialists about DM1. It may, therefore, be important not only to assess and
clarify patients’ knowledge, but also to provide in-services, one page “DM1 fact sheets”
for family and generalist physicians, or to give presentations to other specialties to ensure
that accurate information is disseminated to health professionals caring for individuals
with DM1. Patients may be a powerful and under-utilized resource for raising awareness
in the clinical setting.

5.3

Conclusion

While patients are knowledgeable about DM1, they have misinformation and
misperceptions that may affect their ability to make important decisions about their
health. Findings suggest that information about genetics is particularly problematic for
patients, and that misinformation may influence decision-making. Therefore, future
research should address the educational needs of patients; in turn, educational
interventions are required to bridge these health literacy gaps and optimize the health and
decision-making capabilities of patients with DM1.
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Chapter 6

6

“[The neurologist] is throwing you a raft”: Exploring
motivations for on-going clinic attendance for
individuals living with chronic, progressive and lifelimiting neurological conditions

6.1 Abstract
Background: Patient-centered care may be challenged for patients with complex chronic
conditions, particularly those presenting with cognitive or behavioral impairments. It is
therefore essential to explore patients’ and caregivers’ perceptions about their health
expectations and their clinical care. Myotonic dystrophy (DM1) and Huntington’s
disease (HD)—chronic, life-limiting neurological conditions with few treatments—are
suitable for this inquiry.
Methods: Constructivist grounded theory—a qualitative research methodology that
explores basic social processes—informed data collection and analysis. Fourteen
patients, 10 caregivers and 11 health care providers (HCPs) were purposively sampled
from one academic medical centre in Ontario, Canada to participate in semi-structured
interviews. Three levels of coding were done to generate themes; in turn, themes were
condensed into categories.
Results: Patient and caregiver participants described continuing clinic attendance to seek
expert information and social support. Medical management, altruism and reassurance
provided the motivation. However, patients’ and caregivers’ motivations change over
time, with clinic becoming more important for caregivers as their loved one’s condition
deteriorates. Regardless, participants describe clinic as a ‘safe place’ that decreases their
isolation and empowers them to actively participate in health care and research.
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Conclusion: In the absence of disease-halting or curative treatments, patient and
caregiver participants perceived that they derived a therapeutic benefit from the attentive
care provided by expert HCPs. However, traditional physician-led medical models may
be less focused on patients’ and caregivers’ supportive goals, and we suggest that nurseled—or other clinical care models—warrant further investigation.

6.2 Introduction
The current health care system more readily accommodates patients with acute, treatable
problems, not those with complex, chronic, and progressive conditions (Nolte & McKee,
2008). Wagner and colleagues (2000) proposed a Chronic Care Disease Model that
makes chronic disease management proactive, not reactive; ideally, key elements
including team-based care, patient self-management strategies, information technologies,
and integrated decision making should coalesce to enhance the patient-provider
relationship and improve health outcomes (Coleman, Austin, Brach & Wagner, 2009).
Wagner et al. (2005) argue that a chronic disease management approach must be patientcentered; that is, care must incorporate the experiences, values, needs, and goals of the
patient and his or her loved ones. Moreover, patients should be encouraged and
empowered to manage their own care; to do this, health care professionals (HCPs) need
to provide patients with adequate information and evidenced-based treatment approaches
(Wagner, 2005). However, we speculate that patients with progressive, chronic diseases
presenting with cognitive and behavioral impairments challenge models of patientcentered, chronic care. Care is further complicated by conditions that are hereditary and
have few treatments available. Myotonic dystrophy (DM1) and Huntington’s disease
(HD)--chronic, progressive, hereditary and life-limiting neurological conditions for which
there are no treatments to slow or reverse neurodegeneration--are well-suited to studying
patient-centered health care delivery and expectations for individuals with complex,
chronic disease.
DM1 and HD are genetic disorders characterized by progressive physical, cognitive and
behavioral symptoms that may impact individuals’ personal relationships and their ability
to fully participate in work or leisure activities (Gagnon, Mathieu & Noreau, 2007;
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Nance, 2006). As a result, individuals may have a lower socioeconomic status and a
reduced quality of life. DM1, the most common adult-form of muscular dystrophy, is a
multi-system condition causing muscle weakness, excessive fatigue, swallowing
dysfunction, heart and breathing problems and endocrine abnormalities including
infertility and diabetes (Harper, 2001). There is also a well-recognized DM1 personality
profile described in the literature suggesting that patients may have cognitive and
behavioral impairments including low IQ and apathy (Sistiaga et al, 2010; Delaporte,
1998; Meola et al, 2003). HD is a progressive neurodegenerative disease with similar
features including involuntary movements, cognitive impairment and psychiatric
manifestations. In particular, apathy and other psychiatric features including depression,
anxiety and psychosis can significantly impact individuals living with HD. However,
both conditions are highly variable, and symptoms can differ substantially, even for
individuals within the same family. Regardless, affected individuals have a reduced life
expectancy; sudden cardiac events and pneumonia are the leading causes of death for
individuals with DM1 (de Die-Smulders et al., 1998; Mathieu et al., 1999), while
pneumonia and suicide are the most common causes of death for HD-affected individuals
(Roos, 2010). While there is no cure for DM1 or HD, there are limited therapies
available to mitigate symptoms.
DM1 and HD are relatively uncommon conditions affecting 1:8000 and 1:10,000
worldwide. Therefore, few family physicians follow DM1 or HD-affected individuals,
and patients typically attend specialty neurology clinics that provide diagnostic
evaluations, follow-up, and referrals to tertiary health care providers (Chouinard et al.,
2009). Treatment plans may include medications to treat symptoms, surveillance for
progressive symptoms, and referrals to specialists to monitor complications and quality of
life, or to physical therapists for mobility occupational therapy to address activities of
daily living or social work to consider disability applications (Gagnon et al, 2007;
Gagnon et al, 2010; Nance, 2012; Roos, 2010; Sturrock & Leavitt, 2010; Turner &
Hilton-Jones, 2008). However, patients’ cognitive and behavioral impairments, coupled
with a lack of treatment options, may complicate clinical care; in particular, the literature
suggests that individuals with DM1 may miss clinic appointments and be disinterested in
their health (Meola & Sansone, 2007) or demonstrate poor adherence to clinical
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recommendations (Chouinard et al, 2009). Moreover, HD patients may be unaware of
their involuntary movements or the extent of their cognitive and behavioral impairments
(Kremer, 2002). Given few treatment strategies, and the lack of awareness that patients
may have about their condition, it is unknown why many DM1 or HD patients maintain
regular follow-up at a specialty neurology clinic.
To our knowledge, motivations for clinic attendance for individuals with DM1 or HD
have not been explored. However, reasons for clinic attendance have been studied in
other chronic conditions including cancer (Brain et al., 2000; Thomas, Glynne-Jones, &
Chait, 1997), HIV/AIDS (Bodenlos, 2007), and asthma (Van Baar et al, 2006). For
example, 833 individuals with a family history of genetic cancers attended clinic to find
out information about their individual and family members’ risk of inheriting cancer, to
participate in research, and to learn about genetic testing, screening and prevention (Brain
et al.,2000). Patients with asthma attended to manage their symptoms, seek further
medical investigations, and to hear information about new treatment options (Van Baar et
al, 2006). However, patients also felt compelled to attend appointments that were
scheduled in advance to avoid adversely affecting their relationship with their health care
provider (Van Baar et al, 2006). It is important to note, however, that unlike DM1 and
HD, these conditions have evidenced based treatments that may slow progression or
improve the outcomes of the underlying disease process. We, therefore, sought to explore
patients’, caregivers and health care providers (HCPs) perspectives about why patients
with life-limiting neurological conditions with few treatment options choose to maintain
regular, on-going follow-up at an outpatient neurology clinic. In particular, what do they
perceive are patients’ health care expectations, and does the current clinical model meet
their needs?

6.3

Methodology

6.3.1

Constructivist Grounded Theory

Constructivist grounded theory (CGT) (Charmaz, 2006; 2014) informed the iterative data
collection and analysis process. Grounded theory is rooted in symbolic interactionism,
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and it uses inductive methods to develop theory about basic social processes that are
grounded in empiric data (Glaser & Strauss, 1967; Strauss & Corbin, 1990; Charmaz
2006; 2014).

6.4

Methods

Individuals with mild to moderate DM1 or HD (by physician report) who maintain
regular clinic attendance were recruited from outpatient neuromuscular and movement
disorder clinics at one academic center in Ontario, Canada. Follow-ups for HD and DM1
patients are typically scheduled every 6 months to two years; therefore, we defined that a
patient maintained ‘regular clinic attendance’ if they had attended at least two
consecutive appointments. Individuals were recruited using purposeful and convenience
sampling; that is, since both DM1 and HD can cause cognitive problems, health care
professionals at each clinic were asked to identify and approach patients who they
perceived were able to provide informed consent and comply with study procedures. To
facilitate participation for individuals with limited mobility, lack of transportation, or for
those who travel long distances to clinic (up to 200km), KAL consented and interviewed
participants directly following their clinic appointments. Health care professionals caring
for patients with DM1 and HD were also invited to participate.
Fourteen patients (n=5 DM1), 10 caregivers (n=2 DM1) and 11 HCPs participated in
semi-structured interviews. The HCPs included neurologists specializing in
neuromuscular conditions or movement disorders, a psychiatrist and a respirologist; a
nurse practitioner; two social workers; and a physical therapist. KAL interviewed most
participants; however, since KAL had working relationships with several of the HCP
participants, a research assistant (CP) conducted the HCP interviews. As the iterative
data collection and analysis progressed, the interview probes evolved to explore themes.
Charmaz (2006; 2014) suggests that grounded theory researchers engage in initial,
focused and theoretical coding. KAL first read the first two DM1, HD and HCP
transcripts as a whole, then coded each line or sentence using gerunds or in vivo codes
that captured the meanings or actions described by the participants. Next, KAL
consolidated the most frequently occurring codes into preliminary categories, then coded
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the next six transcripts using these categories to determine their fit and relevance. KAL
met frequently with SLR and SLV to discuss preliminary findings. The research team
finalized a list of categories by consensus that KAL used to re-code the entire dataset.
Throughout the research process, data within and between transcripts were constantly
compared, and KAL wrote memos and drew diagrams to capture and explicate
increasingly abstract ideas about the data. Memos were invaluable not only for making
the emerging analysis more theoretical, but also for determining avenues for theoretical
sampling to elaborate on the categories. For example, while the focus of this study was
on individuals living with chronic neurological disease, it became apparent very early in
the research process that caregivers were integral to clinic attendance for several
individuals. Therefore, we amended our ethics application to include caregivers. While
they were given the option of participating in separate interviews, all patient-caregiver
dyads chose to be interviewed together.
Recruitment and data collection ceased when the researchers determined that theoretical
sufficiency had been reached; that is, while gathering additional data might have
provided new insights, we determined that the collected data was sufficient for obtaining
a robust exploration of the participants’ perceptions of—and motivations for—clinic
attendance. NVivo©, a qualitative research software program, was used to organize and
manage the data. This study was approved by the Western University Research Ethics
Board; all participants were assigned a pseudonym to ensure confidentiality.

6.5

Results

The process for choosing to attend an outpatient neurology clinic follows a trajectory
from seeking a diagnosis, to monitoring symptoms, to seeking guidance as the condition
manifests and progresses. Participants described that living with an uncommon condition
was isolating, and they framed their reasons for maintaining clinical follow-up at a
specialty neurology clinic by describing negative experiences with former health care
providers and members of the public. In essence, the clinic was a “safe place” where they
felt understood and where they could seek information and actively participate in their
care. Importantly, the DM1 and HD clinics were not just resources for patients living
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with manifest disease; instead family members, especially partners and children who
were at risk, also came to clinic for counseling and support. Sometimes this care was
informal, but in some situations family members were able to access clinic staff (for
example the social worker or the nurse practitioner) without the patient present.
However, the motivation, emotional experience and the importance of attending clinic
seemed to change over time for both patients and their family members along various
points of the disease trajectory.

6.5.1

First Contact: Seeking a Diagnosis

Patients typically present to a specialist clinic for an initial consultation to seek a
diagnosis (1) when there is a family history of DM1 or HD, but the individual does not
know his/her gene status; (2) when individuals are gene positive but pre-symptomatic; (3)
or when individuals are experiencing neurological symptoms and may or may not have a
positive family history for DM1 or HD.

Findings suggest that individuals often

experience anxiety prior to visits because they are apprehensive about their “genetic fate”
(Dr. Green, neurologist).

6.5.2

Recalling Negative Experiences

Apprehension is also heightened by the genetic nature and variable and unpredictable
disease course of these conditions. Patient and caregiver participants framed their
reasons for seeking regular, on-going follow-up at a specialty clinic by reflecting on
negative experiences in their daily lives or during encounters with HCPs. Often, patients
had been caregivers for affected family members; consequently, they had seen first-hand
the “devastating” progression of DM1 and HD and the judgment and negative attention
focused on their loved one. Participants described that their loved one had been mocked
in public, misdiagnosed and/or prescribed inappropriate treatments. These experiences
seemed to cause great anxiety for patients as they contemplated what their future might
hold:
But she (mother) just had a lot of movements and stuff. So a lot of people made
fun of her all the time. But coming to the neurologist back then, it was horrific to
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just see what my mom was going through. And the two of us would just bawl all
the way home… just because they couldn’t do nothing. And oh my God, I was
freaking out for myself too (Patricia, HD patient).
Participants understood that DM1 and HD are uncommon conditions; few participants
had heard about DM1 or HD prior to a family member’s diagnosis, and they perceived
that the conditions were poorly understood by the general public and most HCPs: “I talk
to some people that they probably heard about it but I don’t think they know much about
it. I know me, the first time I find out about it, I didn’t know what the hell it was, I didn’t
have the slightest idea. Hell, my doctor didn’t know what it was” (Lucy, HD Caregiver).
Participants also described that they or their loved one were sometimes dismissed by
HCPs who were perplexed about their symptoms: “His mother really wandered for, I'm
going to say a good 10 years. Everybody just thought she was crazy… nobody would
pay attention to her…” (Michelle, HD Caregiver).
Some participants described having to undergo numerous medical tests that sometimes
resulted in a misdiagnosis or inappropriate pharmacological management. Negative
experiences further impacted patients following their diagnosis. While not unique to
DM1 or HD, some participants had a poor relationship with their treating neurologist
which impacted their willingness to attend clinic; consequently, they either temporarily
stopped attending or they asked to be referred to another specialist such as the participant
below:
I wasn’t followed for anything for the myotonic dystrophy because I never really
had any problems, right? I mean other than little stuff and then when I started
falling, my gait had changed and I started falling a lot. Then they sent me to
(doctor) and (we) had a bit of a misunderstanding shall we say. I just don’t like
the (doctor’s) bedside manner (Maxine, DM1).
Given the uncommon occurrence of these conditions, they were usually the only patient
with DM1 or HD in their family physician’s practice. Therefore, they stated that their
family physician had little knowledge about--or experience managing—their complex
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symptoms. When asked if her husband’s family physician managed his HD symptoms,
Michelle (HD caregiver) responded:
Our family doctor knows nothing, actually. It's a bit disturbing…. his doctor told
us, ‘I've been a doctor for 25 years and I've never had a patient with it and I'm not
prescribing for you. Go to the other doctor’….I don't think you should be
shutting a door on someone who gets something that you didn't learn about. I
mean, there's so much on the internet, that he could at least give him a little bit of
sympathy…

6.5.3

Clinic is Experienced as a ‘Safe’ Place

Once patients adjusted to the initial shock of their diagnosis and had developed rapport
with a specialist neurologist, most participants perceived that the clinic was a comfortable
place where patients and families could seek the therapeutic benefit of expert
information, reassurance and support. As Jeff (HD) and his father described, it was
sometimes difficult for participants to articulate what made the clinic seem comforting:
“It’s just whenever I come here, it’s hard to put into words…”(Jeff, HD patient). “It’s
like a shrine, it’s like you’re going to go to, it’s like going to church on Sunday, it’s like
going to a shrine, like when he comes here he feels, I don’t know, it gives you a different
feeling of something I guess (Frank, Jeff’s caregiver).”
Patients and caregivers seemed to experience the specialty neurology clinic as a ‘safe’
place staffed by experts who were aware of their limitations and treated patients as
individuals, not as a disease. They seemed comforted knowing that someone was
“…looking after me that way, rather than being out there on your own and all this stuff
starts happening and you have nobody to turn to” (Tim, DM1). In contrast to their
experiences in non-neurological practice settings or in the community, patients felt
understood at clinic; that is, they did not have to explain their condition, their physical
and behavioral impairments or their appearance. Participants like Doug (HD) felt
comfortable talking about HD with the clinic social worker, but not with others because
“they don’t understand it.” Moreover, some HCPs perceived that being understood at

153

clinic seemed to reduce some of the anxiety of living with—and the fatigue of having to
continuously explain—an uncommon condition.
I think them just knowing that people understand and that they care… I think
when you make that connection, even how insignificant it might seem to us
because we don’t think we’re doing a lot… it’s someone that’s trying or does
understand that they have challenges and that they’re dealing with that, and
someone that will just listen to their frustrations (Mae, allied health professional).
Seeing others with their condition was another aspect of feeling understood. While it was
troubling for some participants to see patients with more severe disease in the waiting
room, for others, it provided a degree of comfort and eased their sense of isolation: “I’m
comfortable coming here because other people if they come here have the same thing…It
just makes me feel better knowing other people have it….(Jeff, HD).” Jeff’s caregiver
added, “Yeah, you just feel that you’re not alone” (Frank).

Figure 6-1: Maintaining Clinic Attendance in a ‘Safe Place’
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6.5.4

Motivations for attending clinic: Seeking Expert Information

At each stage of the disease trajectory, seeking expert information was described as the
main motivating factor for clinic attendance. “Just having a doctor or social worker or
nurse who is an expert in that field, really helps them. More often than not, they have
lots of questions to ask as well, which could be on a social front, medical front, nursing
front, whatever. But they really have got quite a lot of questions to clarify each time that
they are with us” (Dr. Night, specialist physician). Information however, meant different
things at different time points, including seeking a diagnosis, education about DM1 or
HD, monitoring symptoms and seeking a prognosis. Participants were particularly
motivated to obtain information from experts about how their condition would impact
their daily lives. Some contrasted the knowledge they received from their specialist with
the care provided by their family physician:
I think since she’s a specialist per se and my family doctor is more general, like
he knows maybe the idea of muscular dystrophy and what it kind of pertains to, I
think Dr. Thompson would know more detail, like digs deeper into it. He might
say, people with muscular dystrophy, yeah, they have trouble with their hands, but
Dr. Thompson knows they have trouble with their hands but she knows why they
have trouble with their hands (Tim, DM1 patient).
The clinic is also a resource for patients to seek pragmatic help completing paperwork for
disability or insurance claims, and for inquiring about—or receiving assistance
obtaining—medical or community resources including medical alert bracelets, support
groups or funding opportunities. Clinic staff sometimes served as a liaison between
patients and employers to facilitate appropriate work conditions for patients’ changing
needs. Expert assistance seemed to ease these daunting tasks for patients:
Yeah, he (Ray, allied health professional) just happened to come out because my
insurance company sent me out to apply for CPP and he offered to come out and
go through it with me. So that was a big help because that was overwhelming. I
just looked at it and I just put it away. …He come right out to the house… He
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wrote everything out and worded things the right way and he was awesome. I
don’t think I would have got it done. (Patricia, HD patient)
Patients and caregivers described that attending a specialty clinic staffed by experts was
also important and necessary for obtaining the latest information about research
opportunities and therapeutic advances and for having their questions answered:
I have questions that cannot be answered by anybody else, they don’t know the
answers. My family doctor doesn’t really know the disease, I come here because
I know it’s helpful and sometimes you have questions that only Dr. Thompson
can answer because that’s what she specializes in. And sometimes, it’s not only
me, sometimes my caregiver will have a question for Dr. Thompson that I don’t
think of, for their personal knowledge or for me. It just helps me see where I’m at
and if I’m having problems with something what can be done to help me, what
different things, depending on what it is (Jackie, DM1 patient).
Another key reason that individuals maintained regular follow up was to have their
symptoms monitored and to measure their disease progression. Often, seeking
information about disease progression provided patients with reassurance that they had
not declined substantially or that their current symptoms may be improved with medical
management. For patients and caregivers, this was described as ‘hearing good news’
that relieved some of the tension of living with a progressive and unpredictable illness:
…one day Martha was testing my strength and she was doing my shoulders and
she told me, she goes, for somebody with MD, you have very strong shoulders.
That makes me feel good because I know, okay, I have strong shoulders at least.
Something is strong on me, right? …. So, I think having them as kind of a safety
net or knowledge of information or just something to fall back on is a good
feeling I think. Everybody needs something. (Tim, DM1 patient)
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6.5.5

Seeking Connection

Given the inherited and unrelenting physical and cognitive decline of DM1 and HD,
participants described experiencing shame or stigma, and in turn, several felt compelled
to ‘hide’ or keep their diagnosis a secret. Participants described that they did not tell
employers about their condition and avoided friends and family; others had family
members who refused to acknowledge or speak about the disease publicly. Participants
feared that their genetic status could impact them financially (job or insurance loss) or
socially (avoidance; fear of being mocked). Isolation and a sense that patients were
‘fighting the battle alone’ permeated the interviews. Therefore, the lack of community
awareness was exacerbated—and patients’ sense of isolation increased— by an
unwillingness for some individuals with DM1 or HD to share their stories: “I would
never go over to your house and just sit down and start chatting about what I have, it just
wouldn’t happen, so it (clinic) kind of makes you kind of talk about it, even though you
may not want to, but it needs to be addressed” (Beth, HD patient).
Clinic, therefore, gave patients and caregivers the opportunity to form relationships and
share their stories with HCPs and other families living with these conditions. For some,
clinic was viewed as a social outing where they could meet—perhaps for the first time—
others with their condition, or form relationships with HCPs who were understanding and
who specialized in their uncommon condition:
Each day goes by and you’re wondering, where is this disease going to end up?
And then, seeing the specialists that know what they’re doing helps to give you
some hope. You see somebody that understands, that can understand the
Huntington’s, or whatever, somebody that wants to take interest in it…(Rob, HD
patient).
Participants described that their HCPs were ”easy to talk to”, and some described their
HCP as a friend. Participants appreciated ‘small talk’ during clinic visits about personal
hobbies or interests, important life events like weddings, and the sense that they were
known and treated as an individual, not as a disease: “I don’t know how they all know
every little detail about me …” (Patricia, HD patient). A sense of connection seemed
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equally important for the HCPs: “I do love it and I don’t need to be doing this job any
longer… but I’ve connected so well with the Society and with the families that I work
with that I feel part of their family now” (Ray, HD social worker). HCPs also described
that it was a “privilege” to care for multiple generations of a family (Dr. Green,
neurologist), and they enjoyed forming warm, long-term relationships with patients and
their family members and helping them navigate complicated decisions (Dr. Matthews,
neurologist).

6.5.6

Drivers of On-Going Clinic Attendance

Seeking expert information and connection are driven by three factors: symptom
management, altruism and hope. While there are no treatments to slow or reverse
neurodegeneration, there are management options available to address problematic
symptoms including medications, assistive devices (e.g., mobility aids; BiPap), referral to
specialists, and counseling. For some patients, however, seeking a tangible
pharmaceutical treatment was not their main goal for attendance. Patients and caregivers
either perceived that there were few treatments available, or they were not aware that
medications or interventions that their clinician had prescribed (e.g., psychiatric
medications for behavioral complications) were treatments for their HD or DM1. HCPs
also indicated that pharmacological treatment was not always the patients’ and
caregivers’ motivation for attending clinic:
From our point of view, we want to make sure that they are getting the right
treatment. But, for them, treatment is just a part of the management. The
physician is very interested to improve the affective symptoms, for example, from
a psychiatry point of view, then you are just very interested in controlling the
motor symptoms. But the patients, all they want is to make sure they get the best
treatment and that’s why they come back. And things change as well, they’re
always evolving (Dr. Night, specialist physician)
Instead, altruism seemed to be the main driver for maintaining regular follow-up.
Patients and caregivers described that they wanted to be advocates for individuals living
with their condition. Some participants described that they believed that little could be
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done to help them, but that their regular attendance at clinic might help future
generations, primarily their children or other at-risk family members. In particular,
participants came to clinic to hear about—and perhaps participate in—therapeutic
advances and research opportunities; for instance, one participant with an unusual disease
presentation consented to having her blood sent for analysis, and several other
participants had enrolled in clinical trials.
Patients viewed themselves as educators; that is, they provided information to their nonspecialist HCPs, and they perceived that by attending clinic and participating in research,
that they were teaching consultants and trainees more about the condition. In turn, their
participation would raise greater awareness for the medical community that could lead to
therapeutic breakthroughs. “I like to participate with (researchers) so people learn about
it, so maybe somewhere down the road there’s a cure or some time down the road there’s
something that people will learn and then, like after I’m gone, people that have it may
have it easier than I do basically” (Tim, DM1 patient).
Most HCPs indicated that their main role was to give patients and their families hope by
providing management strategies and information about research and therapeutic
advances. For some, attending clinic gave patients and their families something to ‘cling’
to, namely reassurance that the patient’s symptoms were being managed and that the
medical and research communities were working toward a therapeutic treatment or a
cure:
It’s kind of like you’re in a lake, drowning. And he’s throwing you a raft, while
other doctors are just standing around doing nothing. At least Dr. Green is
throwing us a raft, some kind of a dingy. Some hope that, if you work hard
enough, you might be able to get on the raft and float away (Thora, HD
caregiver).
However, while symptomatic management and altruism provided hope for some
participants, this experience was mixed. Others sensed that they faced progressive
decline with few treatment options to reverse or mitigate deteriorating symptoms,
therefore they believed that “hope is what you make. I don’t depend on anybody else for
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it…”(Maxine, DM1 patient). Instead, some individuals described that they attended
clinic to seek social support and information, not hope:
Hope, well, I think I’m going to die with Huntington’s and not of
Huntington’s...I’m not in a rush to cure me. So, if people are sort of younger, got
children, then the hope is somewhere there’s a tablet that’s going to cure this. I
can see why people would go for hope. I never even ask it of the doctor. I just
figure Dr. Green will tell me when there’s a tablet he wants to put me on. But
right now, there isn’t one available that will slow it down because it’s (disease
progression) slow enough as it is. I don’t know. I could see the hope. I don’t go
for hope, no, I go for information, definitely not hope. Maybe in 10 years I might
say, oh well, maybe they’re going to do something (Margaret, HD patient).

6.5.7

Evolving Motivations

However, patients’ and caregivers’ motivations for attending and their degree of
participation in their health care changed over time; immediately following diagnosis,
some caregivers had to prod their loved one to attend. However, once patients had
adjusted to their diagnosis, attending clinic generally became less anxiety provoking, and
patients typically became active and enthusiastic care participants:
He didn’t want to go…it was a fight, his girlfriend at the time and myself had
been trying to get him to go because we knew he needed to. And finally, I was so
worried he would cancel the day we finally were to go …Once he met Dr. Green
and Ray, everything was great…. he just felt very comfortable with both of them
(Sue, HD caregiver).
Some participants indicated that, over time, the need to measure progression became
more important for caregivers than for patients because this information helped
caregivers manage uncertainty and provided guidance about seeking different care or
resources for their loved one. For instance, several patients were not interested in
knowing how their condition was progressing, while caregivers acknowledged that
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having this information was important for considering future care responsibilities as one
caregiver discusses her:
And we want to be prepared …we had a lot of stuff for my mom with, like, a
walker and … we have lots of bars for him. And Dr. Thompson mentioned the
community help at … So I think it’s us that are more seeking the information
than Nick because he just takes every day at a time (Vanessa, DM1 caregiver).
Moreover, as the patients’ cognitive and behavioral function progressively declined,
caregivers once again took an increasingly active role getting patients to clinic and
directing the clinical encounter. Caregivers were a source of information for clinicians,
particularly if the patient was unaware of—or downplayed—his or her symptoms:
So I think from a patient’s perspective, they walk in there presenting the best that
they possibly can and as much as they’re coming for a reason, they don’t want to
talk about those reasons. And the caregiver comes with, ‘and here’s what’s really
happening’ and ‘this is why I’m here today’. So I think that there are two
different agendas that are always happening when two people come into that room
together. (Ray, HD social worker)
In the end stages of disease, while visits still addressed symptom management for the
patient, the focus of the visit often shifted to supporting family members as they coped
with their loved one’s complex and progressively worsening condition. In a sense, as the
patient’s condition deteriorated, ‘caring for the caregiver’ often became the goal of clinic
visits.

6.5.8

Taking Charge—Encouraging a Patient and Family Centered
Approach

Despite their motivations for attending, participants acknowledged—and HCPs
encouraged— that patients and caregivers were responsible for taking charge of health
care decisions and directing care. Sometimes caregivers would speak for the patient—
particularly as the patient’s cognition or speech became increasingly impaired— but
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HCPs would continue to encourage the patient to speak for him or herself: “It was funny
because we were answering questions for Nick and she (Dr. Thompson) goes, I know you
love him and you’re his care-keeper but I would like Nick to talk” (Vanessa, DM1
caregiver). Moreover, when asked about her goals for clinical follow-up, the nurse
practitioner stated that the focus of the clinic visit was to address patient-identified needs:
“I don’t have any goals, it’s whatever the patient determines is their goal. So, I ask the
patient, what do they think the visit is for, do they have any questions, concerns, things
that they specifically want to address, they want me to address, and then I’ll address
those.” HCPs typically used the clinical encounter to identify worsening symptoms in
order to manage and prevent complications, but a psychosocial approach sometimes
usurped the traditional medical model if patients identified concerns they wanted to
address:
(Describing a typical dictation): ‘You’ll see that today I didn’t examine him or
her because we spent all the time…talking about their difficulty with weight loss,
eating properly and making sure that blah, blah, blah.’ So, not necessarily did I
have to examine their reflexes every time, because we spent 15 minutes…talking
about personal issues…” (Dr. Bennett, neurologist).
Patients and caregivers also decided if, when and how much information they wanted to
obtain about their condition. For some, reading about their condition or attending a
support group was beneficial. Others, however, were determined to take it ‘day by day’
and not research what their future might hold, or they did not feel emotionally prepared to
read about the potentially devastating complications of HD or DM1:
Well I know what it is and I know what it does and stuff like that but for me to
learn more about it I have to be in a certain state. I don’t like to read about it too
much, I have to be in a certain frame of mind to read about it, because it’s not
exactly the most enjoyable reading material, I have to be in a certain state to read
about it and learn more about it (Jackie, DM1 patient).
For most patients, the clinic was enough of a supportive resource that they did not feel
inclined to seek further support elsewhere. Some patients and caregivers were opposed to
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the idea of attending a support group; participants were either uninterested in the topics
presented at group, or they were not ready to see individuals with more severe disease.
Reasons for choosing to obtain information or support varied for patients and caregivers:
I think it probably would be a great idea if Rose went and talked to people about
that kind of stuff because it’s just going to get worse. It’s not getting better
obviously. And me telling her or saying it upsets me, it doesn’t do anything. But
maybe if she heard from other people, maybe how they deal with somebody like
me. That’s how I dealt with my mom, but that’s just me. You have to do your
own thing, right? But maybe the support groups, not with me. I’m not ready to
go to it. But I know one day I want to, but not right now. But maybe it would
make you feel better (Patricia, HD patient).

6.6 Discussion
We identified that patient and caregiver participants attend clinic to be proactive seekers
of expert medical management, community support, and information about DM1 or HD;
these factors are driven by their motivation to manage symptoms, decrease their isolation,
and learn about their uncommon condition. Researchers who used an exploratory
qualitative approach to explore the experiences of 9 individuals (n=1 DM1) attending a
neuromuscular rehabilitation centre in the United Kingdom also found that information
seeking and a sense of community were important factors for clinic attendance (Hartley,
Goodwin & Goldbart, 2011). However, our study advances the work of Hartley,
Goodwin and Goldbart (2011); that is, the authors’ study explored the experiences of
attending clinic for patients with various nerve and muscle conditions, but our study adds
descriptions about what motivates individuals with DM1 and HD to present to clinic, and
the factors that facilitate their desire to maintain follow-up. We also captured the
perspectives of caregivers and health care providers regarding on-going clinical followup for DM1 and HD. Patient and caregiver participants’ describe that attending clinic
was beneficial because of the attentive care delivered by DM1 or HD experts. We
suggest, however, that a different clinical model might more efficiently address
participants’ educational and psychosocial support needs.
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Participants framed their reasons for maintaining on-going follow-up by describing prior
negative experiences that they— or other affected family members—had with health care
providers or members of the general public. In particular, participants perceived that the
general public and most HCPs lacked knowledge about DM1 and HD; consequently,
participants described feeling judged, shamed and isolated. At clinic, however,
participants described that they felt understood and validated by experts who were
interested in their condition. This is similar to findings from Hartley, Goodwin &
Goldbart (2011) who suggest that the clinic becomes a place of “empathy” (p. 1022 &
1029). Ultimately, the actions, motivations and drivers of clinic attendance seem to
indicate that—in the absence of pharmaceutical treatment to change the underlying
disease process—patients, caregivers and HCPs perceived that attending clinic was, in
and of itself, a form of ‘treatment’. Patients and caregivers indicated that the act of being
monitored by an expert HCP meant that they were being proactive about their health, and
actively participating in the “fight’ to find a cure. Attending clinic gave patients and
caregivers the opportunity to be advocates and educators by participating in research and
educating clinicians about their condition. Additionally, patients and caregivers
discussed that seeking connections with other patients in the waiting room or with HCPs
with a specific interest in their condition was therapeutic because they felt understood
and cared about. In particular, the belief they were seen as an individual, and not a
disease, was key to experiencing this benefit.
Hartley, Goodwin and Goldbart (2011) posit that the specialist care provided at a multidisciplinary neuromuscular centre in the UK might be a source of hope and optimism for
patients. For some participants, the therapeutic benefit of seeking information and
connection was experienced as hope, but this was not universal. Furthermore, treatment
and research did not appear to be participants’ primary motivations for attending clinic.
Instead, the rapport that patients had with HCPs fostered their ability to talk about their
condition and to seek social support. Clinic attendance seemed to ease participants’
isolation and reassure them that the medical community had not forgotten them.
Attending clinic provided patients with the opportunity to be proactive in managing their
unpredictable health. Patients with chronic and progressive conditions may feel
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disempowered by their progressive functional decline, which contributes to a sense of
insecurity or to a ‘disrupted’ or shifting identity (LaDonna & Venance, in press;
Aujoulet, Luminet & Deccache, 2007). Moreover, patients living with hereditary illness
may feel powerless based on the fear they may have passed the gene to their children
(Aujoulet, Luminet & Deccache, 2007). Our participants’ narratives were threaded with
suggestions that they had experienced some degree of disempowerment, but coming to
clinic appeared to be a way for them to exert some control. Participants indicated
participating in disease surveillance by attending clinic with expert HCPs meant that they
were being proactive about their health. That is, clinic attendance was perceived as a
tangible way to ‘do something’ to address their complex and evolving needs. We suggest
that patient and caregiver participants perceived that they were collaborators with HCPs
in trying to find answers for their uncommon disorders, and were therefore active, not
passive recipients of care. We propose that patients and caregivers attend clinic—not
necessarily for hope—but to be reassured that they are actively ensuring that the medical
community has not forgotten—nor will forget-- their rare condition.
That patients with DM1 and HD are interested and engaged in their health is a novel
finding considering that the literature—particularly with respect to the DM1 population—
suggests that patients are disinterested in their health (Meola & Sansone, 2007) or adhere
poorly to treatment recommendations (Chouinard et al, 2009). This has significant
implications for patient-centered care provision in these populations; in particular, our
analysis suggests that patient and caregiver participants are proactive about seeking and
providing information and support throughout the disease trajectory. While HCP
participants wished to be patient-centered, they indicated that this approach was
complicated by patients’ progressive cognitive and behavioral decline; in particular, they
described that patients become less aware of their symptoms and the importance of
managing potential complications. Moreover, previous research suggests that issues of
clinical concern to HCPs may not be what patients or caregivers prioritize (Authors,
2014, Heatwole, 2012; Kremer, 2002). We speculate that time-limited appointments or
other system impacts may preclude traditional physician-led clincs from providing
opportunities for in-depth discussions about patients’ and caregivers’ understanding of
disease implications or their psychosocial concerns. Since our patient and caregiver
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participants seem proactive and engaged, we speculate whether another—perhaps nurseled model— might be advantageous for collaborating with patients to develop strategies
for self-management.

6.6.1

Limitations

This is a small, highly contextualized study and may not reflect other clinical settings.
For instance, many DM1 and HD clinics in the United States are multi-disciplinary
‘centers of excellence’ funded by the Muscular Dystrophy Association (MDA, 2014) or
the Huntington’s Disease Society of America (HDSA, 2014).
We recruited patients followed in clinics at one academic health science center , therefore
we do not represent the voices of patients who chose not to seek follow-up or are
followed in other clinical settings. Since we speculate that motivations for attendance
change over time and that caregivers take a more active role as the patient deteriorates, it
is a challenge to recruit individuals in the later stages of disease. These patients may be
institutionalized, lost to follow-up, or difficult to interview because of profound speech or
cognitive impairments. We did, however, ask participants to speculate about a time when
they might choose not to follow-up. Most participants envisioned that they would
continue to attend clinic until they were physically unable to come, or if they believed
that nothing more could be done to help them. And finally, while the interviews were
conducted by a researcher not involved in patient care, participants may still have
provided information that they believed the researcher, or their HCP, wanted to hear.
Attempts were made to reassure participants that their responses would not affect their
care, but we cannot ensure that participants were not impacted by this concern.
We acknowledge that patients’ have variable disease presentations, and that some
patients with significant central nervous system involvement— including memory
impairments or problems with executive function—may not have the same degree of
interest or ability to participate in their health care. However, we speculate that patients
may be judged as a homogenous group rather than as individuals with separate concerns,
interests and abilities; consequently, their knowledge and contributions to selfmanagement may be overlooked.
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6.6.2

Future Directions

Our findings have raised additional questions that are well-suited to qualitative inquiry.
For example, while the purpose of this study was to focus on individuals and their family
members who are living with manifest disease; the data suggests that clinic attendance
prior to diagnosis is often anxiety-provoking and problematic for patients and their
families. Additionally, partners and children of affected parents also access clinic staff to
seek information and counseling. This leads to questions about who is considered a
‘patient’ and how resources are allocated. Research exploring clinic access by nonaffected individuals has implications for health care delivery and potentially could lead to
recommendations for better supportive care for caregivers and those at-risk. Exploring
the experiences of patients who attend well-funded and resourced, multi-disciplinary
clinics might inform both funding agencies and individual practitioners about clinical
care models and guidelines for best practice.

6.7 Conclusion
Our findings suggest that patients and their loved ones living with chronic, progressive
and life-limiting neurological illness maintain regular attendance at an outpatient
neurology clinic because they perceive that the clinic is a ‘safe’ place where they can
seek information, personal connection and explore avenues to advocate for their
condition and contribute to scientific advancements. Clinic visits are, therefore, a form of
being proactive; that is, patients and caregivers experience a benefit from learning about
their condition, educating the medical and general communities about DM1 or HD,
helping future generations and seeking social support. While motivations for clinic
attendance change over time for patients and caregivers, these factors seem to reduce
some of the anxiety of living with a life-limiting condition. However, these findings lead
us to question whether the current clinical models in this academic center should shift
from a physician-led model to one that supports an increased role for allied health
professionals. The study shows that people come to clinic primarily for the safe place it
provides, and to escape judgment and isolation. Traditional medical models and
traditional physician training are less focused on these supportive goals, suggesting that
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perhaps nurses, whose training emphasizes more holistic models of care, could provide
productive and cost effective leadership of such clinics. Regardless, despite the lack of
treatment options to halt or reverse the disease process, on-going clinic attendance
appears to be therapeutic in and of itself, and seems to provide a tangible benefit for
patients and loved ones living with DM1 or HD. We anticipate that findings from this
research will inform health care professionals about DM1 and HD patients’ perspectives
about being proactive about their clinical care; in turn, this knowledge may contribute to
scholarly conversations that may enhance or change current care practices for these and
other chronic disease populations with progressive cognitive and behavioral decline.
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Chapter 7

7

“We Like to Think We’re Making a Difference”: Health
Care Providers’ Perspectives About Caring for
Individuals with Myotonic Dystrophy and Huntington’s
Disease

7.1 Abstract
Background: Patient-centered care for individuals with Myotonic dystrophy (DM1) and
Huntington’s disease (HD)--chronic, progressive and life-limiting neurological
conditions—may be challenged by patients’ cognitive and behavioral impairments.
However, no research has explored health care providers’ (HCPs’) perspectives about
patient-centered care provision for these patients along their disease trajectory.
Methods: Constructivist grounded theory informed the iterative data collection and
analysis process. HCPs at one academic centre in Ontario, Canada were invited to
participate in semi-structured interviews; 5 neurologists, 2 specialist physicians, a nurse,
two social workers and a physiotherapist consented. Three stages of coding (initial,
focused and theoretical) were used to analyze participants’ transcripts, and codes were
collapsed into themes and categories.
Results: Three categories including An Evolving Care Approach, Evolving Roles, and
Making a Difference were identified. Participants described that their clinical care
approach evolved depending on the patient’s disease stage and caregivers’ degree of
involvement. Regardless, HCPs described that their main goal was to provide hope to
patients and caregivers through medical management, crisis prevention, support and
advocacy. Despite the lack of curative treatments, HCPs described that patients benefited
from on-going clinical care provided by proactive clinicians.
Conclusion: Providing care for individuals with DM1 and HD is a balancing act. In
particular, HCPs must strike a balance between (1) the frustrations and rewards of
patient-centered care provision, (2) addressing symptoms and preventing and managing
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crises while focusing on patients’ and caregivers’ quality of life concerns, and (3)
advocating for patients while addressing caregivers’ needs. This raises important
questions about physician-led, patient-centered clinical care models, and we propose that
a nurse-led model may be more appropriate for addressing patients’ and caregivers’
complex biopscyhosocial needs.

7.2 Introduction
Patient-centered care for individuals with uncommon neurological disorders may be
complicated by variable symptom presentations, limited treatment options, and a lack of
evidence-based clinical management models (Jaglal et al, 2014). Moreover, shared
decision making is considered the ‘pinnacle’ of patient-centered care (Barry & EdgmanLevitan, 2012), but researchers and clinicians struggle to define what this means in
practice, and whether a patient-centered care approach is always feasible, achievable or
desirable (Berwick, 2009). Previous qualitative research found that clinicians caring for
patients with progressive neurological disease face numerous challenges as patients
approach end of life; in particular, patients’ complex and variable disease presentations
complicate prognostication, and it is difficult for clinicians to communicate effectively
with individuals who have cognitive or speech impairments (Wilson, Seymour &
Aubeeluck, 2011). However, end of life is only one phase of chronic neurological
diseases; therefore, it is necessary to explore the complex and evolving needs of patients
over a long disease trajectory that may span years or decades. While there are numerous
articles that suggest care guidelines for patients with DM1 or HD (Nance, 2007; Roos,
2010; Sturrock & Leavitt, 2010; Turner & Hilton-Jones, 2008; Gagnon, Mathieu &
Noreau 2007)—to our knowledge clinicians’ perspectives about providing care for these
patients along their disease trajectory has not been explored. This knowledge gap is
significant because we speculate that a patient-centered care approach may be
challenging to enact for individuals living with complex, chronic conditions, particularly
those presenting with cognitive or behavioral dysfunction. Myotonic dystrophy (DM1)
and Huntington’s disease (HD)—genetic, chronic, progressive and life-limiting
neurodegenerative conditions—are well-suited to exploring clinicians’ perspectives about
caring for patients living with protracted physical, behavioral and cognitive impairments.
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Exploring care approaches in DM1 and HD may illuminate care delivery for a range of
chronic neurological conditions that also impact mobility, cognition and social function.
DM1, the most common adult-form of muscular dystrophy, is a multi-system disorder
affecting the muscular, ocular, cardiac, endocrine, gastrointestinal, and central nervous
systems. The clinical manifestations of DM1 include muscle weakness, delayed muscle
relaxation, arrhythmias, excessive sleepiness, and early-onset cataracts (Harper, 2001).
There is a well-recognized DM1 personality pattern described in the literature suggesting
that patients may have low IQ and apathy (Winblad, Lindberg & Hansen, 2005); in turn,
patients may miss clinic appointments and seem indifferent about their health (Meola &
Sansone, 2007). Similarly, while HD is characterized by impaired motor function, its
psychiatric issues --including depression, apathy, anxiety, obsessions and compulsions,
impulsivity, irritability and aggression, and psychosis—are often far more debilitating to
patients and their families (Roos, 2010; Sturrock & Leavitt, 2010). Moreover, cognitive
impairment variably affects individuals with HD, but when present, results in difficulty
with executive function, and problems acquiring, processing and remembering
information (Bonelli & Hofmann, 2004). Therefore, patients may be unaware of the
extent of their symptoms and deficits. Both conditions are life-limiting, and pneumonia
is a common cause of death in DM1 and HD (de Die-Smulders et al., 1998; Mathieu,
Allard, Potvin, Prevost, & Begin, 1999).

Additionally, DM1 patients may experience

sudden death secondary to choking or a cardiac event (de Die-Smulders et al., 1998;
Mathieu, Allard, Potvin, Prevost, & Begin, 1999), and the suicide rate in HD is higher
than the general population (DiMaio et al, 1993).
There are no treatments for DM1 or HD that slow or reverse neurodegeneration, and
there is no cure for either condition. However, there are strategies to manage symptoms,
and the goal for treating individuals with DM1 and HD is to increase quality of life to
“reduce the burden of symptoms, maximize function, and to eliminate unnecessary
‘surprises’ as affected individuals pass expected disease milestones” (Nance, 2007, p.
176). Due to the relative rarity of DM1 and HD, most family physicians, and many
neurologists for that matter, have little experience managing these patients; thus, care is
often provided by specialty neuromuscular or movement disorder clinics (Chouinard et
al., 2009). The literature suggests that a multidisciplinary approach that supports the
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individual and his or her family along the disease trajectory is an ‘ideal’ care plan for
individuals with DM1 (Chouinard et al, 2009; Gagnon et al, 2007) and HD (Nance,
2007; Nance, 2012). Chouinard et al (2009) proposed a DM1 Management Model that
considers the multi-system nature of the disorder, the propensity for individuals to have
limited educational, economic and social opportunities, and the lack of knowledge of
non-specialist health care providers (Chouinard et al, 2009). Similarly, Nance (2007)
proposed the “HD Molecule” as a model for HD care: the patient and his or her family
members are at the center of complex care needs including symptomatic and crisis
management, family issues, education and support that—ideally--should be addressed at
each visit by a multi-disciplinary care team. Treatment plans may include medications to
alleviate symptoms, referrals to specialists to monitor complications, and assessments by
physical therapy, occupational therapy or social work to address activities of daily living
and quality of life (Nance, 2012; Roos, 2010; Sturrock & Leavitt, 2010; Turner & HiltonJones, 2008). However, treatment approaches may be complicated because symptom
presentation, severity, and disease course vary by individual, even among individuals
within the same family. Patients’ progressive functional decline may further challenge
clinical approaches, and therefore family members may become instrumental for
monitoring an individual’s physical and behavioral changes, and ensuring that he or she
is following treatment recommendations (Sturrock & Leavitt, 2010).
There are no studies that explore clinicians’ approaches to patient-centered care for
patients with DM1 or HD along their disease trajectory. Therefore it is unknown if
current care approaches are optimizing patient-centeredness, and if patients’ and
caregivers’ concerns are being heard and adequately addressed. The challenges of caring
for these complex patients warrant investigation because findings may have health care
delivery implications—not only for patients with DM1 and HD--but for patients with
other chronic diseases that present with cognitive or behavioral impairments. Therefore,
our purpose was to explore how health care professionals perceive of-- and provide care
for—individuals with DM1 or HD throughout their disease course. How do they
approach the care of these individuals, how effectively do they feel they are meeting
patients’ needs, and how does their approach to care evolve over the course of the illness?
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7.3 Methods
This analysis is part of a larger study that explored perceptions about clinic attendance for
individuals living with DM1 and HD (Authors, in preparation). Briefly, the iterative data
collection and analysis process was informed by constructivist grounded theory, a
qualitative research methodology that studies basic social processes to develop an
explanatory theory (Charmaz, 2006; 2014). Patients with mild to moderate DM1 or HD
(by physician report), their caregivers, and health care professionals were purposively
sampled from the neuromuscular and movement disorders outpatient clinics at an
academic medical center in Ontario, Canada. Table 1 provides a snapshot of the clinical
contexts. Participants were invited to participate in semi-structured interviews; 14
patients (n= 5 DM1), 10 caregivers (n= 2 DM1), and 11 HCPs including five
neurologists, a psychiatrist, a respirologist, a nurse, two social workers, and a
physiotherapist consented. We ceased recruitment when we determined that the collected
data was sufficient to provide a robust exploration of participants’ experiences of caring
for individuals with HD and DM1. This study reports on the data collected from health
care providers; patient and caregiver data will be reported elsewhere (LaDonna, Watling,
Ray & Venance, In Preparation)
Table 7-1: Clinical Care for DM1 and HD Patients at One Academic Center in Ontario, Canada
Myotonic Dystrophy (DM1)
Clinical Cohort



Huntington’s Disease (HD)

Approximately 150 patients
are followed every 6 months



to 2 years.

Clinical Context



DM1 patients are seen in a

Approximately 125 patients are
followed every 3-6 months.



HD patients may be seen in the

general adult muscle disease

monthly HD multi-disciplinary

clinic.

clinic.
--Or-

in a general movement
disorders clinic.
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Staff/Personnel



All DM1 patients are
followed by one



Four neurologists specialize in

neuromuscular specialist.

movement disorders; one staffs

One nurse practitioner

the multi-disciplinary clinic.

follows most adult







A psychiatrist and social

neuromuscular patients.

worker staff the multi-

Medical students, residents

disciplinary clinic; their

or fellows may participate in

services are also available by

care.

referral.


There is not a nurse affiliated
with the HD multi-disciplinary
clinic.



Medical students, residents or
fellows may participate in care.

Management





Neurological examination,



Neurological examination,

evaluation of cardiac,

evaluation of motor and

respiratory and swallowing

psychiatric symptoms, and

symptoms, and assessment

assessment of psychosocial

of psychosocial needs.

needs.

Medical treatment:



Medical treatment: anti-

stimulants for fatigue, bipap,

depressants or anti-psychotics

cpap

to treat psychiatric symptoms;



Annual ECG

tetrabenazine to manage



Referrals may be made to
cardiology, respirology,

chorea.


Referrals may be made to

speech language pathology,

speech language pathology,

occupational or physical

occupational or physical

therapy, or other specialists

therapy, or for psychiatric or

or allied health professionals.

psychological care. Patients
may also see the HD social
worker or psychiatrist
independently from regular
neurological follow-up.
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CP conducted all of the HCP interviews, which were recorded and transcribed verbatim;
in turn, KAL coded each line or sentence of the first two transcripts from each participant
group using words or phrases that captured the experiences or actions described by the
participants. Next, KAL consolidated the most frequently occurring codes into
preliminary categories, and used these to code the next six transcripts to determine their
fit and relevance. KAL met frequently with SLR and SLV to discuss preliminary
findings. The research team finalized a list of categories by consensus; KAL then recoded the entire dataset. Throughout the research process, data within and between
transcripts were constantly compared, and KAL wrote memos and drew diagrams to
capture and explicate increasingly abstract ideas about the data.

Nvivo, a qualitative

research software program, was used to organize and manage the data. This study was
approved by the Western University Research Ethics Board; to protect confidentiality, all
participants were given a pseudonym.

7.4 Results
Three categories including An Evolving Care Approach, Evolving Roles, and Making a
Difference were identified. The participants described that their approach to care evolved
along the disease trajectory and was dependent on the patient’s disease stage, and the
presence of caregivers and their degree of involvement. HCPs also perceived that their
role in care evolved over the disease trajectory, encompassing educating patients and
families, preventing crises, and providing medical management, support, and advocacy.
In the absence of disease-halting or curative treatment, these roles contributed in various
ways to an overarching goal of providing hope. Reflecting on their efforts to make a
meaningful difference to patients and their families, HCPs described the rewards and
challenges of their care approach; in particular, while participants expressed frustration
and a sense of futility about their inability to provide a cure, they perceived that patients
benefited from regular follow-up with proactive clinicians.
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7.4.1

An Evolving Care Approach

7.4.1.1

First contact

Patients are typically referred to a specialty neurology clinic for three reasons: (1) they
are at-risk for inheriting DM1 or HD; (2) they are gene positive but pre-symptomatic; or
(3) they have neurological symptoms with or without a family history. Initial visits
typically include a review of symptoms and family history, and a comprehensive
neurological exam. Clinicians perceive that patients come to seek a diagnosis and
information from a specialist regarding symptoms, genetic status or the impact that the
disease will have on their families. Family members often attend the initial visit not only
to support their family member, but also because there is a—perhaps unspoken-expectation that they will also receive information and counseling. Patients who do not
know their gene status or who are gene positive but pre-symptomatic may be
apprehensive about their initial clinic visit:
I’m kind of the physician that people hate to meet…There was one lady who was
a runner, and literally her husband came bolting upstairs…and said ‘have you
seen my wife?’...He tried to drop her off…and she just bolted…because coming
to see me is potentially coming face-to-face with your genetic fate (Dr. Green,
neurologist).

7.4.1.2

A flexible approach to follow-up

The approach and content of the follow-up visit varies at each time point, and continues
to evolve once HD and DM1 patients begin to manifest symptoms. A typical 60 minute
visit for both DM1 and HD consists of a neurological exam including a review of
symptoms and a functional assessment, followed by a discussion about treatment options
and research opportunities. Medications—including stimulants to treat excessive fatigue
in DM1, or anti-depressants for the psychiatric manifestations of HD-- are available to
mitigate symptoms, but are generally only prescribed if the patient is experiencing
decreased quality of life. Patients and caregivers are then given the opportunity to ask
questions or to have their concerns addressed.
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We would talk about any of the cognitive issues, memory problems, any
behavioural change, any problems with interpersonal with their working, or at
home with the family. And, then we’d review generally how they’re doing,
functioning, working, how work is going, how are things going with the family,
plans and things long-term. We might talk about driving issues, if that were a
problem. And, then any other, obviously starting out first with any concerns they
have or any issues. Usually a caregiver would come and I would also speak with
the caregiver about how things are going (Dr. Roberts, neurologist).
While the clinicians’ approaches were similar at both clinics, the structure of care and the
role of allied health professional participants differed.

While the neuromuscular clinic

team has access to allied health professionals including physical therapy and social work,
these clinicians cover a large spectrum of neurological illness and do not specialize in
DM1. DM1 patients are therefore only referred to a physiotherapist on an as-needed
basis: “So, I don’t follow them. I don’t follow their progression. I don’t know when
they’re coming” (Diane, allied health professional). Similarly, the social worker typically
works with DM1 patients on a one-time referral basis to assist with disability paperwork.
In contrast, the social worker is an integral member of the multi-disciplinary HD clinic.
In addition to providing care outside of the clinical setting, the social worker evaluates
patients concurrently with a neurologist and a psychiatrist during clinic visits:
… it’s an extremely thorough dialogue and what I really like about it is, it’s not
your typical medical model. It’s much more of a bio-psycho-social … not just
the physical function of the person but how they’re interrelating with their work,
peers, how they’re interrelating with their family members, how is it affecting
their quality of life…(Ray, allied health professional).
While HCPs seemed to have standard templates for how they conducted initial and
follow-up visits, they described encouraging patients and their loved ones to direct the
focus of the clinic visit, and to be actively engaged in making health care decisions.
However, HCPs described that this had variable efficacy because patients were
sometimes unaware or disinterested in addressing symptoms that could lead to morbidity
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and mortality; in particular, patients’ progressive cognitive and behavioral functional
decline directly impacted their ability to recognize and address problematic symptoms.
Participants stated that family caregivers became increasingly important for addressing
concerns and making decisions:
It’s often significant, again in the patients that have cognitive involvement
because they may have lost the cognitive capacity to understand what’s going on,
or they’ve become apathetic so they don’t really care. They need somebody to
motivate them to do all the right things like take the medications they’re
prescribed for other conditions, to understand why they need investigation for
certain things, and why they need to go to other appointments. It’s very helpful to
have a caregiver there to help them do all of those things (Dr. Matthews,
neurologist).
Sometimes, a conversation with patients about the purposes and goals of follow up visits
was perceived as mutually beneficial:
So, I ask the patient, what do they think the visit is for, do they have any
questions, concerns, things that they specifically want to address, they want me to
address, and then I’ll address those. I generally will do a physical exam and
surveillance for their breathing, cardiac, swallowing, speech and how they’re
managing at home in terms of a functional perspective. That’s within the realm of
whether or not they’re interested in that and sometimes their goals will be, ‘I was
just told to come here, and so I’m coming.’ And, so, then we have to discuss that
as well (Martha, nurse).

7.4.2

Evolving Roles

One participant described that neurologists perceive that they are the “quarterback” (Dr.
Matthews) who is responsible for directing all aspects of the patient’s care with support
from nurses, specialists and allied health professionals. Moreover, participants
recognized the lack of curative treatments for DM1 and HD, and therefore defined their
role as primarily one of providing hope by: (a) providing expert evaluation and
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education; (b) preventing and managing crises, (c) being an advocate, and (d) providing
support. These roles were not seen as mutually exclusive; rather, they were perceived as
inter-related and evolving over time. In particular, the HCPs perceived that discussing
research opportunities, offering symptomatic management options and reassuring patients
about their functionality provided patients with the sense that “… somehow in seeing us,
we’re dealing with the active disease and, in seeing someone, something’s being done to
help treat them” (Dr. Roberts, neurologist). Clinicians also sought to ease patients’
isolation and to reassure them that they had not been forgotten by the wider medical and
research communities:
One of the things I see as my job is to let them know that no, actually there is a lot
of stuff that’s happening. I think they’re starting to see it now in the sense that 10
years ago former doctor didn’t talk to them about clinical trials in Huntington’s
disease because there weren’t any; whereas, now we’ve got a couple of research
opportunities for you if you’re interested…. I think they do get some hope from
that (Dr. Green, neurologist).

7.4.2.1

Providing expert evaluation and education

Prior to, and following diagnosis, participants stated that the primary role of the specialist
clinician was to provide education and guidance to patients and family physicians, while
providing surveillance for emerging or worsening symptoms. Participants described the
importance of specialists’ expertise in relation to family physicians’ lack of familiarity
with these uncommon conditions, and perceived their role as one of educating family
physicians and augmenting primary care:
Some family docs are quite knowledgeable, or take it upon themselves to learn a
little bit about the disorder. But when you think that it’s really 1 in 8,000, not
every family physician will have an individual or a family with myotonic
dystrophy….it’s an uncommon disorder when you think about all the other things
that family physicians have to deal with…So, my role… is that our clinic notes
serve as a guide or a template for what needs to be watched for (Dr. Thompson,
neurologist).
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Patient education largely involved describing inheritance patterns, symptoms and the
variability of disease progression. Providers also supplied patients with pragmatic
information regarding management strategies (e.g., breath stacking to improve respiratory
function for DM1 patients), assistive devices, and information about funding or support
resources. Some HCPs prioritized keeping abreast of the latest research and
pharmaceutical options then distilling information for patients. While HCPs perceived
most patients to be active participants in their care, they identified that information
seeking was often a more important priority for caregivers, especially as the patient’s
condition deteriorated. Therefore, HCPs made judgment calls about the amount, content
and timing of information that was given to patients at different points along the disease
trajectory.
I try to encourage them to ask questions because at the first visit after I say you’ve
got Huntington’s disease, I could yammer on for another 20 minutes, but they
hear nothing because they’re just stuck on I’ve got HD...that’s led me to not give
them too much information the first time because it’s going to have to be
reinforced on subsequent visits …(Dr. Green, neurologist).

7.4.2.2

Preventing and managing crises

In the absence of treatments to reverse or slow disease progression, HCPs stated that their
treatment approaches centered around preventing complications and managing crises.
Clinic visits were an opportunity to monitor symptom progression and order tests or refer
to other specialists to evaluate potentially life-limiting complications.
The reason that I’ve gotten into the care of that patient population (DM1) here is
because … We want to identify patients that potentially need some type of
breathing support for the rest of their life and can we identify that group that’s
going to do well … and then try to look for those resources (Dr. Vincent,
specialist physician).
The HCPs described that an essential part of their role was to be flexible about care
approaches and to put structures in place to enable a rapid response to serious and acute
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issues. Specialists and allied health professionals were aware that mobility and
transportation difficulties complicated patients’ ability to come to clinic, and therefore
made efforts to accommodate patients. Strategies included evaluating the patient in
tandem with other doctor’s appointments, making house calls (HD social worker), having
nurses or social workers respond quickly by phone to emergencies or acute issues, and to
‘squeeze’ patients into clinic for acute needs.
…if they’re coming to, say, see the doctor, and we know they need this done,
there might be transportation issues or distances, so then I’ll offer them up I can
do it on a day they’re coming for other tests or other doctors visits if they could
wait that long. But, if it’s a whole year, I try and get them in just on my own day
or see them when they’re coming to see Dr. Vincent or see them when they’re
coming to see Dr. Thompson or Martha (Diane, allied health professional).

7.4.2.3

Being an advocate

Participants emphasized the importance of advocating for patients by raising community
awareness about these uncommon conditions. HCPs described ‘being a spokesperson’
for DM1 or HD by participating in charity events and giving talks at support groups or
patient education conferences. Clinicians—particularly nurses and social workers—were
instrumental in helping patients obtain funding and community resources. “Martha
(nurse) is very good at connecting people…I think Martha is the lynch pin…for linking
people to resources” (Dr. Thompson, neurologist). Moreover, HCPs sometimes acted as
a liaison between the patient and his or her employer, family physician or family
member. In particular, clinicians tried to balance caregivers’ concerns with being a
‘voice’ for the patient and encouraging the patient to express his or her needs.

7.4.2.4

Providing support

Similarly, supportive care meant a number of things to participants including providing
counseling to help patients and families adjust to the diagnosis and strategies for
managing the disease as it progressed, seeking resources for patients and their families, or
offering guidance for family physicians to provide primary care for HD or DM1

187

individuals. Specialist physicians perceived an inverse relationship between their role
and the patients’ disease progression; that is, as patients begin to deteriorate and options
for symptomatic treatments diminished, allied health professionals become increasingly
important for obtaining resources and helping patients and their families cope with
behavioral and cognitive changes.
Dr. Green will often say that…I’m more important to be at these clinics than he is
because it’s (HD) much more of a psycho-social disease and there’s not a whole
lot that can be done likely to stop the disease at this point. He can manage some
of the symptoms but it’s important for someone, like myself, to be around to help
manage all the social challenges that come along with the disease (Ray, allied
health professional).

7.4.3

Making a Difference

7.4.3.1

Frustrations

The variable and unpredictable features of DM1 and HD--namely the behavioral and
cognitive impairments—frustrated practitioners and challenged their ability to
prognosticate and provide education and care. These frustrations were exacerbated by a
lack of resources including limited funding and community resources, few treatments and
research advances, and lack of time to address patients’ complex care needs. Clinic time
was limited and some HCPs had a backlog of patients requiring initial consultations and
follow-up; consequently, providers were not always able to address patients’ multiple
physical and psychosocial needs. Moreover, there was limited funding available for
allied health professionals to provide supportive services:
There’s probably a greater need for these services… particularly social work,
speech and swallowing. … Certainly the social work position that we have
funded…is only a part-time position.

I’m quite suspicious that he does more

than 1½ days per week, but that’s all he gets paid for (Dr. Green, neurologist).
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HCPs devoted a significant amount of their limited clinic time providing education about
DM1 and HD, including management strategies to mitigate symptoms. HCPs described
that patients did not retain information, and some were either unaware--or apathetic
about--the importance of following treatment recommendations:
They are draining in the sense that, you can see them year after year after year and
nothing has changed, they’re still eating like they’re not supposed to, they’re still
smoking and they’re not supposed to, they may or may not take care of
themselves, and that’s just the way they are. So, I find them a significant
challenge to take care of (Martha, nurse).
Moreover, HCPs expressed a sense of futility that despite their best efforts, patients’
function and quality of life would continue to deteriorate:
We do contribute for sure because we manage fairly complicated aspects of the
disease, including, for example, the behavioural aspects… It is not satisfying in
any way because this is a progressive, relentless degenerative disease and we
can’t do anything. Unlike, for example, dystonia torticollis, blepharospasm, or
even Parkinson’s disease, where we have excellent medications that can improve
the quality of life for potentially 20 years. (Dr. Bennett, neurologist).

7.4.3.2

Rewards

These challenges were tempered by the perceived rewards of caring for individuals with
DM1 or HD. Most HCPs stated that they pursued a career in health care because of an
intrinsic desire to make a difference in peoples’ lives. Moreover, the specialist
physicians were inspired—and rewarded--by the intellectual challenge of diagnosing and
managing complex neurological disease. Therefore, despite a sense of futility, HCPs
received small and intangible benefits by being proactive about providing care for
patients and families. In essence, HCPs believed that providing support and advocacy
was the ‘right thing to do’ in the absence of other therapeutic options: “neurology seems
to be a specialty that you could make a difference in, despite not having curative
treatments for a lot of the conditions that we have. So, having a relationship with patients
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and families was an important aspect of neurology as a career path” (Dr. Thompson,
neurologist).
One participant described that caring for these patients filled a void in care that had not
previously been addressed by his departmental colleagues: “I didn’t think that our
(specialist) group was providing them with all the necessary service that was required to
properly care for this population (DM1)” (Dr. Vincent, specialist physician).

Other

participants enjoyed forming long-term relationships with patients; having the “privilege”
to care for multiple generations of a family (Dr. Green, neurologist), and guiding patients
through difficult and emotional situations:
… you follow these people along for years you get to know them. I’ve followed
several mothers through pregnancies. Another whole issue is the genetic
counselling of a woman in childbearing years about the risks that she might have
an affected child ….There is some reward in being able to take somebody through
that, even though you can’t actually treat the disease (Dr. Matthews, neurologist).

7.5 Discussion
When asked whether patients benefit from regular on-going follow-up, Martha (nurse)
responded:
I’m biased, because I’m the one that’s giving them care. It’s hard to know. I
think there, again, we do not know whether or not it makes any difference to their
life, quality of life, or their health--if they come to the clinic or don’t come to the
clinic--because I don’t think that study’s been done. We like to think we’re
making a difference, but I don’t think we know that.
The lack of literature exploring clinicians’ perspectives about patient-centered care
provision for patients with DM1 or HD left us with similar questions: how do health care
professionals describe their management approach for these patients, and do they believe
that the current patient-centered clinical care models meet patients’ needs? Participants
described the necessity and importance of providing proactive, expert, evolving and on-
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going care in specialty neurology clinics because they recognized that the uncommon
prevalence of DM1 and HD and limited system resources precluded primary care HCPs
and generalists from addressing patients’ and caregivers’ complex needs. However,
similar issues—coupled with patients’ variable disease presentation—also challenged
specialist HCPs abilities to provide patient-centered care. Researchers seeking to develop
a chronic care model for neurological conditions (CCM-NC) interviewed 180 HCPs,
community members and policy makers identified similar challenges (Jaglal et al, 2014).
While this study comments on general care for a number of neurological conditions, it
does not specifically explore the perspectives of providing patient-centered care for DM1
and HD affected individuals along their disease trajectory. Our findings, however,
suggest that patient-centered care provision for patients with DM1 and HD is a balancing
act; in particular, HCPs must consider whether system capabilities—including time,
funding, and their medical training-- afford them the opportunity to address concerns that
are most important to patients and their families.
Moreover, HCPs must constantly temper their frustrations and sense of futility with the
perceived rewards of caring for individuals with DM1 and HD. While our participants
had expert knowledge about these conditions and were able to form long-term
relationships with patients, they described that they were frustrated by the lack of
pharmaceutical treatments, limited community resources and funding opportunities,
overburdened clinics with long wait lists, and the emotional cost of caring for these
patients. Our findings that HCPs have limited time to address caregivers’ needs resonate
with other providers caring for chronic neurological conditions (Jaglal, 2014; Nance,
2009). In particular, the current physician-led model at our academic centre is not
designed to provide this degree of social support. In the current fee-for-service model in
Ontario, specialist physicians are paid for services provided only to the individual
referred for consultation, therefore—while our participants described that they spent
considerable time addressing caregivers’ needs--there are limited opportunities for
remuneration for this important work. Similar challenges—particularly time-limited
appointments and a lack of adequate resources to support allied health professionals—
was echoed in a small qualitative study examining the perspectives of physicians caring
for patients with Alzheimer’s disease (Hinton et al., 2007). In essence, there was a sense
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amongst our participants that the current physician-led care model at our academic centre
was not doing ‘enough’; that is, participants were unsure if their care approach was
making a difference in patients’ and caregivers’ daily lives. As Dr. Thompson
(neurologist) stated: “we can do a lot better.”
HCPs also seemed to struggle striking a balance between their role as a patient advocate
with their reliance on—and need to support—caregivers. While participants stated that
they encouraged patients to direct the clinical encounter, they raised concerns that
patients’ progressive cognitive decline and behavioral impairments challenged education
and symptomatic management, and they had to rely on caregivers’ to provide health
information as patients’ health deteriorated. Moreover, the hereditary nature of DM1 and
HD—and the complex care needs patients require as they progressively decline—requires
health care professionals to address the needs of caregivers and those at-risk (Sturrock &
Leavitt, 2010). In addition, our findings resonate with previous literature (Heatwole,
2012; LaDonna, Koopman, Ray & Venance, In Press) that suggests that issues of clinical
concern to HCPs may not be what patients and caregivers are aware of or want to
address. In particular, while HCPs focus on symptoms that may cause morbidity or
mortality, patients and caregivers are generally concerned with issues that impact their
relationships (Cup et al, 2011) and participation in education, employment, and leisure
and recreational activities (Gagnon, Mathieu & Noreau, 2007). We speculate that our
physician participants perceived that they were qualified to treat symptoms, but were less
comfortable addressing patients’ and caregivers’ social and quality of life issues. This
has important implications for treatment approaches and raises questions about patientcentered clinical care models: Is care still ‘patient-centred’ if HCPs address issues they
know to be important, even if they are not prioritized by patients and families? Are HCPs
trained adequately to maintain patient-centred care as patients functionally
decline? Finally, are health care teams sufficiently nimble to engage allied health
professions who may be better equipped to address patients' evolving needs?
Reconciling these questions and complications to create a clinical model that is
responsive to patients’ and caregivers’ needs is challenging. The multi-disciplinary team
at our institution’s HD clinic seemed to alleviate some of these challenges. In contrast,
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the neuromuscular specialists described that there was not a structure in place to support a
multi-disciplinary DM1 clinic, and they differed in their beliefs about the feasibility and
utility of creating one. Further, our participants suggested that—in the absence of
disease-halting or curative treatments—that their main role was to provide hope for
patients at each stage of their disease process through education, advocacy, support, and
medical management.
We question, however, whether the traditional ‘neurologist-as-quarterback’ clinical
model described by our participants is the most efficient and effective model for
providing hope and addressing the evolving needs of patients and caregivers.
Furthermore, participants suggested that the physician’s role may become less useful as
patients deteriorate because the issues that physicians are best trained to address may not
be the issues that concern patients and caregivers most. Too often, HCPs efforts to make
a difference in patients’ and caregivers’ lives may focus on the ‘margins’ of the illness
experience – those things that are readily addressed by traditional medical models of care,
such as providing education about illness, prescribing medications to treat symptoms, and
assessing and preventing complications. We are not suggesting that these efforts are not
important. Rather, we are suggesting that these efforts may be insufficient, and may miss
critical opportunities to make a difference in patients’ and caregivers’ daily lives.
Participants in the present study recognized that nurses and allied health professionals
become increasingly more important as patients’ symptoms progress, perhaps because
their expertise is better aligned to the needs of patients and families with evolving chronic
illnesses. We therefore propose that alternate models of care and leadership, including
family health care teams, or rehabilitation or nurse-led clinics, may have merit in these
populations. Research suggests that a chronic care model for neurological conditions
should be an ‘intersectoral collaboration’ between policy makers, community members,
and the health care system (Jaglal, 2014). Moreover, multi-disciplinary, nurse-led clinics
are the standard model for other chronic disease populations including heart failure
(Strömberg et al, 2003) cancer (Moore et al, 2002), and diabetes (Denver, Barnard,
Woolfson & Earle, 2003); this research suggests that patients attending nurse-led clinics
have improved self-care behaviors and/or better outcomes. Our findings support
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Chouinard and colleagues (2009) who proposed a nurse-led model for the care of patients
with DM1. While physicians remain integral to diagnosis and treatment, we propose that
nurses are ideally suited to providing holistic, patient-centered care for patients and their
families along the disease trajectory; that is, nurses are able to monitor symptoms and
treat complications while also providing education, advocacy and on-going support.
Nurses are trained to see--and provide emotional support—to the patient and caregiver as
a unit (personal communication, Wilma J. Koopman), and may therefore be best-suited to
creating a comfortable clinic space where patients and caregivers can have their complex
biopsychosocial needs addressed.
Work is currently being done to create and assess a nurse-led, integrated clinical care
pathway for DM1 at a neuromuscular clinic in Quebec (Chouinard et al 2009, Gagnon et
al, 2010). The DM1 clinic is led by a nurse care manager (NCM) who works with an
interdisciplinary team to fulfill the essential care roles identified by our study
participants; that is, the NCM monitors symptoms, treats complications, educates, and
supports the psychosocial needs of the patient and his or her family (Gagnon et al 2008).
Moreover, several clinics for DM1 and HD in the United States are funded by patient
advocacy groups that support a multi-disciplinary group of clinicians to provide care and
present research opportunities to patients and families (Muscular Dystrophy Association,
2014; Huntington’s Disease Society of America, 2014). However, to our knowledge,
while multi-disciplinary, nurse-led or the CCM-NC clinical models show promise, they
have not yet been systematically evaluated or implemented across North America (Jaglal,
2014; Gagnon et al 2008).

7.5.1

Limitations and Future Directions

This is a small study describing the perceptions and experiences of health care providers
caring for patients with DM1 and HD at one Canadian academic centre. We recognize
that clinics and treatment approaches may vary at different locations, and our highly
contextualized study is therefore not generalizable to other settings.
Study participants described the challenges of supporting family physicians to care for
DM1 and HD in the community. We did not, however, interview any family physicians
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about their perceptions of, and approaches to, providing primary care for these
individuals. Similarly, we suggest that nurse-led clinics might be a useful model of care
for DM1 and HD patients, yet recruitment challenges and the limited number of nurses
specializing in DM1 and HD at our institution precluded greater nurse participation.
However, since care for patients with DM1 and HD is complex, future research should
explore the perspectives of nurses, family physicians and other care allied health
professionals. Finally, it is essential to understand the experiences and health care
expectations of DM1 and HD individuals and their families prior to proposing a model of
care.

7.6 Conclusion
Despite challenges providing patient-centered care, HCP participants perceive that DM1
and HD patients benefit from clinical follow-up with expert clinicians who are proactive
about managing complications, providing support, and conveying hope. However, our
findings suggest that patients’ and caregivers needs may not be sufficiently addressed by
traditional physician-led clinical models. Moreover, participants identified a need for
greater involvement from allied health professionals, and we suggest that nurses are wellsuited for enacting a holistic care approach. It may also be necessary to modify current
medical education curricula and resident training programs to ensure that clinicians are
better equipped to holistically integrate the complex needs of patients living with chronic
disease into collaborative practices. Regardless, we propose that research exploring
clinical models for patients with complex physical, cognitive and behavioral needs is
warranted. We anticipate that our findings will add to scholarly conversations about
patient-centered care for patients with complex chronic conditions, and that our findings
may resonate with-- and inform-- care practices for various patient populations who
experience unrelenting, chronic and progressive physical and cognitive decline.
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Chapter 8

8

Discussion

Patient-centered care—“care that is respectful of and responsive to individual patient
preferences, needs, and values” (Institute of Medicine, 2014)—may be challenged by
DM1-affected individuals’ complex needs (Gagnon et al, 2010; Heatwole et al, 2012),
and the lack of disease-halting or curative treatments. Limited research has explored the
perspectives of DM1-affected individuals and their caregivers, and researchers have not
yet used qualitative methodologies to explore patient-centered care provision in DM1.
Similarly, patients’ motivations for maintaining follow-up at a neurology outpatient clinic
are unknown. The relative absence of DM1 patients’ experiences in the literature
questions whether their voices are being heard or if their psychosocial needs are being
met.
Thus, the purpose of this research was to add patients’ and caregivers’ perspectives to the
literature and to explore how patient-centered care provision for DM1 is perceived—and
if it is feasible—at one academic centre in Ontario, Canada. Three qualitative
methodologies were used to illuminate patients’ and caregivers’ experiences living with
DM1 (Chapters III and IV), their health care expectations, and their motivations for clinic
attendance (Chapter VI). Individuals living with Huntington’s disease and their
caregivers were purposively sampled to increase the breadth and depth of the experiences
of clinical care for patients with inherited and life-limiting neurological conditions
(Chapter VI). I also explored health care providers’ perspectives about providing care for
these patients and families (Chapters VI; Chapter VII). Findings from this research
suggest that there are numerous challenges—and rewards—to effective patient-centered
care provision for DM1 and HD. However, most patient, caregiver and HCP participants
perceived that affected individuals and their families receive tangible benefits from
maintaining follow-up at a neurology outpatient clinic. Patient and caregiver participants
described being proactive seekers of information and care, and they conceptualized the
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neuromuscular and movement disorders clinics at our institution as a ‘safe place’ (Figure
8-1).

Figure 8-1: Clinic is a “Safe Place”

8.1
8.1.1

What is Already Known
Myotonic Dystrophy (DM1)

DM1 is a multi-system disorder that is characterized by an unrelentingly progressive and
devastating disease course. The muscular, cardiac, respiratory, endocrine,
gastrointestinal and central nervous systems are affected, and primary clinical
manifestations include progressive muscle weakness, muscle stiffness due to delayed
relaxation (myotonia), arrhythmias, excessive sleepiness, early-onset cataracts, and
cognitive and behavioral manifestations, namely low IQ and apathy (Harper, 2001). In
particular, “the general clinical impression in most cases is one of apathy, decreased
emotional participation, and psychomotor delay” (Meola & Sansone, 2007, p. 296), and
there is a well-recognized DM1 personality pattern described in the literature (Winblad,
Lindberg & Hansen, 2005). In particular, “a TCI (Temperment and Character Inventory)
based portrait of the average DM1 patient, then, is that of a private, introverted individual
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with little self-esteem, burdened by fatigue and low energy” (Winblad, Lindberg &
Hansen, 2005, p. 290). While it is unknown if the emotional symptoms are a reaction to
the disease process or an organic part of the disorder caused by central nervous system
lesions (or both), it is important for health care providers to assess cognitive and
behavioral impairments because they may have a significant effect on an individual’s
quality of life (Bungener, Jouvent & Delaporte, 1998).
Qualitative and quantitative inquiries have described the impact of DM1-affected
individuals’ physical, cognitive and emotional symptoms on social participation
(Gagnon, Mathieu & Noreau, 2007; Gagnon et al, 2008), their relationships (Cup et al,
2011), and their quality of life (Laberge et al, 2013)). Care for DM1-affected individuals
may be challenged by their variable symptom presentations (Heatwole, 2012; Gagnon et
al, 2010) lifestyle risk factors and challenges engaging in health promotion behaviors
(Gagnon et al, 2013). Apathy and disinterest in their health have been attributed causality
for missed clinical appointments (Meola & Sansone, 2007) or failure to adhere to
treatment recommendations (Chouinard et al, 2009). Guidelines for DM1 care have been
proposed (Gagnon et al 2007, Chouinard et al, 2009), but these have not yet been
systematically implemented or evaluated. Potentially, one of the main challenges facing
the implementation and evaluation of patient-centered care provision is the lack of a
uniform conceptualization or definition of what ‘patient-centered’ care is and how it is
applied in practice. In particular, clinicians and researchers debate the feasibility,
achievability and desirability of taking a patient-centered care approach (Berwick, 2009).

8.2

What Participants Have Taught Us

8.2.1

Challenges to providing patient-centered care for individuals
with DM1

While participants described that on-going clinic attendance is beneficial for DM1affected individuals and their caregivers, this research uncovered several challenges to
patient-centered care.

205

8.2.1.1

Variable knowledge

Studies describe that DM1 patients’ have variable understanding about their condition
(Laberge et al, 2010; Faulkner, 1998) and I speculate that this impacts clinical practice.
Our findings suggest that while some participants were well-informed about their
condition and were able to articulate their symptoms, some individuals accepted
misinformation about DM1 as fact—particularly in regard to genetic information—that
they in turn used to make important decisions (Chapter V). This occurred despite formal
genetic counseling consultations and discussions during clinic visits. Previous research
suggests that individuals with DM1 either do not accept their diagnosis or do not
understand the hereditary ramifications of their condition (Nätterlund, Sjöden &
Ahlström, 2001). These findings resonate with the present research, but we suggest that
poor understanding of chronic health conditions is not specific to DM1; in particular,
patients with other chronic health conditions may also have difficulty synthesizing and
understanding complex genetic information (McKibbin et al, 2014). It may therefore be
necessary to assess patients’ knowledge at each clinic visit, or to provide patients with
more frequent follow-up—perhaps with a nurse or social worker—to provide ample
opportunity for patients to ask questions and to resolve knowledge gaps.

8.2.1.2

Striking a Balance: Providing Care for Patients with
Chronic Neurological Conditions

Findings from Hard to Swallow (Chapter III) and Picturing the Experience (Chapter IV)
resonate with previous literature suggesting that patients and clinicians may have
divergent clinical care goals (Heatwole et al, 2012). While speculative, it appears that
patients and caregivers focus primarily on symptoms that impact their daily activities and
quality of life (Chapter III, Chapter IV), while clinicians focus on symptoms that either
have the potential to cause serious complications or result in sudden death, and/or those
that they are able to treat. Some of the caregivers in the Hard to Swallow study were
perplexed that I was interested in studying dysphagia since they perceived that their loved
one had to face far more troubling symptoms like weakness and fatigue. Similarly, none
of the patient participants in the Picturing the Experience study volunteered swallowing
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dysfunction as one of their troubling symptoms, and only reflected on it when asked
direct questions about their diet. It is possible that dysphagia develops slowly and
individuals are therefore able to compensate for their swallowing problems by developing
strategies like avoiding certain foods, regurgitating objects or having liquids with meals.
We speculate that caregivers’ lack of concern mirrors their loved one’s attitudes about
swallowing dysfunction; that is, swallowing is—in essence—not on patients’ or
caregivers’ ‘radar’ because patients have found ways to cope with, or adapt to this slowly
progressive symptom. In contrast, weakness and fatigue significantly impacted
participants’ ability to work or participate in recreational or leisure activities. This
finding resonates with previous research that describes symptom impact on DM1-affected
individuals’ social participation (Gagnon, Mathieu & Noreau 2007; Gagnon et al, 2008)
and health related quality of life (Antonini et al, 2006; Peric et al, 2010; Laberge et al
2013). Cup et al (2011) also described the impact of chronic neuromuscular conditions
on the marital relationship and on caregivers’ quality of life (Geirdal, Lund-Petersen &
Heiberg, 2014). Our caregiver participants’ described having to prod loved ones to leave
the house, exercise or participate in social activities. Some caregivers also described that
their loved ones’ fatigue impacted their relationship; that is, individuals with DM1 were
either too tired to participate in activities, or they would fall asleep at inappropriate times
– sometimes in the middle of a conversation.
We speculate that physician-led clinical care models typically address diagnosis and
treatment; consequently patients’ and caregivers’ educational and psychosocial needs
may not be sufficiently managed. HCP participants described that allied health
professionals should become more involved in care as patients’ symptoms progress
(Chapter VII); we therefore suggest that there is a need for a holistic clinical approach
that addresses patients’ symptoms and emotional needs while supporting patients and
families with their daily challenges.

8.2.1.3

Adapting the care plan across the disease trajectory

Findings suggest that clinical care evolves throughout the patients’ disease trajectory
(Chapters VI and VII). This may occur not only because of progressive functional
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decline, but also because of the emotional difficulty patients may experience as they
adjust to their diagnosis and their shifting identity (Chapter IV; Nätterlund, Sjöden &
Ahlström, 2001). Patients, caregivers and HCPs described that patients’ and caregivers’
motivations for clinic attendance changed over time. Moreover, while HCPs described
having a ‘template’ for clinic visits, it was evident that they adapted their approach based
on a patient’s stage of disease and his or her cognitive or behavioral abilities.
Despite the lack of disease-halting or curative treatments— and other HCP-identified
challenges providing patient-centered care for individuals with DM1 (and HD)— all
participants described that patients and caregivers experience tangible benefits from ongoing clinical care. Findings from an exploratory study in the United Kingdom that
examined the experiences of patients attending a neuromuscular disease rehabilitation
centre found that patients attend clinic to obtain knowledge and understanding about their
condition from experts, and to receive community support from individuals with similar
conditions (Hartley, Goodwin & Goldbart, 2011). In turn, the rehabilitation centre may
become a place of “empathy” that can provide hope for patients (Hartley, Goodwin &
Goldbart, 2011).
However, ‘hope’ was not universally experienced by patients; instead, patient and
caregiver participants seemed to attend clinic to be understood, and to collaborate with
experts to educate the general and medical communities. Participants were aware that
there was likely little that could be done to help them; consequently, participants wanted
to help future generations by collaborating with experts to work toward therapeutic
advancements and ‘fight’ for a cure. This resonates with the experiences of patients with
other chronic illness (Karlawish, Casarett & James, 2002; Tong et al, 2008 , Madsen,
Holm & Riis, 1999) but was perhaps an unexpected finding given the literature that DM1
patients may lack awareness or motivation (Chouinard et al, 2009; Meola & Sansone,
2007).
The idea of clinic as a place of hope may therefore need to be re-considered; instead, we
suggest that clinic be conceptualized as a place to empower patients through education
and collaboration. For example, patients and their families may not fully appreciate the
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implications of their life-limiting symptoms, so clinic is an ideal—and perhaps safe—
place for experts to educate patients and their families, and engage them in conversations
about self-management. Clinic visits are an also an opportunity for HCPs to collaborate
with patients to advocate for research or to educate medical and other health professional
students and the general public about these uncommon illnesses.

8.2.2

Being Proactive

Despite challenges, the patients at the centre of the care at our institution demonstrated
that they actively seek information about their condition and opportunities to make a
difference for future generations. This research found that, in general, the patient
participants attended their clinic appointments and were interested in their health.
Most participants in the studies described in Chapters III-VII were actively engaged and
articulate about the impact of symptoms on their daily lives and their health care
expectations. I recognize that individuals with DM1 have variable disease presentations,
and that our research participants were purposively recruited. However, we speculate
that—in general—DM1-affected individuals’ physical appearance and speech
impairments may cause them to be unfairly labeled by the general public or health care
providers. Participants in this research perceived that they were judged by members of
their community. This resonates with previous muscular dystrophy literature that
suggests that individuals living with different forms of muscular dystrophy experience
judgment, shame or stigma (Boström & Ahlström, 2004). However, the photovoice
participants described that they found solutions for coping with their shifting identity and
for managing the challenges of everyday activities. Participants were resilient, and
problem-solved solutions for daily challenges like opening doors, jars or bottles, and
participants were also able to mitigate difficulties with study procedures. For instance,
participants recruited friends or caregivers to assist them with picture taking, participate
in their individual interview, or transport them to the clinic visit.
Patients were not only active research participants, but also active in deciding if and
when to seek health information and social support (Chapter VI). Some chose not to
attend support groups or to read about DM1, while others actively sought information
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from medical journals and patient advocacy groups (Chapters III-VI). Participants took
their role as patient educators seriously; that is, participants stated that their clinic
attendance taught HCPs about their uncommon, variable and unpredictable condition
(Chapter VI). A qualitative analysis of interviews and focus groups conducted with 30
patient educators/mentors living with arthritis found that sharing their stories with health
professional students helped them “reframe” their illness from a negative experience into
something that makes a positive contribution to student learning. In turn, the patient
educators believed that their contributions may improve the wider health care system
(Laukner, Doucet & Wells, 2012). Similarly, our participants valued their own
expertise, and took it upon themselves to educate non-specialist clinicians or members of
the public by giving them information about DM1 or participating in patient advocacy
groups (Chapters III-VI). One of our study participants is a leader in the DM1 patient
advocacy community, and another shared his pictures and experiences with a graduate
class in occupational therapy to teach future clinicians about DM1.

8.3 What This Research Adds
This research is the first to explore caregivers for individuals with DM1 and dysphagia,
collaborate with participants using photovoice, and include the perspectives of patients,
caregivers, and HCPs about the expectations and motivations for ongoing clinic
attendance. While the experiences of caregivers for individuals with muscular dystrophy
have been explored, these studies did not specifically address the experience of providing
care for an individual with dysphagia. Moreover, caregiving for DM1-affected
individuals has not previously been explored in the context of caregivers’ lived time,
space, bodies and relationships. This work contributes to a deeper understanding of the
perspectives of providing care for individuals with DM1, and supports previous research
suggesting that symptoms that clinicians prioritize are not necessarily those that are most
concerning for individuals with DM1 and their caregivers (Heatwole et al, 2012).
This research used photovoice—a novel and innovative qualitative methodology— to
engage DM1-affected individuals as research collaborators. The visual representation of
patients’ perspectives of their illness experience—including their knowledge and
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misperceptions about DM1 (Chapter IV)—is a novel contribution to the literature. This
research also contributes photographic representations of DM1 patients’ problem-solving
techniques and provides insight into how they cope with the challenges of daily activities.
Previous research has explored European neuromuscular disease patients’ experiences of
attending a rehabilitation centre (Hartley, Goodwin & Goldbart, 2011); however, our
research advances this work by contributing an exploration of patients’, caregivers’ and
health care providers’ perceptions of health expectations and motivations for on-going
clinic attendance across the disease trajectory. To our knowledge, DM1 and HD have not
previously been explored together to provide a greater sense of the experiences of
patients living with genetic, life-limiting neurological conditions. The idea that patients’
and caregivers’ motivations for clinic attendance change over time has also not been
reported. From this research, we learned that DM1 and HD individuals and their
caregivers are proactive about managing patients’ health, and are driven by symptomatic
management, altruism, and reassurance. In particular, they look for information and
social support in a clinical context that they experience as ‘safe’. Previous work has
described a neuromuscular clinic as a place of “empathy” (Hartley, Goodwin & Goldbart,
2011) that provides supportive care (Gagnon et al, 2010). However, DM1 and HD
patients’ and caregivers’ conceptualization of clinic as a ‘safe place’ is a novel finding.
This research contributes that—in the absence of disease-halting or curative
pharmaceutical therapies—clinic attendance for these individuals is considered treatment.
To our knowledge, neither HCPs descriptions of their roles caring for patients with DM1
and HD, nor the challenges and rewards of patient-centered care for this population, have
previously been reported. HCPs describe patient-centered care for DM1 and HD as a
‘balancing act’ in which HCPs have to balance (1) patients’ medical and psychosocial
needs, (2) their sense of futility that their best efforts will not prevent patients from
deteriorating, (3) their rewards for caring for these individuals (4) and the need to be a
patient advocate while addressing caregivers’ concerns. Hope might be expected as a
dominant theme and has been suggested as a reason for creating neuromuscular disease
clinics (Hartley, Goodwin & Goldbart, 2011), and here, HCPs identified providing hope
as one of their main roles in the care of these individuals. However, hope was not
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universally experienced—or sought—by patients and their caregivers. Instead,
participants appeared more interested in proactively seeking reassurance that they were
being cared for, and that they were collaborating with HCPs to find answers to their
uncommon conditions. Our novel research findings suggest that maintaining clinical
follow-up empowered participants to exert control over their unpredictable illness.
Clinicians and researchers may therefore need to rethink assumptions about what patients
may want from their care, and perhaps offer patients opportunities—including research,
education or advocacy roles—that will enable them to make tangible contributions to
their health. Finally, perhaps the most novel and significant contribution of this work is
that it has identified that individuals with DM1 are proactive research participants and
collaborators, advocates and educators.

8.3.1

Implications

Findings from this research have started to change practice. One clinician noted that
seeing the photographs and reading participants’ experiences from the Picturing the
Experience (Chapter IV) study was the first time that she felt that she understood and
‘knew’ her DM1 patients. Prior to reading the manuscript, this clinician had difficulty
identifying whether patients were interested in participating in clinic or whether they
fully grasped the implications of DM1. However, the photovoice study gave this
clinician a tangible ‘picture’ of patients’ lives, and she was therefore better able to
understand how patients cope with their condition.
Another clinician stated that she altered her approach to clinic visits after reading the
Hard to Swallow manuscript. Previously, this clinician had devoted a significant amount
of clinic time to addressing dysphagia at each visit and discussed the importance of diet
and swallowing studies. After reading the paper and discovering that swallowing function
may not be what patients and clinicians want to spend clinic time addressing, this HCP
altered the approach and switched the focus from discussing potential complications to
ensuring that patients knew how to safely manage a choking episode (i.e. “what is the
universal sign for choking?” “do you know the Heimlich maneuver?”).
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8.3.1.1

Considerations Using Qualitative Research for
Exploring DM1

Relatively few studies have qualitatively explored individuals living with myotonic
dystrophy, and it is unknown if patients’ cognitive and behavioral impairments have
impacted the lack of patient-centered research in this population. However, interviews
with DM1 individuals were excluded from previous research because patients’ speech
impairments complicated interviews, and the researchers’ perceived that were not able to
reflect on their condition (Nätterlund, Sjöden & Ahlström, 2001). There were challenges
using these methodologies in DM1 including (1) difficulty conducting and transcribing
interviews with patients’ with speech impairments, (2) fatigue precluding participation,
and (3) participants’ challenges with problem-solving. For example, it was difficult to
conduct and transcribe an interview for a participant with dysarthria, one participant
withdrew from photovoice because of fatigue, and two participants were unable to use the
digital cameras. However, the benefits of using qualitative methodologies and methods
with DM1-affected individuals were considerable. All participants—regardless of their
symptom presentation and challenges complying with study procedures—had keen
insights into their condition and the impact of symptoms on their daily lives. They also
were able to articulate their strategies for proactively managing their condition and
discussing their health care expectations. I am confident that qualitative research methods
and methodologies are appropriate and useful for adding DM1 patients’ voices to the
literature. All participants were enthusiastically engaged in the research process, and
some appreciated having the opportunity to share their stories and educate researchers
and clinicians about DM1:
It (research study) gives them an idea of what it’s like and learn that it’s not all
negative and that … like I say, you don’t know what it’s like unless you live it,
but to take pictures you can see what my life is like. Not all negative, but not all
positive either. Yeah, it’s a good idea (Photovoice Participant 4).
The greatest challenge of using qualitative research came not from patient participants,
but from trying to have their voices included alongside those of basic scientists and
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clinicians in academic medical journals. Previous research has explored the limited
proliferation of qualitative research in these journals (Gagliardi & Dobrow, 2011; Shuval
et al, 2011). Two medical journals declined to send our photovoice article for peer
review; one editor stated that their journal “did not publish this kind of work” and another
sent a thoughtful email in which he expressed his personal interest in our manuscript but
stated that financial limitations and page restrictions prevented him from publishing
“sociological” work. Given that ‘patient-centered’ care is a ‘hot topic’ in medical
education and care provision, it is puzzling that medical journals are reluctant to publish
qualitative work that directly reflects patients’ and caregivers’ experiences. However, we
suspect that this is not an uncommon experience despite calls for greater inclusion of
qualitative work in medical journals (Malterud, 2001), and discussions about the
importance and usefulness of qualitative methodologies for exploring neurological
conditions (Macdonald & Chalk, 2011). I have argued throughout this research that
patient-centered care cannot be examined without exploring patients’ experiences and
needs. Qualitative research is well-suited to this, and steps—including educating the
wider medical community about the value and rigor of qualitative inquiry, finding
reviewers skilled in qualitative research for scientific journals, and creating better funding
opportunities for qualitative research—need to be implemented in order for qualitative
research to become more widely-distributed (Krumholz, Bradley & Curry, 2013).

8.3.1.2

Future Directions

The theme of ‘patients (and caregivers) as educators’ was identified across my research
studies, and this is an important area for future exploration, particularly since anecdotal
evidence suggests that two clinicians changed aspects of their practice based on patients’
and caregivers’ perspectives. A modified grounded theory analysis of 356 second year
medical students’ written reflections about the role of patient educators in their
undergraduate medical education found that patient educators enabled students to see
chronic disease in context with patients’ lives. In turn, they were better able to
understand the complexities of patient-centered care. Students viewed patient educators
as experts and collaborators who enhanced their medical education (Oswald, Czupryn,
Wiseman & Snell, 2014). Therefore, I suggest that patients should be encouraged to
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speak to medical and other health professional students, and participate in medical rounds
presentations with consultant specialists. In particular, future studies might pair medical
students with patients to conduct or evaluate research.
However, while some DM1 participants described themselves as educators who were
responsible for teaching the general public or non-specialist HCPs about their uncommon
condition (Chapter IV; Chapter VI), they had variable understanding about their DM1
(Chapter V). We identified knowledge gaps—particularly in regard to genetic
information—but we did not formally assess participants’ health literacy. Since poor
health literacy can negatively affect patients’ health outcomes (DeWalt et al, 2004), a
formal assessment of health literacy in DM1 is warranted.
Similarly, patients and caregivers may lack awareness about the implications of their
symptoms; consequently, patients’, caregivers’ and HCPs’ goals may not align. This
raises important questions about how clinicians can address issues that may contribute to
morbidity and mortality while addressing concerns that are important to patients and their
caregivers. I suggest that the first step is to continue to ask patients what is important to
them and to disseminate this information to clinicians and researchers; in turn, additional
research and better education for patients, caregivers and clinicians is necessary to
highlight the issues of concern and develop innovative ways to create patient education
materials or other educational initiatives. For example, including participants’
photographs in educational materials may be a novel way to share coping strategies with
the DM1-patient community. Further, nurses and allied health professionals may close
some of the gaps by addressing psychosocial concerns while physicians provide medical
surveillance.
This research suggests that patient-centered care in DM1 warrants further investigation
and focus the role of caregivers in clinical care. It may therefore be important to re-frame
the conceptualization of ‘patient-centered’ care to one that is ‘patient and family
centered’. In particular, I question whether the physician-led clinical care model at our
academic centre is the most efficient approach for meeting patient and caregiver
participants’ complex needs. Findings suggest that physicians may provide care on the
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‘margins’ of the illness experience; that is, they are able to provide education and
symptomatic management, but HCP participants identified that they have limited time—
and perhaps training—to address psychosocial needs. While physicians are integral to
DM1 patient care, I speculate that consolidated clinic models—such as family health care
teams, rehabilitation centres or nurse-led clinics—may be important to explore. An
integrated care pathway led by a nurse care manager (NCM) in Quebec has been
evaluated, and findings suggest that the NCM provides systematic, comprehensive and
evidenced based follow-up to DM1-affected individuals. This evaluation of the NCM is
a first step to developing the role of nursing at other neuromuscular clinics, but has not
yet been formally implemented or evaluated at other centres (Gagnon et al, 2010).

8.3.2

Trustworthiness

A number of strategies can be used by qualitative researchers to establish the
trustworthiness of their findings. Guba & Lincoln (1985) suggest that trustworthy
qualitative research demonstrates credibility, transferability, dependability and
confirmability. We used several of the approaches described by Shenton (2004) to ensure
that these criteria were met. Member checking, an iterative data collection and analysis
process, and peer debriefing and review were used to ensure that we represented a “true
picture” (Shenton, 2004, p. 63) of participants’ experiences (credibility). Member
checking was part of the iterative data collection and analysis process; that is, questions
were added to the semi-structured interview guides to probe themes identified in early
interviews (Chapter III, IV and VI). We were therefore able to determine whether
experiences resonated with multiple participants; in addition, we purposively recruited
two participants for the photovoice study (Chapter IV) to add their perspectives and to
review preliminary study findings with them. Additionally, the research team met
frequently to discuss the analysis; any discrepancies were resolved by consensus. Finally
three of the studies have been peer reviewed (Chapter III; Chapter VI; and Chapter V);
one has been accepted (Chapter III), one accepted with revisions (Chapter IV), and one
invited for further consideration (Chapter V). Transferability—rather than
generalizability—is the goal of qualitative inquiry. We ensured that readers have enough
information to evaluate resonance and whether findings can be applied to another setting
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by providing a detailed description of the research context and participants. In addition,
there is an extensive audit trail of each study that details the data collection and analysis
procedures; other researchers can therefore recreate our studies (dependability), although
we anticipate that the co-construction of findings from different researchers and
participants might produce different interpretations. Finally, a combination of previously
mentioned strategies—including a detailed audit trail, member checking and iterative
data collection and analysis—ensures that our findings were identified through rigorous
and emergent research (confirmability).

8.4 Conclusion
This research sought to explore the experience of living with—and providing care for—
DM1; three qualitative research methodologies were used to examine questions
pertaining to lived experience and patient-centered care provision. The objectives of this
research (1) to add patients and caregivers voices to the literature and (2) explore health
care expectations and motivations for on-going clinic attendance to add to scholarly
conversations about patient-centered care provision in DM1 have been met. Patients and
caregiver participants were proactive about seeking health information, managing their
care, and were engaged research collaborators. While care for DM1 patients is
complicated by their variable symptom presentations, the lack of disease-halting or
curative treatments, and limited time to address patients’ and caregivers’ psychosocial
needs, findings suggest that patients and caregivers benefit from regular clinical care.
Findings have important implications for patient-centered care provision in DM1; that is,
we have identified that current physician-led clinical models at our academic centre may
not be meeting the complex biopsychosocial needs of individuals with DM1, and we
suggest future avenues for research. Moreover, the variable definitions and
conceptualizations of patient-centered care make it difficult—if not impossible—to
evaluate current models. Therefore, a unified patient-centered care definition—based on
the experiences of patients, caregivers, and clinicians—needs to be devised, implemented
and evaluated; qualitative research is well-suited to this inquiry.
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